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Abstract 
Phorbaketal A (I) and phorone A (II) are members of a growing family of 
biologically active sesterterpenoid natural products, derived from marine sponges.  
These compounds possess potent biological activities and intriguing molecular 
architectures, which have inspired efforts towards their total synthesis. 
 
 
Early work in this thesis describes how new methodology is developed aimed at the 
synthesis of phorbaketal A (I).  The synthesis and subsequent treatment of the model 
hydroxyphenol III with PhI(OAc)2 led to the development of a new method for 
spiroketal synthesis via cascade oxidative dearomatisation. 
 
 
This new spiroketalisation method was then further elaborated for the total synthesis 
of phorbaketal A (I). This required the construction of the noralotane carbon skeleton 
IV, employing the union of the aryl aldehyde V and the propargylated geraniol VI.  
Treatment of the noralotane IV with PhI(OAc)2 gave the spiroketal VIII as a 
complex mixture of labile diastereomers. This new method for spiroketalisation 
ultimately proved unsuitable for the total synthesis of these spiroketal natural 
products. Following this, attempts at expanding the substrate scope for this new 
oxidative dearomatisation method were explored for the formation of a range of 
saturated spiroketals.  
v 
 
 
The second part of this thesis describes efforts towards the total synthesis of the 
related sesterterpenoid natural product phorone A (II). Considerable synthetic effort 
led to synthesis of the novel (Z)-bromoalkene IX and the drimane aldehyde X, which 
were coupled to give the ansellane alcohol XI, in a total of 17 steps.  This work 
represents the first ever synthesis of the ansellane skeleton.  Efforts to oxidise and 
cyclise the alcohol XI were initiated; however difficulties with eliminative 
dehydration prevented its conversion to phorone A (2). The final work in this thesis 
describes alternate coupling methods aimed at circumventing these unforeseen 
issues.    
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1. Introduction 
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1.1 Total Synthesis of Natural Products 
The science and art of total synthesis continues to captivate and inspire scientists. 
Conceived in 1828 with F. Wöhler’s synthesis of urea (1),1 this Science saw rapid 
growth during the 20
th
 century, with outstanding chemists such as Nobel laureates R. 
B. Woodward and E. J. Corey making ground-breaking contributions to the field 
(Figure 1).
2
 Often inspired by the graceful way in which Nature constructs complex 
organic frameworks, this discipline acts to push forward the boundaries of synthetic 
organic chemistry. 
 
Figure 1 - Total synthesis of urea (1)
1
,
 
quinine (2)
3
 and prostaglandin F2α (3)
4
 
This ability to synthesise biologically active compounds has had a momentous 
impact upon medicine. The synthesis of natural products and their derivates plays a 
key role in drug discovery and development today. Success in achieving the total 
syntheses of biologically active compounds has particular advantages in offering a 
reliably large supply of a rare compound, allowing for detailed structure–activity 
relationship (SAR) studies and lead optimisations.
5
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1.2 Marine Natural Products 
It is often remarked that we know more about the surface of the moon than we do the 
oceans on Earth. Since more than 70% of our planet is covered by oceans, marine 
organisms provide a considerably large and unexplored bioresource for drug 
discovery.
6
 The sedentary lifestyle adopted by many marine organisms requires them 
to often produce highly toxic secondary metabolites as a means of defence against 
predators.
7
 Such secondary metabolites and their derivatives have been used for the 
treatment of many diseases, most notably for the treatment of various cancers. Over 
the past decade several marine natural products and their derivates have been 
identified and approved or in clinical trials as anti-cancer drugs.
8
  
An example is synthetic compound E7974 (4), a derivative of marine natural product 
hemiasterlin, which is now under phase I clinical trials as an anti-tumour drug 
candidate (Figure 2).
9
  Upon the isolation of halichondrin B (5) from sponge H. 
okadai, this 32 chiral centre bearing natural product was found to have potent 
cytotoxicity against cancer cell lines.
10
 However, clinical trials of 5 as an anti-cancer 
drug were abandoned due to issues in sponge supply.
11
 If 5 had become a successful 
drug, multi-tonne quantities of the sponge would have been required annually, 
inevitably causing significant environmental disruption. However, after SAR studies, 
the more potent and chemically simplified synthetic compound eribulin mesylate (6) 
was designed, which is now a US FDA (Food and Drug Administration) approved 
drug for the treatment of breast cancer.
12
 
4 
 
 
Figure 2 - E7974 (4); halichondrin B (5); eribulin (6) anti-cancer drug 
 
1.3 Sesterterpenoids 
Sestertepenoids are a class of terpenoid that have been isolated from various sources 
in nature including fungi, insects, plants and marine species.
13
 They are constructed 
of five isoprenyl units, bearing C25 carbon skeletons (Table 1).  
Table 1 - Nomenclature of terpenes  
 
 
 
 
 
Although the rarest class of terpenoid, consisting of only around 1000 known 
compounds,
14
 the sesterterpenoid class of natural product exhibits diverse structures 
 Number of Isoprenyl Units 
Hemiterpenes 1 
Monoterpenes 2 
Sesquiterpenes 3 
Diterpenes 4 
Sesterterpenes 5 
Triterpenes 6 
Tetraterpenes 8 
5 
 
with a range of biological properties.
15
 The first ever identified sesterterpenoid was 
ophiobolin A (7), isolated in 1965 from the terrestrial fungus Ophiobolus 
miyabeanus, and later shown to exhibit nanomolar toxicity towards certain cancer 
cell lines.
16
 Manoalide (8) is a potent analgesic and anti-inflammatory isolated 
initially from the marine sponge Luffariella variabilis in 1980.
17
 The scalaranes are a 
relatively large family of biologically active sesterterpenoids; the recent isolation of 
several cytotoxic scalaranes including similan A (9), from the Thai marine sponge 
Hyrtios gumminae has been reported.
18
 
 
Figure 3 - Example sesterterpenoid natural products 
With the vast number of possible arrangements of a C25 framework, sesterterpenoids 
have unsurprisingly presented many new carbon skeletons. A new biosynthetically 
related family of sesterterpenoids derived from marine sponges has emerged over 
recent years, exhibiting exciting structural diversity and biological properties.  
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1.4 Alotane Derived Natural Products 
An ever-expanding family of biosynthetically related sesterterpenoid marine natural 
products possess a number of newly identified carbon skeletons. The first disovered 
of this family being the alotane carbon skeleton (10), in 2009 by Andersen et al., 
with the isolation of the 6,6-spiroketal containing alotaketals A (11) and B (12) from 
the Papau New Guinean marine sponge Hamigera sp.
19
 This was shortly followed by 
the reported isolation of the related phorbaketals A, B and C (13–15), from the 
Korean marine sponge Phorbas sp., by Rho and co-workers (Scheme 1).
20
 
The alotane carbon skeleton (10) is biosynthetically derived from partial cyclisation 
of geranyl farnesyl pyrophosphate (16), in the formation of a six-membered ring. It is 
proposed that processes to oxygenated intermediates e.g. 17, are followed by 
spiroketalisation processes towards the alotaketal and phorbaketal frameworks.   
 
Scheme 1 - Biosynthesis of the alotaketals A, B (11, 12); phorbaketals A−C (13–15) 
7 
 
Skeletal rearrangements of the alotane carbon skeleton (10) give rise to a number of 
other recently discovered sesterterpenoid skeletons including the ansellane (16),
21
 
phorane (17),
22
 phorbasane (18)
23
 and isophorbasane (19) skeleton groups of natural 
product (Figure 4).  
 
Figure 4 - Carbon skeletons deriving from the alotane  carbon skeleton (10) 
It is proposed that the trans-decalin systems possessed by the ansellane (16) and 
phorane skeletons (17) are formed via cyclisations of farnesyl tethers (Scheme 2). 
With the formation of the trans-decalin intermediates e.g. 20, cyclisation processes 
may occur in the formation of various ansellane skeleton bearing natural products 
e.g. cyclisation steps to form ansellone A (21) or ansellone B (22).
*
 
Alternatively, aromatisation of the cyclohexenone ring leads to aromatic ring 
intermediates e.g. 23, which are prone to intramolecular electrophilic aromatic 
substitution processes e.g. in the formation of phorone A (24). Alternative 
----------------------------- 
* There are mistakes in the lettering of ansellones (A−F) in the literature. The author  
has reassigned them in chronological order of discovery. Ansellones A−D were 
correctly assigned by J. Daoust in her PhD thesis, University of British Columbia, 
2005. Ansellone E (previously ansellone B) in Org. Lett., 2012,  14, 4486−4489; 
ansellone F (previously ansellone C) in J. Nat. Prod., 2015, 78, 218–224.  
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nucleophilic attack from an acetate ion may result in the formation of ansellone E 
(25).  
 
Scheme 2 - proposed biosynthesis of various alotane derived sesterterpenoids 
This alotane carbon skeleton derived family of sesterterpenoids have shown 
consistent expansion throughout the course of the work described in this thesis. They 
have emerged as a family of exciting biologically active metabolites, displaying a 
broad range of biological properties. Amongst this family, a large number of 
alotaketal and phorbaketal natural products have now been identified.  
1.5 Alotaketals and Phorbaketals 
As previously mentioned, the isolation of alotaketals A and B (11, 12) from marine 
sponge Hamigera sp. was reported by Andersen and co-workers in 2009.
19 
This 
9 
 
discovery was shortly followed by the reported isolation of the structurally similar 
phorbaketals A, B and C (13–15) by Rho and co-workers from the Korean marine 
sponge Phorbas sp.
20 It was found that these natural products displayed intruiging 
biological properties, which probably acted to spur on isolation of many other related 
natural products.  
 
Figure 4 - Isolation of alotaketals (A and B) and phorbaketals (A−C) 
 
In 2013, Wang et al. reported the isolation of phorbaketals D–K (26–33)24 from the 
South Korean marine sponge Monanchora sp. (Figure 5).  This was followed by the 
reported isolation of phorbaketals L–N (34–36)25 from marine sponge Phorbas sp. in 
2014. Additionally, alotaketal C (37) was isolated from the same marine sponge 
species in 2013.
24
 Seemingly also derived from the alotane carbon skeleton, the 
related gombaspiroketals A–C (38-40)26 should be noted, being isolated very recently 
from the sponge Clathria gombawuiensi.  
10 
 
 
Figure 5 - Phorbaketals D–N (26–36); alotaketal C (37); gombaspiroketals A–C (38–
40) 
Some of these alotaketal and phorbaketal analogues have demonstrated intruiging 
biological properties. It seems that this ever-growing family of natural products 
provide an exciting opportunity for drug development investigations into the 
treatment of a range of diseases and also for use as important biological tools.  
1.5.1 Biological Properties of Alotaketals and Phorbaketals 
Currently the diterpenoid forskolin (41) is strongly relied upon as a biological tool to 
provide increased intercellular levels of cyclic adenosine monophosphate (cAMP) 
(42) by activation of adenylyl cyclase.
27
 The enzyme adenylyl cyclase facilitates the 
conversion of adenosine triphosphate (ATP) (43) to cAMP (42) (Scheme 3). The 
formed cAMP can bind to cAMP dependent protein kinase (PKA) resulting in an 
11 
 
increased rate of the phosphorylation of certain proteins. These proteins are often 
important for cellular functions such as gene transcription or ion channels. Small 
molecules that can alter intercellular levels of cAMP thus have important effects 
within the cell, making them powerful biological tools.  
 
Scheme 3 - Forskolin (41) for increased levels of cAMP (42) 
As a result of its bioactivity, forskolin (41) is a commonly used biological tool for 
investigating the role of cAMP in cellular processes.
28
 In particular, increased levels 
of cAMP are known to potentiate the differentiation of stem cells into dopamine 
producing neuron cells, and so forskolin (41) is an important tool in the development 
of potential neurodegenerative disease (e.g. Parkinson’s disease) treatments.29  
It has been found that alotaketals A and B (11, 12) activate the cAMP pathway, with 
identified EC50 (the concentration giving 50% maximum effectiveness) values of 18 
and 240 nM respectively.
19
 Remarkably, it was found that alotaketal A (11) is in fact 
170 times more potent than forskolin (EC50 3 µM) for activation of the cAMP 
signalling pathway (Table 2). Hence, alotaketal A (11) has potential utility as an 
12 
 
attractive replacement to forskolin (41), which is expensive
*
 due to its scarcity in 
nature and has greater structural complexity.  
 Table 2 - cAMP pathway activators 
 
 
 
The phorbaketals have also displayed various striking biological activities. It has 
been identified that phorbaketal A (13) acts to promote osteogenic differentiation in 
human mesenchymal stem cells, suggesting its potential use in drug discovery 
towards treatments for the progressive bone disease osteoporosis. Added to this, 
phorbaketal A (13) has also displayed inhibition of adipocyte differentiation and fatty 
acid synthesis in the liver, indicating its potential use in the drug discovery of obesity 
treatments.
30 
 
Phorbaketals H (30) and I (31) have been shown to exhibit weak cytotoxicity against 
renal cancer cell lines.
24 
More strikingly, phorbaketal N (36) has displayed potent 
cytotoxicity against human pancreatic cancer cell lines. It has been proposed that 
phorbaketal N (36) could assist discovery of much needed drug leads for the 
treatment of pancreatic cancers.
25 
Due to these potentially very useful biological activities, there has been interest in 
the total synthesis of the alotaketal and phorbaketal natural products. 
Contemporaneously to the work described within this thesis, two total syntheses of 
----------------------------- 
*sigmaaldrich.com - £14.50/mg ‘Forskolin from Coleus forskohlii, ≥98%’  
Substrate EC50 
Forskolin 3 µM 
Alotaketal A 8 nM 
Alotaketal B 240 nM 
13 
 
alotaketal A (11) and work towards the total synthesis of phorbaketal A (13), have 
been reported in the literature. 
1.5.2 Contemporaneous Total Syntheses of Alotaketals and Phorbaketals 
1.5.2.1 Total Synthesis of Alotaketal A by Yang et al.  
The first total synthesis of alotaketal A (11) was reported by Yang et al. in 2012.
31
 
Their retrosynthetic analysis revealed a potential acid catalysed strategy for 
formation of the 6,6-spiroketal core, via a lactol fragment 44. The synthesis of the 
lactol 44 was anticipated to proceed via the late-stage coupling of allyl iodide 45 and 
bicyclic lactone 46 (Scheme 4).  
 
Scheme 4 - Retrosynthetic analysis of alotaketal A (11) by Yang et al. 
The synthesis of bicyclic lactone 46 started from readily available (R)-(–)-carvone 
(47) (Scheme 5). A key step involved use of an unusual SmI2-induced reductive 
allylation step from allyl iodide 48, to give lactol 49. After oxidation of the lactol 49 
to the lactone 50 using 2-iodoxybenzoic acid (IBX), the employment of Hg(OAc)2 
assisted regioselective formation of allylmercury chloride species 51. This species 
was then converted to the para-methoxybenzyl ether (PMB) protected alcohol 46 
over three synthetic steps.  
14 
 
 
Scheme 5 - Synthesis of bicyclic lactone 46 
The synthesis of the allyl iodide 45 was achieved in ten steps from β-ketoester 52 
(Scheme 6). A key step involved employing the Nagao aldol protocol for 
diastereoselective addition to aldehyde 53, giving allylic alcohol 54 as the major 
diastereomeric product. After methanolysis and TBS protection to ester 55, 
conversion to allyl iodide 45 was achieved over three subsequent steps.  
 
Scheme 6 - Synthesis of allyl iodide 45 
Attempts of the generation of organolithium or organomagnesium species from allyl 
iodide 45, to faciliate nucleophilic addition to the bicyclic lactone 46, were 
unfruitful. Instead, Barbier conditions mediated by SmI2 were found to assist the 
addition of allyl iodide 45 to lactone 46, to give lactol 56 (Scheme 7). Subsequent 
desilylation using fluoride and acid catalysed spiroketalisation using para-
15 
 
toluenesulfonic acid (pTSA) were performed without purification of the 
intermediates, giving the spiroketal 57 as a single diastereomer. The final steps to 
alotaketal A (11) involved oxidation of the allylic alcohol 57 to the ketone 
functionality using IBX and lastly removal of the PMB ether protecting group with 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) (Scheme 7).  
 
Scheme 7 - Final steps towards alotaketal A (11) 
This pioneering total synthesis of alotaketal A (11) served to confirm the 
stereochemical assignments previously made by Andersen et al.
19
 
1.5.2.2 Total Synthesis of Alotaketal A by Dalby et al.  
Only half a year later, a second total synthesis of alotaketal A (11) was reported by 
Dalby et al.
32
 Overall, the strategy was similar to that of the pioneering work by 
Yang et al. In this strategy, addition of allyl bromide 58 to lactone 59 was planned 
for the formation of lactol 60, with subsequent steps involving acid catalysed 
formation of the spiroketal core (Scheme 8).    
16 
 
 
Scheme 8 - Retrosynthetic analysis of alotaketal A 
The synthesis of bicyclic lactone 59 started from (R)-carvone (47) (Scheme 9). 
Following base assisted formation of silyl dienyl ether 60 from ketone 61, Rubottom 
oxidation using mCPBA allowed access to tertiary alcohol 62. PDC mediated the 
allylic rearrangement of tertiary alcohol 63 for formation of an enone intermediate 
which was reduced using L-selectride to give alcohol 64.  
 
Scheme 9 - Towards bicyclic lactone 59 
The synthesis of the bicyclic lactone 59 from alcohol 64 was achieved via a Horner-
Wadsworth-Emmons olefination strategy. Cleavage of the terminal alkene using 
Johnson-Lemieux conditions gave ketone 65 and subsequent Yamaguchi conditions 
with phosphonate 66 were used to assist the formation of β-keto-phosphonate 67. 
17 
 
Subsequent deprotonation of the phosphonate 67 with barium hydroxide mediated 
intramolecular olefination to the bicyclic lactone 59.  
 
Scheme 10 - Synthesis of bicyclic lactone 59 
The synthesis of allyl bromide 58 started from readily available starting material 
geraniol. In brief, a similar Nagao aldol approach to that used by Yang et al. was 
used to install the secondary alcohol with dr 95:5, which was subsequently silylated 
to the TES protected allyl bromide 58 (Scheme 11).  
In a similar observation to Yang et al., difficulties in forming organolithium or 
organomagnesium species from allyl bromide 58 were encountered. However, it was 
found that using an excess of lithium di-tert-butylbiphenyl (LiDBB) facilitated the 
required nucleophilic addition to the lactone 59 (Scheme 11). Treatment of the 
addition product with HF·pyridine assisted selective removal of the triethylsilane 
(TES) ether protecting group, with concurrent acid catalysed spiroketalisation to give 
spiroketal 67. Final steps to alotaketal A (11) involved removal of the remaining silyl 
ether protecting groups and the required oxidation level adjustments. 
18 
 
 
Scheme 11 - Total synthesis of alotaketal A (11) by Dalby et al.  
This shorter synthesis of alotaketal A (11) employing readily available starting 
materials (R)-carvone and geraniol will likely be useful for the synthesis of 
alotaketal, phorbaketal or other non-natural analogues for SAR studies and biological 
evaluations.  
1.5.2.3 Efforts Towards Phorbaketal A by Brimble et al.  
Efforts towards the total synthesis of phorbaketal A (13) were reported very recently, 
in February 2015, by the group of M. Brimble.
33
 Upon unsuccesful attempts to 
reproduce the synthesis of silyl dienol ether 60, as was reported by Yang and co-
wokers, a synthetic strategy which deviated from the previously discussed (R)-
carvone based syntheses of alotaketal A (11) was devised. Their retrosynthetic 
analysis led them to an oxidative cyclisation strategy for formation of the 6,6-
spiroketal core from 68, via the late-stage coupling of mono-cyclic fragments 69, 70 
(Scheme 12).     
19 
 
                           
Scheme 12 - retrosynthesis of phorbaketal A (13) by Brimble et al. 
The synthesis of allyl silane fragment 69 was achieved via a Horner-Wadsworth-
Emmons olefination strategy. Firstly, conjugate addition of allyl bromide 71 to (Z)-
ester 72, via an organocopper species, gave ester 73 (Scheme 13). Addition of 
deprotonated diethyl ethylphosphonate (from 74) to the ester 73 assisted conversion 
to phosphonate 75, which was subsequently converted to benzoyl enol ether 76.  
 
Scheme 13 - Synthesis of benzoyl enol ether 76 
Final steps towards allyl silane 69 involved Swern oxidation, to give unstable 
aldehyde 77 (Scheme 14). In an elegant step, the treatment of aldehyde 77 with 
sodium hydride mediated alkoxide formation resulting in intramolecular transfer of 
20 
 
the benzoyl group, and thus generation of the phosphonate anion 78, which then 
participated in an intramolecluar olefination process to give allyl silane 69.   
 
Scheme 14 - Synthesis of allyl silane 69 
The synthesis of acetal fragment 70 began with a Nagao-Fujita aldol reaction 
between the acetylated auxillary and geranial to give alcohol 79 (Scheme 15). A key 
step involved formation of lactone 80 via an intramolecular Horner-Wadsworth-
Emmons olefination of phosphonate 81. Subsequent conversion of the lactone 80 to 
the acetal 70 was achieved over reduction and acetalisation steps. 
                 
Scheme 15 - Formation of acetal fragment 70  
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The coupling of allyl silane 69 with lactone 70 was achieved using InCl3-promoted 
Hosomi-Sakurai conditions to give alcohol 82 (Scheme 16). Following removal of 
the benzoyl protecting group and epoxidation of the terminal alkene, the key 
oxidative cyclisation step using DDQ was successful for formation of the 6,6-
spiroketal 83. The anticipated final step to phorbaketal A (13) would involve 
conversion of the epoxide 83 to the required allylic alcohol motif. However after 
extensive screening, the required conditions for this transformation were not found, 
and the total synthesis of phorbaketal A (13) was not achieved. 
 
Scheme 16 - Final steps towards phorbaketal A (13) 
This synthesis of the phorbaketal core structure will undoubtedly assist future 
endeavours towards the synthesis of phorbaketal and alotaketal natural and non-
natural analogues for biological testing and SAR studies.  
1.6 Methods for the Formation of Spiroketals 
1.6.1 The Anomeric Effect 
The anomeric effect is a stereoelectronic effect which describes the preference for 
electronegative substituents adjacent to a heteroatom with an available lone pair of 
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electrons in a cyclohexane ring to adopt an axial conformation, instead of the 
normally encountered preference for subtituents to reside in the sterically favoured 
equatorial position. There have been many postulations on the origins of this effect.
34
 
Among these, n-σ* hyperconjugation stabilisation is often regarded as the most 
significant.
35
 The stabilising exo anomeric effect involves a donation of the exocyclic 
heteroatom lone pair to the σ* orbital of the C–heteroatom bond within the ring. The 
stabilising endo anomeric effect involves the donation of the lone pair of the cyclic 
heteroatom to the σ* orbital of the exocyclic C–heteroatom bond (Figure 6).  
These effects have particular importance in heteroatom-substituted tetrahydropyran 
rings and thus play a crucial role in the stereochemical outcome of many spiroketal-
forming reactions.  
 
Figure 6 - Exo and Endo anomeric effects  
1.6.2 Acid catalysed spiroketalisation 
Acid catalysed cyclisation of dihydroxy ketals e.g. 84 is probably the most prevalent 
method for spiroketal synthesis (Scheme 17). The reversible nature of this process 
allows exploitation of the stabilising anomeric effect.  A voluminous number of 
strategies towards dihydroxy ketal derivates e.g. 84 have been devised.
36
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Scheme 17- Acid catalysed spiroketal formation from dihydroxy ketal derivates 84 
A common strategy for the formation of dihydroxy ketal derivates uses an umpolung 
approach involving ketones protected as 1,3-dithianes, as acyl anion equivalents. An 
example of this was reported by Stepanian et al. towards the synthesis of the tricyclic 
spiroketals 85a and 85b (Scheme 18).
37
 The construction of 86 was achieved from 
1,3-dithiane 87. Following the removal of all protecting groups, spiroketalisation via 
intermediate 88 was achieved using HgO and BF3·OEt2.  
 
Scheme 18 - 1,3-Dithiane approach to tricyclic spiroketals 85a and 85b 
The nucleophilic addition of organometallics to aldehydes and lactones is commonly 
utilised for the formation of dihydroxy ketals. This strategy was employed by 
Marshall et al. towards the formal total synthesis of tautomycin. Nucleophilic 
addition of alkyne 89 to aldehyde 90 was followed by oxidation to ketone 91 
(Scheme 19). Hydrogenation of the di-alkyne substrate 91 was followed by acid-
catalysed spirocyclisation to give the 6,6-spiroketal 92.
38
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Scheme 19 - Acetylide anion approach 
1.6.3 Other Methods for Spiroketal Formation 
Cycloisomerisation is an emerging strategy for the synthesis of spiroketals that 
harnesses the alkyne π system activating properties of many transitions metals, and 
has been utilised in a number examples (Scheme 20). Examples of 
cycloisomerisation of alkynediols (e.g. 93) have been reported using rhodium, 
iridium, palladium, gold and other complexes.
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Scheme 20 - Cycloisomerisation approach 
A recent study by Tlais et al. explores the ability of a number of late transition metal 
complexes to catalyse alkyne diol cycloisomerisation.
40
 It was found that gold(I) 
chloride was most suited for the required transformation. The proposed mechanism 
involves gold catalyzed cyclisation of alkyne 94 to furanyl intermediate 95 which 
then leads to the formation of spiroketal 96. 
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    Scheme 21 - Gold(I)-catalysed spiroketalisation 
Oxidative radical cyclisation is a less common approach towards spiroketal 
formation (Scheme 22). This method was briefly introduced in previously discussed 
efforts towards phorbaketal A (13) by Brimble et al., using DDQ.
33
 This method can 
be utilised during the synthesis of acid-sensitive compounds as a substitute for more 
traditional acid catalysed methods. The hydrogen abstraction e.g. from 97 can be 
driven by radical species, heat or light (Scheme 22).
41
 
 
Scheme 22 - Intramolecular hydrogen abstraction 
Much of the initial exploration of this method was pioneered by Suarez.
42
 In his 
reported synthesis of a spiroketal containing steroid 100, a 1,6-hydrogen shift process 
was postulated (Scheme 23). The initial step involves formation of an I–O bond 98 
from alcohol 99, which undergoes light- or heat-induced homolytic cleavage. A 1,6-
hydrogen shift is proposed to be followed by carbocation formation upon oxidation 
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with I2. In the final proposed step, nucleophilic attack of the hydroxyl group leads to 
formation of the spiroketal 100. 
 
Scheme 23 - 1,6-Hydrogen shift towards steroid 100. R1, R2 = steroidal framework 
A number of strategies involving conjugate (Michael) addition have been devised. A 
common approach using α,β-unsaturated ketones was firstly demonstrated by 
Danishefsky et al., when treatment of cyclic enone 101 with neutral alumina 
mediated the conjugate addition of the hydroxyl group tether, in the 
diastereoselective formation of  the 6,6-spiroketal 102 (Scheme 24).
43
 The reversible 
nature of the conjugate addition step allows for excellent stereocontrol, allowing one 
to exploit anomeric effects.  
 
Scheme 24 - Conjugate addition to α,β-unsaturated ketone 101 
The formation of spiroketals can be achieved via a hetero-Diels-Alder (HDA) 
cycloaddition reaction between an α,β-unsaturated carbonyl compound (e.g. 103) and 
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vinyl ethers (e.g. 104). The formation of enol ethers e.g. 105 is advantageous since it 
allows for further modification of the ring system (Scheme 25).  
 
Scheme 25 - Example of Hetero-Diels-Alder approach 
It is well-documented that the spiroketal core of the natural product (–)-reveromycin 
A undergoes thermodynamically driven acid-catalysed isomerisation, in the 
alleviation of steric interactions between alkyl side chains - be it at the loss of the 
stabilising anomeric effect. To overcome this problem, Sous et al. employed a 
hetero-Diels-Alder approach for the formation of the spiroketal core 106 (Scheme 
26).
44
 This kinetically controlled reaction between α,β-unsaturated ketone 107 and 
vinyl ether 108 was promoted by the Lewis acid Eu(fod)3 (fod = tris[6,6,7,7,8,8,8-
heptafluoro-2,2-dimethyloctane-3,5-dione]) and afforded spiroketal 106 as a single 
diastereomer.  
 
Scheme 26 - HDA towards the total synthesis of (−)-reveromycin A  
The ring-closing metathesis of alkenes for the synthesis of spiroketals is an approach 
which was pioneered by Ghosh et al. in 2004, with the synthesis of spiroketal 109. In 
this example, Grubbs 1
st
 generation catalyst was employed for the ring closing 
metathesis of acetal 110 (Scheme 27).
45
 
28 
 
 
Scheme 27 - Ring Closing Metathesis approach by Ghosh et al.  
1.6.4 Cascade Oxidative Dearomatisation for Spiroketal Formation 
Very relevant to the work presented within this thesis is the cascade oxidative 
dearomatisation strategy for the formation of spiroketals. Such a pathway was first 
demonstrated by Wong in the total synthesis of aculeatins A (111) and B (112), 
which are anti-malarial natural products.
46
 Treatment of dithiane phenol 113 with the 
PhI(OCOCF3)2 (PIFA) as oxidant resulted firstly in removal of the dithiane 
protecting group and then concomitant oxidation of the phenol, resulting in 
spiroketalisation to give the spiroketal epimers, aculeatins A (111) and B (112) 
(Scheme 28).  A possible mechanism for spiroketalisation would involve the 
formation of phenoxenium intermediate 114, which is prone to nucleophilic attack 
from the tethered hydroxyketone chain.  
 
Scheme 28 - Synthesis of aculeatins A (111) and B (112) 
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This strategy was also adopted by Baldwin et al. for the total synthesis of aculeatin D 
(115) (Scheme 29).
47
 Hydrolysis of the acetonide protected 1,3-diol 117 in aq. HCl 
resulted in an equilibriating mixture of lactol 118 and ketone 116. Treatment of this 
mixture with PhI(OCOCF3)2 (PIFA) resulted in spiroketalisation to give a varying 
ratio of products, dependant upon the choice of solvents. A 9:1 mixture of 
Me2C=O:H2O gave a 19:43:27 ratio of percentage yields for aculeatin D (115), 
aculeatin D epimer (120) and ketone 121.  
 
Scheme 29 - Formation of aculeatin D (115) 
These syntheses of some aculeatin natural products demonstrate an elegant cascading 
method for the formation of the spiroketal cores. This cascading oxidative 
dearomative strategy facilitates a rapid increase in molecular complexity, with the 
formation of a chiral centre and two C−O bonds in one single step.  There are 
significant opportunities for the development of new methods for spiroketalisation by 
exploiting similar oxidative dearomatisation techniques.  
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1.7 Oxidative Dearomatisation of Phenols 
Electrophilic aromatic substitution reactions, e.g Friedel-Crafts treactions,
48
 exploit 
the nucleophilicity of the aromatic π-system, typically involving reactions with 
strongly electrophilic species. However, two-electon oxidative dearomatisation of 
phenols enables an umpolung reactivity, whereby the phenol ring becomes 
electrophilic and prone to intra- and intermolecular nucleophilic attack (Scheme 
30).
49
   
Dearomatised phenol substrates e.g. 122a/b and 123a/b are useful synthetic entities 
and can be used in a range of transformations: including Diels-Alder and conjugate 
(Michael) addition reactions. Alternatively, with the substitution occurring on a 
carbon atom on which a hydrogen atom is attached, thermodynamically driven 
rearomatisation back to an aromatised system e.g. to 124a/b and 125a/b can occur.  
 
Scheme 30 - Reactivity of phenols 
Heavy metal oxidants e.g. thallium(III), lead(IV) and bismuth(V) have traditionally 
been used to mediate the two-electron oxidation of phenols.
49
 However, in recent 
years, these extremely toxic heavy metal oxidants have largely been substituted for 
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the non-toxic, bench-stable and inexpensive hypervalent iodine(III) reagents. In 
particular, the commercially available reagents PhI(OAc)2 (PIDA) and 
PhI(OCOCF3)2 (PIFA)  have been shown to be especially versatile oxidants in 
phenol oxidative dearomatisation reactions.  
There is not a universally accepted pathway for the two-electron oxidation of phenols 
using iodine(III) reagents, and differing mechanisms have been proposed with 
varying conditions and phenol substrates. The phenyl-λ3-iodanyl group (126, Scheme 
31) has remarkable nucleofugality, with quantitative analysis by solvolysis 
experiments for the Ph(BF4)I unit revealing one million times better leaving group 
ability than the triflate group!
50
 This super-nucleofugality has been argued in favour 
of a dissociative mechanism, which would lead to phenoxenium intermediates e.g 
127, being highly susceptible to inter- or intramolecular nucleophilic attack.
51
 An 
associative mechanism has also been proposed, whereby the departure of the phenyl-
λ3-iodanyl group and nucleophilic attack occur in a concerted mechanism (Scheme 
31).
52
 Other proposed mechanisms for iodine(III) species phenol oxidation include 
ligand-coupling processes
53
 and radical pathways
54
. The mechanisms for two-
electron phenol oxidation with iodine(III) species are not yet fully understood and 
are still subject to much discussion and debate in the literature.  
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Scheme 31 - Dissocative and associative mechanisms of phenol oxidations 
Nevertheless, regardless of the exact mechanism for oxidation, coordination of a 
phenol to form phenyl-λ3-iodanyl intermediates e.g. 126 makes the respective ring 
highly susceptibile to inter- and intramolecular nucleophilic attack. As has already 
been alluded to, this versatile umpolung strategy has been employed for use in a 
range of synthetic transformations, including: C–O, C–C and C–N bond forming 
reactions.
49 
1.8 Oxidative Dearomatisations by Pelter et al.  
Pelter et al. have described the oxidative dearomatisation of phenols with 
nucleophilic attack from exogenous methanol and intramolecular ortho-cyclisation of 
tethered alcohols to give dearomatised acetalised products. For example, treatment of 
phenols 128a−c with PhI(OAc)2 in MeOH resulted in the formation of dearomatised 
substrates 129a−c (Scheme 32).
55
   
                                                                  
Scheme 32 - Oxidative ortho-dearomatisations acetalisations reported by Pelter et al. 
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1.9 Initial Aims of Work  
The initial aims of the work presented within this thesis were the development of a 
new method for spiroketalisation via cascade oxidative dearomatisation for use in the 
total synthesis of the alotaketal and phorbaketal natural products.  
Treatment of a hydroxyphenol substrate e.g. 130 with a suitable oxidant was 
envisaged to mediate a cascade oxidative dearomatisation process and lead to the 
formation of the 6,6-spiroketal core and cyclohexadienone moiety e.g. 131 in a single 
synthetic step (Scheme 33). The previously discussed cascade oxidative 
dearomatisation strategies employed for the synthesis of the aculeatin natural 
products involved ipso-cyclisation of a tethered hydroxyketone chain onto an 
oxidised ring to form a 5,6-spiroketal (Scheme 28). However, this newly envisaged 
strategy required an unexplored ortho-cyclisation of a hydroxyketone chain 
(comparable to Pelter, Scheme 32), for the formation of a 6,6-spiroketal. Phorbaketal 
A (13) was selected as the first natural product to demonstrate the envisaged strategy 
(Scheme 33). 
 
Scheme 33 - Cascade oxidative dearomatisation for the synthesis of phorbaketal A 
(13) R = H or leaving group (LG) 
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The employment of a suitable reducible leaving group (R = LG) would give direct 
access to the cyclohexadienone substrates e.g. 131. It was thought that a suitable 
leaving group could then be removed in reduction steps from 131 towards the 
cyclohexenone moiety possessed by the target natural product.  
Rearomatisation of intermediate 131 was expected for when R = H, to give aromatic 
substrates e.g. 132 (Scheme 34). Immediate reduction of ketone intermediate 131 to 
alcohol 133 could circumvent rearomatisation when R = H, and subsequent 
adjustments could give access to the desired cyclohexenone moiety possessed by the 
alotaketals and phorbaketals. However this strategy was less favoured, chiefly since 
it was thought that the lifetime of the intermediate 131 would likely be too short for 
trapping with a hydride before aromatisation would occur.  
 
Scheme 34 - Envisaged strategy towards phorbaketal A (13) 
Initial work involved an investigation into the newly proposed method for 
spiroketalisation by cascade oxidative dearomatisation using a model system.  
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2. Results and Discussion I 
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2.1 Development of Spiroketalisation by Cascade Oxidative Dearomatisation 
2.1.1 Initial Model Studies  
An investigation into the effect of treating hydroxyphenol model substrate 134 with 
an oxidant would give insight into whether ortho-spiroketalisation in such a system 
was possible. The stability of the proposed cyclohexadienone spiroketal product 135 
was unknown, although thermodynamically driven rearomatisation to phenol 136 
was expected (Scheme 35). Nevertheless, the aim of this initial model study was to 
prove that formation of the 6,6-spiroketal core was achievable via the envisaged 
cascade oxidative dearomatisation pathway.  
 
Scheme 35 - Proposed spiroketalisation via cascade oxidative dearomatisation 
Retrosynthetic analysis of model substrate hydroxyphenol 134 revealed the 
possibility of a key addition of a haloalkene fragment 137 to aldehyde 138, via a 
halogen-metal exchange/trapping process (Scheme 36). The synthesis of haloalkene 
137 was envisaged to proceed via a (Z)-selective Wittig halo-olefination of the aryl 
aldehyde 139. The synthesis of alkyl aldehyde 138 was expected to proceed via 
mono-hydroxyl protection of 1,5-pentanediol, followed by oxidation via various 
oxidation method options, to give aldehyde 138.  
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Scheme 36 - Retrosynthetic analysis of hydroxyphenol 134 
It was decided to protect the phenol 139 as a tert-butyldimethylsilyl (TBS) ether 
since this silyl protecting group has well-established stability in a range of reaction 
conditions as well as its frequently reported ease of removal by a myriad of methods. 
Accordingly, treatment of 3-hydroxybenzaldehyde with tert-butyldimethylsilyl 
chloride (TBSCl) in the presence of NEt3 and 4-dimethylaminopyridine (DMAP) 
mediated protection of the phenol, to give aryl aldehyde 140 (Scheme 37).
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The aldehyde 140 was subjected to Wittig olefination using (iodomethyl)triphenyl 
phosphonium iodide, which was deprotonated with sodium hexamethyldisilazane 
(NaHMDS), to give the novel (Z)-iodoalkene 141 (Scheme 37). Analysis of the 
1
H 
NMR spectrum revealed the (Z)-alkenyl proton signals had a coupling constant of 
3
Jcis = 8.7 Hz. This value exactly matched those for the (Z)-alkene protons reported in 
the literature for the analogue (Z)-iodo-2-phenylethene.
57
 The (E)-alkene minor 
product was not observed by analysis of the 
1
H NMR spectrum of the crude reaction 
mixture after protic work-up. 
 
Scheme 37 - TBS protection and Wittig olefination to (Z)-iodoalkene 141 
38 
 
Following previously reported procedures, the mono-silyl ether protection of 1,5-
pentanediol was achieved by treatment with TBSCl in the presence of imidazole, to 
give the mono-alcohol 142.
58
 As before, the TBS protecting group was chosen due to 
its known stability under the forecasted reaction conditions and its ease of removal 
when required. Moreover, the use of a TBS ether protecting group alongside TBS 
group protected (Z)-iodoalkene 141 opened up the possibility for a late-stage global 
deprotection strategy. The primary alcohol 142 was then oxidised to the aldehyde 
143 by Swern oxidation (Scheme 38).
59
  
 
Scheme 38 - TBS ether mono-protection and Swern oxidation to aldehyde 143 
The iodine-lithium exchange of (Z)-iodoalkene 141 was mediated using n-BuLi for 
in situ formation of the desired organolithium species, which was added to aldehyde 
143 to give (Z)-alcohol 144 after protic work-up (Scheme 39). The low 40% yield 
may have been due to enolisation of the aldehyde 143 under the basic conditions.  
 
Scheme 39 - Addition of (Z)-iodoalkene 141 to aldehyde 143  
Oxidation of the (Z)-allylic alcohol 144 to a (Z)-enone intermediate was achieved 
using the Dess-Martin periodinane (DMP) (Scheme 40).
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 At this point, a concern 
was the possible isomerisation of the (Z)-enone moiety to the thermodynamically 
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more stable (E)-enone system by either photolytic or thermal pathways. For this 
reason, the substrate was stored in the dark at 4 °C and used within 2–3 days. Under 
such conditions, no degradation was detected by TLC or 
1
H NMR spectroscopy.  
Following this, the concurrent removal of both silyl ether protecting groups was 
conveniently achieved using TBAF as a source of fluoride (2 eq.) to give (Z)-
hydroxyphenol 134 (Scheme 40). Retention of the crucial (Z)-alkene stereochemistry 
was confirmed by comparison of the 12.8 Hz alkenyl J coupling constant with 
analogous (Z)-enone moieties in the literature, which typically range from 12.5–13.0 
Hz.
61
 In contrast, (E)-enone moieties have alkenyl J coupling constants ranging from 
16.0–16.5 Hz.62 Upon storage, the degradation of 134 to a complex mixture was 
observed, however this was prevented by storing under an atmosphere of argon in the 
dark at 4 °C and using the unstable substrate within 2–3 days.    
 
Scheme 40 - DMP oxidation and TBAF deprotection to (Z)-hydroxyphenol 134 
Upon the successful synthesis of (Z)-hydroxyphenol 134, an investigation into the 
proposed method for spiroketalisation via cascade oxidative dearomatisation was 
initiated. Firstly, conditions for similar cascades reported by Baldwin et al. (Scheme 
41) were implemented.
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Scheme 41 - Oxidative ipso-dearomative cyclisations reported by Baldwin et al.  
Following conditions reported by Baldwin, attempts at spiroketalisation using 
PhI(OAc)2 in MeCN and then Me2CO:H2O (9:1) were unfruitful (Scheme 42). Under 
these conditions analysis by TLC and 
1
H NMR revealed a mixture of unidentifiable 
by-products and the desired spiroketal product 136 was not observed.  
 
Scheme 42 - Attempted oxidative cyclisation of hydroxyphenol 134 
One concern with this reaction was that upon rearomatisation of the spiroketal 
intermediate 135, the newly regenerated phenol 136 could react further with 
PhI(OAc)2 leading to a variety of unknown by-products. An additional concern was 
the nucleophilic competition of water versus the desired cyclisation of the tethered 
alcohol. The nucleophilic attack of water at various stages in the cyclisation could 
result in a range of poly-oxygenated by-products.  
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2.1.2 Model studies using MeOH as exogenous nucleophile 
As previously mentioned, Pelter et al. have demonstrated the treatment of phenols 
128a−c with PhI(OAc)2 in MeOH in the formation of dearomatised substrates 
129a−c (Scheme 43).
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Scheme 43 - Oxidative ortho-dearomatisations acetalisation reported by Pelter et al. 
In a similar fashion to Pelter et al., it was decided to investigate using MeOH as an 
exogenous nucleophile towards the formation of the desired spiroketal core 147.  
 
Scheme 44 - Proposed route for spiroketalisation using MeOH an exogenous Nu 
It was of interest to explore the use of this strategy since it could give direct access to 
cyclohexadienone spiroketal structures. With interest in the future utilisation of this 
method for the total synthesis of phorbaketal A, a route was devised for the 
replacement of the undesired methoxy substituent with the required hydrogen atom 
(Scheme 45).   
The devised route firstly involved removal of the undesired alkene in the 
cyclohexadienone motif 147. In this model system, this was believed to be 
unfeasible, since di-substiuted alkenes are normally reduced more rapidly than tri-
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substitiuted alkenes. However, in the phorbaketal A system both alkenes are 
trisubstitued and it was believed the primary alcohol at C9 (see Scheme 45) could 
steer chemoselective reduction of the desired alkene. For example, Wilkinson’s 
catalyst is known to assist very selective hydrogenation of conjugated alkenes in the 
presence of other alkenes. Additionally, Wilkinson’s catalyst is known to coordinate 
hydroxyl groups allowing very selective hydrogenation of allylic or homoallylic 
alkenes.
63
 Other alkene reduction methods could involve various metal hydrides (e.g. 
copper hydrides), also taking advantage of the hydroxyl group to coordinate to the 
metal. 
In this model system, reduction of the ketone 148 to alcohol 149 was then proposed 
to potentially result in elimination of the undesired methoxy substituent to give enol 
150. This enol intermediate 150 could then tautomerise to cyclohexenone 151 to 
install the desired hydrogen atom. One concern with this strategy was the ejection of 
the spiroketal ether rather than the desired methoxy group. 
 
Scheme 45 - Route to phorbaketal A model 151 from methoxy substrate 147  
To investigate this incorporation of methanol, an initial reaction involved treatment 
of hydroxyphenol 134 with PhI(OAc)2 (2 eq) using MeOH as solvent. The reaction 
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was periodically monitored by TLC over 4 h which indicated consumption of the 
starting material. After this time 
1
H NMR analysis revealed a number of signals 
corresponding to methoxy group protons (i.e. incorporation of MeOH). The major 
products were partially isolated
*
 by flash column chromatography and after analysis 
of the 
1
H NMR spectrum were deduced to be dearomatised substrates 152a and 
152b. Starting from 30 mg of starting material 124, these compounds were isolated 
in small quantities (≈1 mg), and a second attempt at purification led to their total loss 
through degradation on silica gel. Consequently, thorough characterisation was not 
possible.  
 
Scheme 46 - Oxidative cyclisation of hydroxyphenol 134 
The 
1
H NMR spectra of 152a and 152b were indicative of two partially separated 
diastereomers.
 
The major singlet resonances at 3.08–3.45 ppm were believed to 
correspond to methoxy group protons. A comparison of key proton resonances with 
dearomatised substrate 153, previously synthesised by Pelter
55
, revealed very similar 
chemical shifts and J coupling constants (Table 2). 
 
 
 
 
----------------------------- 
* Eluted from the column as partially separated mixtures with variable amounts of 
each diastereomer.  
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Table 2 - Dearomatised substrates 152a/b comparison to literature compound 153 
 
                                           
To help visualise the similarities of the chemical shift values of these compounds a 
∆∂ bar chart* was devised. Note similar and typically small ∆∂ values for H-1 to H-5.  
 
Chart 1 - * ∆∂ values comparing substrates 152a and 152b to compound 153 
 
----------------------------- 
* ∆∂ = │∂152 - ∂153│ 
0.00 
0.05 
0.10 
0.15 
0.20 
0.25 
0.30 
0.35 
0.40 
H1 H2 H3 H4 H5 OMe OMe 
a 
b 
 153 (ppm, Hz) 152a 152b 
H-1 6.18 (dd, J= 10.2, 2.0) 6.30 (dd, J= 10.3, 2.0) 6.26 (dd, J= 10.3, 2.0) 
H-2 6.25 (d, J=10.2) 6.61 (d, J= 10.3) 6.50 (d, J= 10.3) 
H-3 5.93 (d, J= 2.0) 6.10 (d, J= 2.0) 6.05 (d, J= 2.0) 
H-4 6.10 (d, J= 10.2) 6.00 (d, J= 10.3) 6.10 (d, J= 10.3) 
H-5 6.65 (d, J= 10.2) 6.73 (d, J= 10.3) 6.76 (d, J= 10.3) 
OMe 3.12 (s) 3.16 (s), 3.08 (s) 3.45 (s), 3.23 (s) 
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Figure 7 – 1H NMR for proposed dearomatised substrates 152a/b 
The exact mechanism for the formation of these dearomatised substrates 152a/b is 
not known. The initial step must involve a ligand exchange, with the nucleophilic 
attack of the phenol 134 onto the iodine(III) centre, to form the phenyl-λ3-iodanyl 
intermediate 154 (Scheme 47). As previously discussed, the oxidation process 
mediated by PhI(OAc)2 (and other hypervalent iodine oxidants) is known to occur 
via different mechanisms depending on a variety of factors, and it is unclear which 
mechanism is at play in this reaction. As an example, a dissociative mechanism has 
been depicted in Scheme 47, with the formation of phenoxenium intermediate 155.  
Scheme 47 - Dissociative mechanism for oxidation of phenol 134 by PhI(OAc)2 
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Regardless of the mechanism of oxidation, the ring becomes prone to nucleophilic 
attack upon formation of a phenyl-λ3-iodanyl intermediate 154. It is unknown by 
which order each nucleophile participates in this reaction. A possible path (path 1) 
involves the initial attack of MeOH onto the oxidised ring. This is followed by 
thermodynamically driven rearomatisation and then the new phenol is oxidised by a 
second equivalent of PhI(OAc)2. The final step involves nucleophilic attack from the 
hydroxyketone tether. Cyclisation of the tether could occur in a concerted fashion, as 
is depicted in Scheme 48. Other possible mechanisms for the attack of the 
hydroxyketone tether involve the formation of oxocarbenium intermediates or lactol 
formation. A second path with the reversed order of addition of each nucleophile is 
also possible (path 2). 
 
Scheme 48 - Mechanism for formation of dearomatised substrates 152a/b 
The apparent observation of these elusive compounds encouragingly revealed that 
PhI(OAc)2 was a suitable oxidant for the oxidation of the phenol ring, which was in 
turn susceptible to the desired site of nucleophilic attack. Cyclisation of the ketone 
tether was believed to have occurred, albeit only partially in the desired fashion.  
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A final minor product present was isolated by flash column chromatography (<1 
mg). The 
1
H NMR spectrum revealed intriguing dearomatised structures seemingly 
as a mixture of two diastereomers, each bearing only one methoxy substituent. After 
careful analysis of the 
1
H NMR spectrum these dearomatised structures were 
assigned as spiroketals 147a and 147b.  
 
Scheme 49 - Formation of spiroketals 147a and 147b  
Again, comparison of the key 
1
H NMR resonances with dearomatised literature 
compound 153 revealed protons in a magnetically similar environment.
55 
In 
particular, the proton resonance corresponding to key hydrogen atom H-5 had a 
notably different chemical shift, being close to the proposed spiroketal core (Table 
3). To help visualise the similarities of the chemical shift values of these compounds 
147a and 147b a ∆∂ bar chart was devised (Chart 2). The protons were notably more 
deshielded (resonated lower field) than in substrate 153, and this was speculated to 
be due to the neighbouring electron withdrawing spiroketal core. Each purported 
diastereomer had remarkably similar and patterned ∆∂ values for all protons H1-H5.  
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Table 3 - Dearomatised substrates 147a/b comparison to literature compound 153 
                                                          
 153 (ppm, Hz) 147a 147b  
H-1  6.18 (dd, J= 10.2, 2.0) 6.25 (dd, J= 10.3, 2.0) 6.29 (d, J= 10.3, 2.0) 
H-2 6.25 (d, J=10.2) 6.38 (d, J= 10.3) 6.44 (d, J= 10.3) 
H-3 5.93 (d, J= 2.0) 6.02 (d, J= 2.0) 6.05-6.07 (m) 
H-4 6.10 (d, J= 10.2) 6.07 (d, J= 10.3) 6.05-6.07 (m) 
H-5 6.65 (d, J= 10.2) 6.85 (d, J= 10.3) 6.78 (d, J= 10.3) 
OMe 3.12 (s) 3.28 (s) 3.18 (s) 
 
 
Chart 2 - ∆∂ values* for comparison of substrates 147a/b resonances to 153 
----------------------------- 
* ∆∂ = │∂147 - ∂153│ 
0 
0.05 
0.1 
0.15 
0.2 
0.25 
H1 H2 H3 H4 H5 OMe 
a 
b 
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Furthermore to this analysis, the OCH2 protons of the alkyl tether which resonated as 
a triplet (J = 7.1 Hz) in the starting material 134 had become diastereotopic, with 
mutual coupling to one another. One OCH proton resonated as an apparent triplet of 
doublets (for each diastereomer, major at 4.15 and minor at 4.05 ppm), with coupling 
constants J = 11.7, 3.2 Hz. For the related spiroketal substrate 146 synthesised by 
Baldwin, the analogous OCH proton resonated as a triplet of doublets at 3.91 ppm 
with J = 11.5, 3.0 Hz, which they assigned as the axial conformer.
47
 With this careful 
analysis the author was confident that the hydroxy group had indeed cyclised. 
 
Scheme 50 - Spiroketals 147a/b versus Baldwin reported spiroketal 146 
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Figure 8 - 
1
H NMR of proposed spiroketal diastereomers 147a and 147b 
With the small quantity of the presumed spiroketals 147a and 147b obtained it was 
not possible to perform thorough analysis of these substrates and a further attempt at 
isolation led to complete loss due to degradation on silica gel. Although the author 
was confident that the spiroketal diastereomers 147a and 147b had been isolated, 
making this bold claim at the time would have been unwise solely from careful 
analysis of 
1
H NMR data. This result will be revisited in a later section within this 
thesis.  
A mechanism for the formation of these spiroketals was theorised. As before, 
regardless of the mechanism of oxidation, the ring becomes prone to nucleophilic 
attack upon formation of the phenyl-λ3-iodanyl intermediate. It is unclear in which 
order each nucleophile participates. The first possible path involves the direct 
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addition of MeOH to the ring (path 1). This is followed by thermodynamically driven 
rearomatisation and then the newly regenerated phenol is oxidised by a second 
equivalent of PhI(OAc)2. The final step involves nucleophilic attack from the 
hydroxy ketone tether. This could occur in a concerted fashion as is shown in 
Scheme 51. Other possible mechanisms for the attack of the tether involve the 
formation of an oxocarbenium intermediate or lactol formation. A second path (path 
2) is also possible, with the reversed order of addition of the respective nucleophiles.  
 
Scheme 51 - Mechanism for formation of spiroketals 147a and 147b 
In this investigation, the presence of the major dearomatised products 147a/b 
indicated that MeOH, being in excess, was competing with the desired 
intramolecular cyclisation of the hydroxyketone tether. For this reason it was decided 
to investigate the effect of lowering the molar equivalents of MeOH in the reaction 
so as to increase the probability of intramolecular hydroxyl cyclisation over 
intermolecular nucleophilic attack from MeOH.  
The reaction was repeated using only two equivalents of MeOH in CH2Cl2, and 
secondly a 25% MeOH solution in CH2Cl2. Both of these attempts were 
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unsuccessful, with 
1
H NMR analysis of the crude mixtures after evaporation of 
solvents indicating a large mixture of unidentifiable degradation products.  
 
Scheme 52 - Attempted spiroketalisation using PhI(OAc)2/MeOH 
The apparent isolation of dearomatised compounds 147a/b was encouraging since 
their presence suggested that oxidation by PhI(OAc)2 was occurring and that 
cyclisation of the ketone tether was occurring; albeit only partially in the desired 
fashion. The suspected isolation of spiroketal diastereomers 147a/b was especially 
encouraging and served as proof-of-concept.  
From this initial model study, the author suspected that the presence of exogenous 
MeOH was hindering formation of the desired spiroketal core by nucleophilic 
competition. In light of evidence suggestive of the formation of the spiroketal core, 
work was continued towards further exploring this newly devised method for 
spiroketalisation. It was decided to eliminate the need for an exogenous nucleophile 
for the synthesis of the desired cyclohexadienone spiroketal structures. 
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2.1.3 Further Model Studies 
After the preliminary investigations, a second model system was envisaged, 
incorporating a methoxy substituent ortho to the tethered hydroxyl ketone chain. 
This revised system would eliminate the need for an exogenous nucleophile, and the 
previously encountered rearomatisation pathways to give direct access to the desired 
cyclohexadienone spiroketal structures. The pre-incorporation of a methoxy 
substituent was believed to be a better strategy towards the total synthesis of 
phorbaketal A. The previously encountered problems with nucleophilic competition 
and undesired by-products would be incredibly detrimental during a future late-stage 
cyclisation step towards the total synthesis of phorbaketal A. Whereas, the pre-
incorporation of a methoxy substituent was envisaged to give direct access to the 
desired cyclohexadienone spiroketal moieties 147 as the major reaction products. To 
this end, a synthesis of methoxy bearing model substrate 156 was devised, with 
which the oxidative cyclisation step could again be investigated. 
 
Scheme 53 - Second model system 156 for spiroketal formation 
Retrosynthetic analysis of hydroxyphenol 156 was conducted in a similar fashion to 
the previous model substrate 134. Retrosynthetic cleavage of a central C–C bond 
revealed synthons corresponding to an organolithium fragment 157 and aldehyde 
fragment 158 (Scheme 54). The formation of the organolithium 157 could be 
generated by in situ halogen-lithium exchange from haloalkene fragment 159 using 
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n-BuLi. The desired (Z)-haloalkene 159 could be synthesised via a (Z)-selective 
halo-Wittig olefination method from aryl aldehyde fragment 160.  
 
Scheme 54 - Retrosynthetic analysis of hydroxyphenol 156 
Initial synthetic efforts were focused towards the synthesis of (Z)-haloalkene 
fragment 159, firstly involving the synthesis of aryl aldehyde fragment 160. Using a 
reported procedure, conversion of 4-hydroxyanisole to methyl carbonate ester 161 
was achieved by treatment with methyl chloroformate in the presence of pyridine 
(Scheme 55).
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 Following this, Rieche formylation of carbonate 161 using TiCl4 and 
Cl2CHOMe gave aryl aldehyde 162.
64
 The carbonate group is far less activating than 
the methoxy group, and hence formylation occurs regioselectively ortho to the 
methoxy group.. Hydrolysis of the carbonate functional group was achieved by 
warming in 1M NaOH. Upon the synthesis of phenol 163 it was decided to protect 
the phenol using a TBS ether group due to its effective employment in the previous 
model study synthesis. This protection was achieved by treating the phenol 163 with 
TBSCl, in the presence of NEt3 and a catalytic amount of DMAP to give novel aryl 
aldehyde 164.  
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Scheme 55 - Synthesis of aryl aldehyde 164 
Unfortunately, in the author’s hands the described Rieche formylation of carbonate 
161 proved to be unreliable and further attempts revealed an unexplainable mixture 
of aldehyde resonances in the 
1
H NMR spectrum of the crude reaction mixture after 
protic work-up. Consequently, a more reliable method for the formation of aryl 
aldehyde 164 was required.  
It was proposed that protection of 4-hydroxy anisole, with a bulky silyl ether group, 
may provide a significant steric barrier and electron donating ability to inhibit 
lithiation ortho to the protected phenol, and consequently promote lithiation 
regioselectively ortho to the less sterically demanding and less electron donating 
methoxy group. Subsequent quenching of the organolithium species with 
dimethylformamide (DMF) was proposed to give direct access to aryl aldehyde 164 
after protic work-up. There is precedence in the literature for the ortho-lithiation and 
formylation of anisole analogues,
65
 however the effect of a silyl ether attached to an 
anisole ring upon the regioselectivity of lithiation was unknown. 
To investigate this proposal, 4-hydroxyanisole was protected as the bulky TBS silyl 
ether by treatment with TBSCl in the presence of imidazole (Scheme 56).
66
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Accordingly, the anisole 165 was subjected to ortho-lithiation using n-BuLi/TMEDA 
at 0 °C in THP
*
 and subsequent quenching of the organolithium with DMF and 
protic work-up afforded aryl aldehyde 164 in 77% yield.
67
 Analysis of the 
1
H NMR 
spectrum after protic work-up indicated completely regioselective formylation ortho 
to the methoxy group. The author was content with having enhanced the previous 
unreliable four step (53% yielding) synthesis to a two step (77% yielding) synthesis 
of the novel aryl aldehyde 164. This was convenient as it allowed the synthesis of 
aryl aldehyde 164 within one working day. The potentially unstable aryl aldehyde 
164 could then be used immediately after purification.   
 
 
                            
Scheme 56 - Novel synthesis of aryl aldehyde 164 
The synthesis of the aryl aldehyde 164 allowed investigations into the subsequent Z-
selective Wittig olefination step to ensue. The first conditions employed for the 
Wittig olefination used (iodomethyl)triphenylphosphonium iodide which was 
deprotonated with NaHMDS. Analysis of the crude 
1
H NMR spectrum after protic 
work-up revealed conversion to the (Z)-iodoalkene 166, with the expected 
iodoalkenyl proton resonances at 6.86 and 7.03 ppm, with mutual coupling constant 
of 
3
Jcis = 8.9 Hz. This J coupling constant was consistent with the previously 
synthesised (Z)-iodoalkene 166 and the aforementioned analogous structures in the 
literature.
57
 Unfortunately, the (Z)-alkene 166 could not be isolated using flash 
----------------------------- 
* The solvent tetrahydropyran (THP) was selected because n-BuLi is known to 
deprotonate THF near room temperature. 
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column chromatography on silica gel. Furthermore, storage of the crude product in a 
fumehood overnight revealed substantial degradation to a mixture of unidentifiable 
products.  This glaring instability issue discouraged the use of similar haloalkene 
entities during the synthesis of model substrate 156.  
 
Scheme 56 - Wittig olefination of aryl aldehyde 164 
A second retrosynthetic analysis of hydroxyphenol 156 was conducted (Scheme 57). 
This revealed an alternative possible synthetic path involving the addition of 
halogenated alkyl fragment 167 to (Z)-aldehyde fragment 168 using a halogen-metal 
exchange/trapping method (Scheme 57). It was anticipated that the formation of the 
(Z)-ester 169 could be achieved via a (Z)-selective Horner-Wadsworth-Emmons 
olefination method from aryl aldehyde 164.  
 
Scheme 57 - Alternative retrosynthetic analysis of hydroxyphenol 156 
To this end, initial efforts in the newly devised synthetic plan were towards the 
synthesis of (Z)-aldehyde fragment 168. The Ando-modified (Z)-selective Horner-
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Wadsworth-Emmons procedure was envisaged for the formation of (Z)-alkene ester 
169. This would be followed by oxidation level adjustments of the ester functional 
group to the desired aldehyde functional group. The Ando-protocol allowed the 
synthesis of the required phosphonate using reagents which were readily available in 
the laboratory. The synthesis of the Ando-modified phosphonate 170 was achieved in 
two steps using a reported procedure.
68
  
An olefination reaction between phosphonate 170 and aryl aldehyde 164 was 
attempted under various conditions reported by Ando.
69
 Optimal conditions for this 
reaction employed NaH as the base, at a temperature of –78 °C. After protic work-up 
1
H NMR analysis revealed conversion to two alkene compounds. Analysis of the 
alkenyl protons revealed Z:E  isomers in a 6.1:1.0 ratio. Conveniently, separation of 
the isomers was achieved by careful flash column chromatography and led to the 
isolation of the desired (Z)-alkene 169 in 80% yield. The geometry of each alkene 
stereoisomer was confirmed by comparison of the alkenyl proton coupling constants 
(169 
3
JZ = 12.4 Hz versus 171 
3
JE = 16.1 Hz).  
 
Scheme 58 - Ando-olefination of aryl aldehyde 164 to (Z)-ester 169 
Following the formation of (Z)-ester 169, procedures for adjusting the oxidation 
levelof the ester group to the desired (Z)-aldehyde 168 was probed. Treatment of the 
(Z)-ester 169 with diisobutylaluminium-hydride (DIBAL-H) at –78 °C unfortunately 
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did not facilitate direct reduction to the (Z)-aldehyde 168, instead over-reduction to 
the (Z)-alcohol 172 occured. This over-reduction is in fact a well-reported 
phenomenon for DIBAL-H reduction of α,β-unsaturated esters.70 Nevertheless, 
reduction of the (Z)-ester 169 using DIBAL-H (2.1 eq.) gave smooth conversion to 
the (Z)-allylic alcohol 172. Subsequently, the (Z)-allylic alcohol 172 was then 
oxidised to the desired (Z)-aldehyde 168 using Dess-Martin periodinane.
60
  
 
Scheme 59 - Synthesis of aldehyde 168 
The previously described retrosynthetic analysis indicated that addition of an alkyl 
halide fragment 167 to aldehyde 168 could give access to the required carbon 
framework. For the synthesis of alkyl halide fragment 167, efforts were focused 
towards the synthesis of alkyl bromide 173 using a reported procedure. Treatment of 
tetrahydrofuran (THF) with aq. hydrobromic acid gave bromo alcohol 174.
71
 The 
bromo alcohol 174 was then protected as a silyl ether by treatment with TBSCl in the 
presence of imidazole, to give the alkyl bromide 173 (Scheme 60).
72
 
Scheme 60 - Synthesis of alkyl bromide 173 
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The formation of a Grignard species from alkyl bromide 173 and its subsequent 
addition to the aldehyde 168 was planned (Scheme 61). The required Grignard 
reagent was generated in situ by heating alkyl bromide 173 over magnesium turnings 
and a crystal of iodine in THF. The Grignard species 175 was added to the (Z)-
aldehyde 168 at –78 °C to give (Z)-alcohol 176 in 44% yield. This low yield was due 
to competing reduction of the (Z)-aldehyde 168
*
 by the α,β-saturated Grignard 
reagent 175, to return (Z)-alcohol 172, as has been described for similar Grignard 
reagents in the literature.
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 Following this, oxidation of the (Z)-alcohol 176 with 
Dess-Martin periodinane
60
 assisted the conversion to (Z)-enone 178. Finally, fluoride 
mediated the concurrent removal of both silyl ether protecting groups, to give 
hydroxyphenol 156. Retention of the crucial (Z)-alkene stereochemistry was 
confirmed by comparison of the 12.7 Hz alkenyl proton J coupling constant with 
similar (Z)-enone moieties in the literature, ranging from 12.5–13.0 Hz.61 
 
Scheme 61 - Synthesis of hydroxyphenol 156 
 
----------------------------- 
*
 Reduction occurs through a 6-membered transition state, whereby the Grignard 
reagent acts as a hydride source.   
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2.1.3.1 Spiroketalisation via Model System 
Upon the succesful formation of hydroxyphenol 156 the key cascade oxidative 
dearomatisation strategy for spiroketal formation was examined.  Gratifyingly, under 
the conditions reported by Baldwin,
47
 oxidation of hydroxyphenol 156 with 
PhI(OAc)2 in MeCN gave two spiroketal products 147a/b in a 2:1 ratio as judged by 
1
H NMR integrations, directly after evaporation of the solvent.  The products were 
isolated by flash column chromatography and assigned as spiroketal diastereomers 
major 147a and minor 147b, in a 56% combined yield.  
 
Scheme 62 - Synthesis of spiroketals 147a and 147b 
The stereochemistry of each diastereomer was revealed through nOe difference 
experiments. For major spiroketal diastereomer 147a, saturation of the OCH3 
resonance in the 
1
H NMR spectrum revealed a 0.1% nOe enhancement to one O–CH 
proton on the pyran ring (Figure 9). For the minor spiroketal diastereomer 147b, 
saturation of the OCH3 resonance revealed a 0.1% nOe enhancement to alkyl C–CH2 
protons of the pyran ring (Figure 10). As expected, both of these very small  nOe 
signals were entirely exclusive for each isolated diastereomer. The very small nOe 
percentage enhancement values observed are probably as a result of a large distance 
between these protons (since nOe intensity is proportional to 1/r
6
).  
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Figure 9 - NOESY difference experiment for major spiroketal 147a 
Figure 10 - NOESY difference experiment for minor spiroketal 147b 
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The spirocentre carbon atom resonated in the 
13
C NMR spectrum at 95.3 (147a) and 
96.3 ppm (147b), within the characteristic chemical shift region for a spiroketal 
centre.  
A precise mechanism for this novel spiroketalisation has not been determined. But it 
can be postulated that the initial step must involve, as in previous examples, 
nucleophilic attack of the phenol onto the iodine(III) centre to form a phenyl-λ3-
iodanyl intermediate. Regardless of the exact mechanism for two-electron oxidation, 
the phenol ring becomes prone to nucleophilic attack from the hydroxyketone tether. 
As an example, a dissociative mechanism with the formation of oxocarbenium 
intermediate 179 is depicted in Scheme 63.  
The order of events for the cyclisation of the hydroxyl ketone tether is also not 
known. Possible mechanisms include: a concerted cyclisation onto the ring, the 
formation of an oxocarbenium intermediate 180 which then suffers attack from the 
hydroxyl group or the formation of a lactol 181 which attacks the ring (Scheme 63).  
 
Scheme 63 - Possible mechanisms for spiroketals 147a and 147b formation 
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2.1.4 Conclusion 
With the successful demonstration of the newly developed method for 
spiroketalisation the author was intrigued to revisit data obtained from the initial 
model study. The 
1
H NMR spectra of each newly isolated spiroketal was compared 
to the 
1
H NMR spectrum of the mixture of proposed spiroketals 147a and 147b 
obtained via the initial model system (Figure 11). Gratifyingly, it was found that 
spiroketals 147a and 147b had indeed been formed in the initial model system, albeit 
as impure minor products.   
 
Figure 11 - 
1
H NMR spectra 147a and 147b formation from methods 1 and 2 
The work presented so far describes the demonstration of two related strategies for a 
new method of spiroketalisation via cascade oxidative ortho-dearomatisation. The 1
st
 
generation method involves the use of exogenous MeOH which is incorporated in the 
final dearomatised spiroketals 147a and 147b, previously described as minor 
products. The 2
nd
 generation method involves the pre-incorporation of a methoxy 
substituent ortho to the tethered chain to give spiroketals 147a and 147b as the major 
reaction products in overall 56% yield.  
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Scheme 64 - Summary of developed spiroketalisation methods 1 and 2 
Upon confirmed formation of the desired spiroketals 147a and 147b, it was decided 
to investigate whether this newly developed method could be applied to the total 
synthesis of phorbaketal A. An investigation into the substrate scope of this new 
methodology was also of interest. Both of these synthetic ventures will be discussed 
in the following sections.  
2.2 Towards phorbaketal A 
An investigation into the use of the newly developed method for the installation of 
the cyclohexenone and spiroketal moieties possessed by phorbaketal A was initiated. 
A challenge towards the synthesis of phorbaketal A would be installation of the 
stereocentre and geranyl chain at C16 (Figure 12). The effect of this stereocentre on 
the diastereoselectivity during the spiroketalisation step was unknown. Moreover, the 
installation of trisubstituted (Z)-alkene moieties at C8–C10 and C12–C13 would pose 
major synthetic challenges. 
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Figure 12 - Spiroketals 147a/b compared to phorbaketal A (13) 
Treatment of hydroxyphenol 182 with an oxidant e.g. (PhI(OAc)2) was proposed to 
effect a cascade oxidative dearomatisation to give cyclohexadienone spiroketal 
substrates 183 (Scheme 65). The removal of the methoxy group, as previously 
discussed, would require some challenging reduction steps towards the 
cyclohexenone moiety possessed by phorbaketal A. 
 
Scheme 65 - Cascade oxidative dearomatisation to phorbaketal A precursor 183 
It was anticipated that upon formation of spiroketal substrate 183, chemoselective 
removal of the undesired C6-C7 trisubstituted alkene could later be achieved using 
the primary alcohol as a directing group. As has been previously discussed, 
Wilkinson’s catalyst can assist selective hydrogenation of conjugated alkenes. 
Additionally, Wilkinson’s catalyst is known to coordinate hydroxyl groups allowing 
selective hydrogenation of allylic or homoallylic alkenes.
74
 Other reduction method 
options could involve metal hydrides, also taking advantage of coordination of the 
hydroxyl group with the metal to steer chemoselective reduction of the C6-C7 
trisubstituted enone. Following this, reduction of the ketone 184 to alcohol 185 could 
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result in elimination of the undesired methoxy substituent to (after tautomerisation of 
186) ultimately give the desired cyclohexenone moiety possessed by phorbaketal A 
187 (Scheme 66).  
 
Scheme 66 - Anticipated reduction steps towards phorbaketal A; R = geranyl 
A synthesis of hydroxyphenol 182 was planned, with which the key cascade 
oxidative dearomatisation pathway and subsequent steps could be probed. 
2.1.1 Synthesis of Hydroxyphenol 182 
Retrosynthetic analysis of hydroxyphenol 182 revealed a possible addition of (Z)-
organometallic fragment 187 to (Z)-aldehyde 188 to give an alcohol 189, which 
would complete a synthesis of the alotane carbon skeleton (Scheme 67). The 
synthesis of (Z)-organometallic fragment 187 was envisaged to proceed from a (Z)-
vinyl iodide formed via an anti-carbometallation step via alkyne 190. Examples of 
anti-carbometallation of homopropargyl alcohols in the literature include those 
proceeding via: carbotitanation,
75
 carbomagnesiation
76
 and (more recently) Negishi-
type Zr-catalysed carboalumination
77
 processes. The synthesis of alkyne 190 was 
projected to proceed using a known procedure for the addition of propargyl bromide 
into geranial. The (Z)-aldehyde fragment 188 was envisaged to originate from 
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coumarin fragment 191, which would allow convenient access to the otherwise 
synthetically challenging trisubstituted (Z)-alkene moiety. The synthesis of the 
coumarin fragment would proceed via a reported Pechmann condensation procedure 
from methyl hydroquinone. In order to concentrate on investigating the key steps of 
the synthesis, it was decided early on that initial investigations would employ a 
racemic mixture of the alkyne fragment 190. 
 
Scheme 67 - Retrosynthetic analysis of hydroxyphenol 182 
Initial synthetic efforts were focused towards the synthesis of aldehyde fragment 
188. The synthesis of coumarin 192 was achieved using a reported Pechmann 
condensation procedure from commercially available reagents methylhydroquinone 
and ethylacetoacetate, using concentrated H2SO4 as solvent (Scheme 68).
78
 This 
convenient reaction gave clean conversion to the coumarin 192, which was used 
directly after work-up and the removal of water.  This step established the 
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synthetically challenging trisubstituted (Z)-alkene (C8−10), whilst also incorporating 
the two additional methyl groups (C4 and C9) present in phorbaketal A.   
 
Scheme 68 - Pechmann condensation for synthesis of coumarin 192 
The sparingly soluble coumarin 192 had its phenol group protected as a silyl ether by 
treatment with TBSCl and NEt3 in DMF, to give the readily soluble and highly 
crystalline coumarin 193 (Scheme 69a). 
 
Scheme 69a - TBS protection of coumarin 192 
At this point the author wishes to mention work which was completed in 
collaboration with an MSci student,
 
Christopher Arul. This work demonstrated the 
installation of the desired C9-hydroxyl group, via a regioselective allylic oxidation 
route from coumarin 193.
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 Treatment of 193 with SeO2 mediated conversion to 
aldehyde 194.  Following this, NaBH4 reduction of the aldehyde 194 and protection 
of the newly formed primary alcohol as its TBS silyl ether gave access to coumarin 
195 (Scheme 69b).  
 
Scheme 69b - Synthesis of C9-oxy coumarin 195 
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These results were encouraging, however initial efforts were focused upon 
establishing the more key synthetic steps of the synthesis, using the easily accesible 
coumarin 193.  Reduction of the lactone moiety within coumarin 193 to the desired 
(Z)-allylic alcohol 196 proved to be challenging (Scheme 70). Treatment of the 
coumarin 193 with a range of reducing agents: LiAlH4, LiBH4, NaBH4 and DIBAL-
H all resulted in low yields (0 – 30%) along with varying amounts of suspected 1,4-
reduction. However, reduction using LiAlH4 and BnCl for the in situ formation of 
AlH3
80
 was optimal; giving (Z)-allylic alcohol 196 in 61% yield. Chemoselective 
methylation of the phenol in the presence of the primary alcohol was achieved under 
basic conditions with Cs2CO3 and MeI. Subsequent allylic alcohol oxidation was 
achieved using MnO2 to give (Z)-aldehyde 197.  
To ascertain the stereochemistry of the potentially isomerisable (Z)-enone motif, nOe 
experiments were conducted. The alkenyl proton was irradiated in a nOe difference 
experiment, leading to a 0.96% enhancement of the neighbouring methyl group 
resonance, confirming the desired (Z)-alkene stereochemistry had been retained. 
Following this, gradual crystallisation of the (Z)-aldehyde 197 over a few days 
allowed for further confirmation of the (Z)-alkene stereochemistry by X-ray 
crystallographic analysis (Figure 13).  
Figure 13 - ORTEP of 197                Scheme 70 - Synthesis of (Z)-aldehyde 197 
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With the formation of (Z)-aldehyde 197, synthetic efforts were focused towards the 
synthesis of alkyne 190. Oxidation of inexpensive and commercially available 
geraniol to geranial was achieved using MnO2 (Scheme 71). Following this, a zinc-
mediated Reformatsky addition
*
 of propargyl bromide to geranial facilitated 
formation of alkyne 190.
81
  Although this method did not allow enantioselective 
formation of the chiral centre required at the C16 position of phorbaketal A (see 
Figure 12, Page 66), it was decided to investigate the key steps towards phorbaketal 
A using this racemic mixture, before enantioselective alternatives could be 
investigated. Such future enantioselective step options were anticipated to include 
asymmetric reduction of a ketone or lipase deacetylation processes. 
 
Scheme 71 - Reformatsky addition for alkyne 190 
With the formation of alkyne 190, attempts at a Negishi anti-carboalumination were 
conducted. Treatment of alkyne 190 with trimethyl aluminium and zirconium 
dichloride was followed by refluxing for three days in order to achieve (E)- to (Z)-
alkene isomerisation to intermediate 198. This was followed by quenching of the 
reaction mixture with iodine. Unfortunately, analysis of the 
1
H NMR spectrum after 
protic work-up revealed a completely unidentifiable mixture of degradation products, 
with no characteristic alkenyl resonances.   
----------------------------- 
* Very violent reaction! Caution needed.  
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Scheme 72 - Attempted Negishi anti-carboalumination of alkyne 190 
Although time invested in the development of this carboalumination step could lead 
us to the desired alkene fragment 199, at this stage it was decided to focus on 
achieving the more adventurous novel key steps later in the sequence towards the 
synthesis of phorbaketal A.  
It was envisaged that in situ formation of a lithium acetylide species formed by 
deprotonation of the terminal alkyne proton of an alkyne 190 analogue would allow 
nucleophilic addition to aldehyde 197. To investigate this, alkyne 190 was firstly 
silyl protected using TBSCl in the presence of NEt3, to give alkyne 200. 
 
Scheme 73 - Synthesis of O-TBS protected alkyne 200 
Treatment of alkyne 200 with n-BuLi mediated in situ formation of lithium acetylide 
species, which was quenched by the addition of (Z)-aldehyde 197 to give (Z)-
propargyl alcohol 201 upon protic work-up (Scheme 74). The noralotane skeleton 
bearing alcohol 201 was isolated as a mixture of two diastereomers which co-eluted 
by flash column chromatography. Being a mixture of diastereomers, unambiguous 
assignment of every carbon atom in analysis of the 
13
C NMR spectrum was 
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unattainable until elimination of the newly formed chiral centre in a later step. 
Following this, treatment of propargyl alcohol 201 with Lindlar catalyst under one 
atmosphere of hydrogen facilitated smooth hydrogenation of the alkyne moiety to the 
desired (Z),(Z)-alkene 202.  
 
Scheme 74 - Synthesis of (Z),(Z)-alkene 202 
Upon isolation of (Z),(Z)-alkene 202, oxidation of the allylic alcohol moiety using 
MnO2 was achieved, to give (Z),(Z)-enone 203 (Scheme 75). With formation of the π 
conjugated enone system possible degradation through (Z)- to (E)-alkene 
isomerisations was feared. With this in mind, the (Z),(Z)-enone 203 was stored in a 
−30 °C freezer under argon, and thankfully no isomerisation was observed by 1H 
NMR analysis during storage. With the removal of one stereocentre and hence the 
substrate no longer being a mixture of two diastereomers, analysis of (Z),(Z)-enone 
203 by 
13
C NMR pleasingly became more simplistic.  
For the concurrent removal of both silyl groups, (Z),(Z)-enone 203 was treated with 
TBAF (2.5 eq) and the reaction was monitored by TLC. After 2 h, TLC analysis 
revealed conversion to a more polar (slower eluting) compound as expected upon the 
deprotection of the polar hydroxyl groups. However, after protic work-up 
1
H NMR 
analysis revealed removal of the phenolic TBS group only to give 204.  
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Scheme 75 - Synthesis of (Z),(Z)-enone 203 and silyl deprotection to 204 
The phenol 204 was again treated with TBAF (1.2 eq), and following of the reaction 
by TLC over 5 h revealed consumption of the starting material. However upon protic 
work-up the 
1
H NMR spectrum revealed degradation to a complex mixture.  
Removal of the stubborn secondary TBS group was then attempted under acidic 
conditions with MeOH and AcCl (1.0 eq) (for the formation of dry HCl). However in 
similar fashion the 
1
H NMR spectrum revealed degradation to a complex mixture. 
Potential degradation pathways of the highly unsaturated substrates, in basic or 
acidic conditions, could include migration of double bonds, isomerisation of double 
bonds and sigmatropic rearrangements or intramolecular hetero Diels–Alder 
reactions. 
 
Scheme 76 - Attempted deprotection of secondary alcohol 204 
Being unable to remove the seemingly stubborn secondary TBS group and the need 
to synthesise greater quantities of alkyne 190, it was decided to employ a more labile 
silyl protecting group on the secondary hydroxyl group.  
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The relative stability of common silyl protecting groups to acid and base hydrolysis 
has been studied.
82
 In acidic media the relative resistance is: trimethylsilane (TMS) 
(1) < triethylsilane (TES) (64) < TBS (20,000) < triisopropylsilane (TIPS) (700,000). 
In basic media the relative resistance is:  TMS (1) < TES (10-100) < TBS (20,000) < 
TIPS (100,000). Each group with added steric bulk displays a very large increase in 
resistance to hydrolysis (Figure 14). Of the common silyl groups, the TES group is 
the next most labile after the TBS group.  
 
Figure 14 - Relative stability of silyl protecting groups   
Thus, it was decided to repeat the same steps of the synthesis, substituting the TBS 
ether protecting group of alkyne 200 with the much more labile TES ether protecting 
group. This strategy was initiated by the treatment of alkyne 190 with TESCl in the 
presence of imidazole, to give smooth conversion to the TES group bearing 206 
(Scheme 77). 
 
Scheme 77 - Synthesis of TES protected alkyne 206 
The synthesis of ketone 209, bearing a TES protected secondary alcohol, was 
achieved in three synthetic steps analogous to those previously discussed (and with 
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better yields) (Scheme 78). To the author's delight, removal of the more labile TES 
group was not encountered during these steps.   
 
 
Scheme 78 - Synthesis of (Z),(Z)-enone 209 
Upon the successful synthesis of the (Z),(Z)-enone 209, a method for the removal of 
both silyl protecting groups was again investigated. Concurrent removal of both silyl 
protecting groups was achieved using TBAF as a source of fluoride, to give 
hydroxyphenol 205 in a 97% yield (Scheme 79). Unfortunately, storage of the 
hydroxyphenol 205 over a few days led to degradation to an unidentifiable mixture 
of compounds, as determined by 
1
H NMR analysis. To avoid this degradation of the 
unstable substrate (after eleven synthetic steps), after work-up, the purified 
hydroxyphenol 205 was stored under argon in a freezer at −80 °C and used within 
2−3 days.  
 77 
 
At this stage, confirmation of both crucial (Z)-alkene geometries was required. The 
C12–C13 alkenyl protons co-resonated as a multiplet in the 1H NMR spectrum at 400 
MHz. However by running the 
1
H NMR experiment at 600 MHz the expected 
coupling constant of J = 11.6 Hz could be extrapolated from the more resolved 
multiplet, to confirm the (Z)-alkene geometry. Added to this, a NOESY experiment 
revealed a nOe between the C12–C13 alkenyl protons. Conformation of the C8-C10 
(Z)-alkene via a nOe difference experiment involved irradiation of the C10 alkenyl 
proton, resulting in a 1.35% nOe enhancement of the adjacent alkenyl methyl group. 
 
Scheme 79 - Synthesis of (Z),(Z)-hydroxyphenol 205 
2.2.2 Spiroketalisation of (Z),(Z)-Hydroxyphenol 205 
Upon the succesful synthesis of (Z),(Z)-hydroxyphenol 205, bearing the noralotane 
carbon skeleton, investigations into the key cascade oxidative dearomatisation step 
ensued. Treatment of hydroxyphenol 205 with PhI(OAc)2 in MeCN (Scheme 80) was 
followed by TLC analysis, and upon consumption of starting material the solvent 
was removed in vacuo. Analysis of the crude mixture by 
1
H NMR spectroscopy 
indicated a complex mixture of unidentifiable products from which no information 
about the fate of the starting material was obtained. By repeating this reaction in 
MeCN-d3 and monitoring by 
1
H NMR, the the build up of the expected acetic acid 
 78 
 
by-product of PhI(OAc)2 at 1.96 ppm was observed, but also unexpectedly revealing 
the build-up of MeOH, observed as a singlet resonating at 3.28 ppm (Figure 15).
*
 
 
 
Scheme 80 - Attempted synthesis of spiroketal 210 
 
Figure 15 - 
1
H NMR observed elimination of MeOH from spiroketal 210  
The apparent build up of MeOH over time indicated elimination of the methoxy 
substituent, presumably via protonation by acetic acid, to give intermediate 211 and 
subsequent elimination to form an oxocarbenium intermediate 212 (Scheme 81). The 
fate of this oxocarbenium intermediate 212 could then be envisaged in a number of 
----------------------------- 
* Reported resonance of MeOH in CD3CN in J. Org. Chem, 1997, 62, 7512−7515.  
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degradation steps including nucleophilic attack from adventitious water to give 
oxygenated by-products.  
 
 
 
 
 
 
Scheme 81 - Acetic acid degradation of proposed spiroketal 210 
In an aim overcome this alarming sensitivity to weakly acidic conditions, the reaction 
was repeated in the presence of pyridine (2.5 eq). This base was chosen to buffer the 
reaction because it is very weak (pKa conjugate acid = 5.3); conforming with very 
mild reaction conditions. Moreover, deuterated pyridine was available, allowing 
1
H 
NMR monitoring to be conducted in a straightforward manor.  
Initially hydroxyphenol 205 was treated with PhI(OAc)2 in the presence of d5-
pyridine (2.6 eq) in d3-MeCN.  Following the reaction by TLC analysis revealed the 
consumption of starting material 205 over 20 min. Before work-up crude 
1
H NMR 
analysis revealed the presence of four well-defined singlets in the methoxy region 
(2.8–3.4 ppm). After this, the reaction was diluted with diethyl ether, and the organic 
layer was washed with water, dried over MgSO4, filtered and evaporated. The 
organic residue was then dissolved in CDCl3 for NMR analysis. Analysis of the 
1
H 
NMR revealed a complex mixture of products, although there was a clear presence of 
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four well defined singlets at 3.39, 3.33, 3.24 and 3.18 ppm. It was presumed that 
these four singlets may have corresponded to the four methoxy signals of the four 
expected diastereomeric spiroketal products. 
Isolation of these sensitive compounds for thorough characterisation proved 
extremely challenging. Simple removal of the volatiles in vacuo after reaction gave 
degradation and was deemed unsuitable since it involved concentrating the acid-
sensitive compounds with pyridinium acetate. Thus, typically the reaction mixture 
was placed directly onto the solid phase of a column. Attempts of purification using 
acidic silica, neutral silica, florisil, basic alumina, grade II basic alumina and 
preparative TLC on silica were unfruitful and gave complete compound degradation. 
Isolation of two of the apparent ‘major diastereomers’ was achieved using grade III 
basic alumina, however in a very low yield. A 56% yield of a mixture of four 
apparent diastereomers was eventually achieved using grade IV basic alumina, 
however the purity of the sample as judged by NMR analysis was poor. 
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Figure 16 - Proposed spiroketals (210a-d) purified on grade IV basic alumina (600 
MHz, C6D6) 
 
Scheme 82 - Proposed formation of spiroketal diastereomers 210a-d 
Being an impure mixture of four diastereomers in an already complex system made 
thorough and conclusive chemical analysis unattainable. The 
1
H NMR for the 
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mixture was highly characteristic of a mixture of four diastereomers (figure 16). Key 
protons could be assigned through a COSY experiment.  
Encouragingly, HRMS analysis of the mixture revealed the expected m/z ion peak for 
the desired spiroketals. The 
13
C NMR spectrum revealed the presence of 6 signals 
around 186 ppm which were believed to correspond to the C=O carbon atom of the 
dearomatised spiroketal diastereomers, and some unidentified by-products. 
Moreover, the 
13
C NMR spectrum revealed the presence of 6 signals around 92 ppm, 
which is a characteristic shift region for a spiroketal centre. However, upon 
observation of the 
13
C NMR spectrum the compounds had shown further 
considerable degradation, and so this could not be assigned fully. It should be noted 
that although their formation seems apparent, their structures were not conclusively 
determined. Attempts of establishing the stereochemistry of each diastereomer by 
NOESY and nOe difference experiments with irradiation of various protons of each 
diastereomer in the mixture were unsuccessful.  
With the aim to overcome these problems in substrate isolation it was decided to 
attempt reduction of the ketone moiety of 210 to alcohol 213, which was then 
envisaged to aromatise via elimination of the methoxy substituent to give the 
presumed-to-be more stable phenolic spiroketals 214 (Scheme 83, pathway 2). Also, 
it was thought that removal of one chiral centre, and the resolution of the mixture 
into two diastereomers, may simplify isolation and characterisation.  Although this 
transformation would not direct the synthesis towards the cyclohexenenone moiety 
possessed by phorbaketal A, it was believed that the removal of the labile methoxy 
substituent would allow proper isolation and characterisation of the spiroketals. 
Additionally, if rearomatisation with ejection of the methoxy group could be 
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demonstrated, this would suggest that elimination of the methoxy group via the 
previously described route (Scheme 83) may also be possible.  
To investigate this, the mixture of four diastereomeric ketones (210a-d), purified 
using grade IV basic alumina, was treated with NaBH4. After protic work-up analysis 
of the 
1
H NMR spectrum revealed a mixture of products which were clearly bearing 
methoxy substituents, with several resonances ranging from 3.74–3.77 ppm. The 
chemical shift of the major methoxy signal strongly indicated it was an anisole 
derivative, and did in fact exactly match the chemical shift of the anisole moiety 
possessed by precursor dihydroxy ketone 205, at 3.74 ppm. This analysis indicated 
aromatisation and ejection of the ether of the spiroketal core had occured rather than 
the desired ejection of MeO (Scheme 83, pathway 2 to give 215). The structure of the 
products could not be fully determined. The presence of the methoxy substituent in 
the 
1
H NMR spectrum clearly indicated that ejection of the methoxy substituent had 
not occurred. Further to this, HRMS analysis revealed the presence of the expected 
ion for phenol 215. These data were sufficient evidence for the author to abandon 
this approach towards obtaining more stable substrates.  
 
Scheme 83 - Reduction of ketone 210 and subsequent rearomatisation.  R= geranyl  
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The instability of the dearomatised spiroketal substrates 210 was very discouraging 
in the efforts towards the total synthesis of phorbaketal A. As previously discussed, 
the future steps towards the total synthesis of phorbaketal A (or close analogue) 
would involve the chemoselective removal of the undesired enone, reduction of the 
ketone moiety and ejection of the methoxy substituent. The investigation into 
rearomatisation pathways via reduction of the ketone 210 revealed a fatal set-back; 
that ejection of the spiroketal ether seemed to be the favoured aromatisation pathway. 
This suggested that elimination of the methoxy group via the previously described 
route (Scheme 83) towards phorbaketal A would likely be unachievable.  With these 
results in mind, coupled with the reduced novelty in any synthesis due to the reported 
syntheses of alotaketal A by Yang and Dalby, it was decided to discontinue this 
approach towards the total synthesis of phorbaketal A. 
2.2.3 Fluorine Incorporation Studies 
Some time was spent investigating the use of fluorine in substitution for the methoxy 
substituent used in the previous investigations. Fluorine is not easily protonated, but 
was potentially a leaving group in place of a methoxy substituent in the envisaged 
strategy towards phorbaketal A. For example, fluorine has been shown to be a 
plausible leaving group, as a consequence of its unparalleled electronegativity, 
during rearomatisation processes e.g. SNAr mechanisms via Meisenheimer complex 
intermediates.
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In this work, it was thought that fluorine could serve as a superior leaving group 
relative to the required spiroketal ether during rearomatisation and/or elimination 
processes. Being non-protonatable, it was hypothesised that fluorine spiroketal 
analogues e.g. 216 may demonstrate better stability, allowing better isolation and 
 85 
 
characterisation of spiroketal products analogous to 210a-d. Since 
19
F possesses spin 
(I = ½) and is NMR active, this could allow observation of nOes between 
19
F and the 
ring systems, potentially allowing structural assignment of the spiroketal 
diastereomers.  
 
Scheme 84 - Proposed fluorine substituted spiroketals 216 towards phorbaketal A 
To investigate this, synthesis of the model substrate 217 was envisaged. Treatment of 
hydroxyphenol 217 with an oxidant would potentially assist cyclisation via oxidative 
dearomatisation to give highly novel cyclised substrate 218 (Scheme 85). The 
observed stability of the cyclised substrate 218 would then allow judgement as to 
whether a similar fluorine system could be employed towards the total synthesis of 
phorbaketal A. Also, treatment of the ketone 218 with a hydride source could then 
reveal whether ejection of fluorine or oxygen was favoured during aromatisation.   
Scheme 85 - Proposed Synthesis of chromene 219 
The synthesis of hydroxyphenol 217 was achieved in five steps. Firstly, the TBS 
protection of 4-fluorophenol was achieved by treatment with TBSCl in the presence 
of imidazole (Scheme 86). Treatment of the protected phenol 220 with n-
BuLi/TMEDA mediated ortho-lithiation (respective to fluorine), and upon quenching 
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with DMF and protic work-up, gave aryl aldehyde 221.
84
 An Ando-modified Horner-
Wadsworth-Emmons olefination of aldehyde 221 using phosphonate 222, gave novel 
ester 223 in a 1:10 E:Z ratio. The (Z)-alkene stereochemistry of the major (Z)-alkene 
product was confirmed by analysis of the J coupling constant value of the alkenyl 
protons, 
3
Jcis = 12.5 Hz.  Following this, DIBAL-H mediated reduction of the (Z)-
ester 223 to the alcohol functionality. Finally, removal of the silyl ether protecting 
group was achieved using TBAF as a source of fluoride, to give hydroxyphenol 217.  
 
Scheme 86 - Synthesis of hydroxyphenol 217 
Hydroxyphenol 217 was treated with PhI(OAc)2 in CDCl3 and the reaction was 
periodically monitored in situ by 
1
H NMR spectroscopy (Scheme 87). 
Dearomatisation with intramolecular cyclisation of the hydroxyl group was suspected 
due to the seperation of the previously co-resonant O-CH2 protons into J-coupled 
diastereotopic OCHa and OCHb protons at 4.42 and 4.30 ppm on the newly formed 
ring. In general, the chemical shift of the previously aromatic protons were shifted 
upfield, as expected upon the destruction of the aromatic system and corresponding 
ring current.  
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However, with monitoring over 5 h, the dearomatised substrate 218 showed gradual 
degradation to an unidentifiable mixture.  
  
 
Figure 17 - 
1
H NMR observed degradation of proposed cyclised substrate 218 
Having observed complete degradation of the proposed dearomatised substrate 218 
under the mild reaction conditions, an investigation into the effect of rapid treatment 
of the unstable intermediate 218 with a hydride source was initiated.  This 
investigation would potentially reveal whether rearomatisation with the elimination 
of fluoride was possible.  
Firstly, treatment of hydroxyphenol 217 with PhI(OAc)2 was buffered with pyridine 
(Scheme 87), and the consumption of the starting was observed by 
1
H NMR analysis 
of an aliquot of the reaction mixture. After this time, an excess of DIBAL-H (5 eq.) 
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was added immediately at 0 °C. Upon protic work-up after 1 h, analysis of the crude 
1
H NMR spectrum revealed the predominant presence of hydroxyphenol 217 starting 
material and a mixture of unidentified products. No evidence for the formation of 
chromene 219, for which 
1
H NMR spectrum data had been previously reported in the 
literature, was obtained.
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 In similar fashion, the dearomatised substrate 218 was also 
treated with an excess of NaBH4 (4 eq.) at 0 °C. After protic work-up analysis of the 
1
H NMR suggested the presence of hydroxyphenol 217, and a mixture of degradation 
products, with no proton resonances matching those reported for chromene 219 in the 
literature.  
Seemingly under these conditions, rearomatisation with elimination of the oxygen 
atom was the preferred pathway (Scheme 87, path 1). Due to this, and also the 
observed instability issues for dearomatised substrate 218, this short investigation 
into the use of fluorine as a substituent during oxidative dearomatisation came to an 
end.   
 
Scheme 87 - Attempted synthesis of chromene 219 
2.2.4 Conclusion and Future Work 
The glaring instability issues encountered from synthesis of the proposed methoxy-
bearing dearomatised substrates 210 and fluorine-bearing dearomatised substrates 
218 were extremely discouraging for the use of this strategy towards the total 
synthesis of phorbaketal A. Subsequent investigations into rearomatisation pathways 
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via reduction of the ketone 210 revealed a fatal set-back i.e. ejection of the methoxy 
substituent was the favoured pathway during aromatisation. The rearomatisation 
pathway explored from fluorine-bearing dearomatised substrates 218 suggested the 
preferred elimination of oxygen over fluorine. 
Therefore it was decided to discontinue investigations into the use of the newly 
developed method for spiroketalisation by cascade oxidative dearomatisation 
towards the total synthesis of phorbaketal A. 
The author believes that some future investigations could involve the effect of using 
different substituents ortho to the tethered chain, in substitution for the investigated 
methoxy or fluorine substituents. One substituent worth investigating could be a silyl 
group. This could provide a better stability of the respective dearomatised substrates 
e.g. 225, and treatment of the dearomatised product with a fluoride source could 
allow for an alternative pathway to phorbaketal A (Scheme 88). 
 
Scheme 88 - Silyl strategy for phorbaketal A (13) 
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2.3 Methodology Scope Exploration 
With the partially successful showcasing of the new method for spiroketalisation, 
efforts towards the expansion of this method into a more general method for 
spiroketalisation were conducted.  The author set out to investigate whether the (Z)-
alkene present in the initial model system was an essential motif and thus to probe 
whether saturated spiroketal rings could be synthesised. The formation of model 
substrates 226 and 227 for the formation of 6,6- and 6,5-spiroketals 228 and 229 
respectively was envisaged (Scheme 89).  
 
Scheme 89 - Proposed synthesis of spiroketals 228 and 229; n =1, 2 respectively 
2.3.1 Synthesis of Hydroxyphenol 227 
Retrosynthetic analysis of hydroxyphenol 227 (n=2) was carried out in similar 
fashion to previous model substrates (Scheme 90). Retrosynthetic cleavage of a 
central C–C bond revealed a nucleophilic synthon 230 which corresponded to an 
acetylide fragment 231, and electrophilic aldehyde fragment 231. In the forward 
synthetic plan it was envisaged that the alkyne moiety would be fully hydrogenated 
to the desired saturated alkyl chain. Formation of the aldehyde fragment 232 was 
anticipated via Horner-Wadsworth-Emmons olefination of the previously synthesised 
aryl aldehyde 164, with subsequent oxidation level transformations.  
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Scheme 90 - Retrosynthetic analysis of hydroxyphenol 227 
Following this retrosynthetic pathway, the synthesis of hydroxy phenol 227 was 
achieved in ten synthetic steps. The aryl aldehyde substrate 164 was synthesised in 
the same novel steps as previously described. Firstly, Horner-Wadsworth-Emmons 
olefination of aldehyde 164, using triethyl phosphonoacetate, gave access to (E)-ester 
233 (Scheme 91). Upon isolation of the novel (E)-ester 233, hydrogenation of the 
alkene moiety over Pd/C gave smooth conversion to the ester 234. Following this, 
the ester 234 was directly reduced to the aldehyde 232 using DIBAL-H at –78 °C.  
 
Scheme 91 - Synthesis of aldehyde 232 
Silyl protection of 3-butyne-1-ol was achieved via a known procedure using TBSCl 
and imidazole, to give alkyne 235 in quantitative yield (Scheme 92).
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Scheme 92 - Synthesis of alkyne 235 
Treatment of alkyne 235 with n-BuLi mediated the in situ formation of the lithium 
acetylide anion, to which aldehyde 232 was added, giving alcohol 236 after protic 
work-up (Scheme 93). Following this, the alkyne 236 was hydrogenated over Pd/C in 
MeCN to give alcohol 237. The secondary alcohol 237 was oxidised using a Swern 
oxidation to give the ketone 238. Finally, the concurrent removal of both TBS groups 
was achieved using TBAF to give hydroxyphenol 227.  
 
Scheme 93 - Synthesis of hydroxyphenol 227  
2.3.2 Attempted Spiroketalisation of Hydroxyphenol 227 
Upon the synthesis of hydroxyphenol 227 spiroketalisation via cascade oxidative 
dearomatisation was examined. Treatment of hydroxyphenol 227 with PhI(OAc)2  
resulted in the consumption of starting material as indicated by TLC. Removal of the 
volatiles in vacuo and observation of the crude reaction mixture by 
1
H NMR 
spectroscopy indicated a complex mixture of unidentifiable products, with no 
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indication of the expected cyclisation products. This reaction was repeated with an 
excess of pyridine to buffer the acetic acid by-product and monitoring by 
1
H NMR 
spectroscopy again indicated a complex mixture with no signs of the expected 
cyclisation products. TLC analysis of these reactions only gave material on the 
baseline (apart from iodobenzene on the solvent front), even in neat EtOAc.  
Treatment of hydroxyphenol 227 with phenyliodine bis(trifluoroacetate) (PIFA) gave 
an unexpected deep blue/green solution, with the 
1
H NMR spectrum after 
evaporation of the solvent revealing a complex mixture of unidentified products.  
 Table 4 - Conditions for attempted spiroketalisation of 227 
 
 
 
  
 
 
 
The fate of the starting material in these attempts could not be determined. It was 
suggested that the dearomatised products may be prone to rapid degradation via 
facile elimination of the methoxy substituent or other unknown processes. 
Alternatively, it was proposed that the acetic acid by-product of the oxidants may 
participate in nucleophilic competition with the desired intramolecular cyclisation.  
Conditions Conversion (%) 
PhI(OAc)2 (1.7 eq.), MeCN, 1h 0 
PhI(OAc)2 (1.5 eq.), pyridine (3.0 eq.), MeCN, 16 h 0 
PIFA (2.1 eq.), pyridine (2.7 eq.), MeCN,1 h 0 
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Contemporaneously to the synthesis of hydroxyphenol 227, the synthesis of 
analogous hydroxyphenol 226, for an investigation into the synthesis of analogous 
6,5- spiroketal 228, was conducted.  
2.3.3 Synthesis of Hydroxyphenol 226 
The synthesis of analogous hydroxyphenol 226 was achieved using the same 
synthetic strategy as for hydroxyphenol 226 (Scheme 94). The silyl protection of 
propargyl alcohol was achieved using the reported procedure with TBSCl and 
imidazole to give alkyne 238.
87
 The subsequent four steps analogous to those 
previously conducted were successful to give hydroxyphenol 226.  
 
Scheme 94 - Synthesis of hydroxyphenol 226 
Attempts for the spiroketalisation of 226 were conducted in similar fashion to the 
previous substrate (Table 5).  
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2.3.4 Attempted Spiroketalisation of Hydroxyphenol 226 
Table 5 - Attempts towards spiroketal 228  
 
 
 
 
 
 
In similar fashion as before, under the attempted conditions, evidence for the 
formation of the desired 6,5-spiroketal 228 was not observed, with apparent complete 
degradation to  unidentifiable mixtures.  
2.2.5 Conclusion  
Seemingly, the presence of the (Z)-alkene moiety is imperative for the previously 
observed spiroketalisation by cascade oxidative dearomatisation to occur under the 
conditions tested. Alternatively, the (Z)-alkene may prevent degradation of the 
dearomatised products. Certainly, the (Z)-alkene forces the ketone into fairly close 
proximity to the aromatic ring, which may be essential for cyclisation to occur under 
the tested conditions.  
Conditions Conversion (%) 
PhI(OAc)2 (1.0 eq.), MeCN, 1 h 0 
PhI(OAc)2 (1.5 eq.), MeCN, 16 h 0 
PhI(OAc)2 (1.0 eq.), pyridine (1.8 eq.), MeCN, 16 h 0 
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In conclusion, it was found that saturated hydroxyl phenol substrates 226 and 227 do 
not allow the isolation of spiroketals 228 and 229 respectively, under similar 
conditions used for the previous synthesis of spiroketals 147a/b. At this point in this 
work the author was discouraged towards further exploring the use of the 
demonstrated spiroketalisation by cascade oxidative dearomatisation method.  
As previously discussed, the utilisation of this method for the total synthesis of 
phorbaketal A was proved unsuitable.  At this point in this work, two total syntheses 
of alotaketal A had been reported
31,32
 and so an investigation into alternative 
synthetic staregies towards the alotaketals and phorbaketals would have reduced 
novelty.  
With an eagerness to further explore the synthesis of the discussed emerging family 
of sesterterpenoid secondary metabolites, and having gained aptitude for the 
synthesis of complex terpenoid structures, the author was drawn towards the 
intriguing sesterterpenoid natural product phorone A.    
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3. Results and Discussion II 
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3.1 Introduction to Phorones A and B 
Phorone A (24) is a sesterterpenoid isolated by Wang et al. from the marine sponge 
Phorbas sp. in 2012.
22
 Very recently in January 2015, the isolation of phorone B 
(242) was reported by Woo et al. from the marine sponge Clathria gombawuiensis 
(Figure 18). 
22
 
These natural products belong to a family of biosynthetically related 
sesterterpenoids, their structure deriving from the alotane skeleton also possessed by 
the phorbaketals and alotaketals. Phorones A and B (24 and 242) are the only known 
natural products possessing the ‘phorane’ carbon skeleton. Added to this, they both 
possess highly novel and intriguing cis-fused seven-membered rings. Phorone B was 
found to be moderately active towards some cancer cell lines.
22
 
 
Figure 18 - Phorone A (24) and phorone B (242) 
The proposed biosynthesis of these sesterterpenoids suggests a key electrophilic 
aromatic substitution process via a carbocation intermediate e.g. 23 (Scheme 95). 
This electrophilic aromatic substitution can occur with para- or ortho-
regioselectivity to the phenol, to give phorone A or phorone B respectively. The 
formation of phorone B via this process requires greater steric demand, forming four 
neighbouring substituents on the aromatic ring. It is proposed that phorone A is the 
major product and phorone B the minor product in this biosynthetic process.  
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Alternative trapping of the carbocation intermediate 23 with an acetate anion, and 
subsequent oxidation processeses, are proposed to proceed to the related 
sesterterpenoid natural product ansellone E (25).  
 
Scheme 95 - Proposed biosynthesis of phorone A (24) and phorone B (242) 
 
Examples of carbocation intermediates similar to 23 and subsequent electrophilic 
aromatic substitution processes are revealed in the synthesis of some analogous 
substrates in the literature (Scheme 96).
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 For example, treatment of alcohols 243 and 
244 with Lewis acid (SnCl4) promotes formation of the carbocation intermediates 
(245 and 246 respectively) which are prone to nucleophilic attack from aromatic 
systems to form trans-fused five- and six-membered rings 247 and 248 respectively. 
Alternatively, as demonstrated by Corey et al.,
89
 a mesylate leaving group (249) 
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allows formation of the carbocation intermediate 250 upon treatment with H2SO4, 
resulting in subsequent formation of trans-fused six-membered ring 251. Presumably 
these examples result in the formation of trans-fused rings due to the steric demand 
provided by the substituted decalin system, in particular the axial methyl groups.  
 
 
Scheme 96 - Analogous examples of electrophilic aromatic substitution  
In light of this precendence, the cis-fused stereochemistry of the seven-membered 
ring possessed by phorone A and B was somewhat unexpected. It was thought that 
the (Z)-alkene moiety possessed by phorone A, or the increased size of the ring, may 
someway favour formation of the cis-fused ring. It is proposed that cyclisation results 
in steric clashing with the neighbouring axial methyl groups, which may promote 
formation of the trans-fused ring (Figure 19). The author suggests that the oxygen 
lone pair of the secondary alcohol may coordinate to the carbocation and block attack 
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of the aromatic moiety from the lower face, to disfavour formation of the trans-fused 
ring. It is plausible that a trans-fused phorone A natural product does exist, but has 
not yet been isolated.   
 
 
Figure 19 - Proposed model for cis- or trans-ring formation towards phorone A 
 
3.2 Retrosynthetic Analysis of Phorones A and B 
The planned total synthesis of phorone A discussed herein is believed to be partially 
biomimetic since it involves formation of carbocation intermediate 23, or an 
analogue, for the formation of the cis-fused seven-membered ring via electrophilic 
aromatic substitution. After the recent isolation of phorone B, it was anticipated that 
the key electrophilic aromatic substitution step would give a mixture of phorones A 
and B. 
Retrosynthetic analysis of phorone A (24) involved initial retrosynthetic cleavage of 
the C–C bond directly linking the aromatic system to the decalin system (Scheme 
97). In the biosynthesis of phorones A and B the electrophilic synthon could equate 
to a hydroxyl, acetyl (refer to ansellone E) or protonatable alkene group. The 
synthesis of ansellane alcohol 252 was envisaged to proceed with the addition of a 
(Z)-haloalkene fragment 253 to aldehyde fragment 254 via a halogen-metal exchange 
method, and thus relied upon similar chemistry to that experienced in the previous 
phorbaketal A project (results & discussion I). The synthesis of aldehyde fragment 
254 was planned over several steps from epoxide 255, via regioselective reductive 
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opening of the epoxide moiety, for installation of the required secondary alcohol. 
The synthesis of epoxide 255 was anticipated to proceed over several steps from 
known ester 256. The synthesis of (Z)-haloalkene fragment 253 was anticipated to 
proceed via an olefination method from acetophenone 257.  
 
Scheme 97 - Retrosynthetic analysis of phorone A (24) 
 
3.3 Synthesis and Reactivity of Aldehyde Fragment 254 Analogues  
This work was initiated with synthetic efforts towards aldehyde fragment 254. Using 
a reported procedure, the synthesis of ester 258 was achieved by the treatment of β-
ionone with dimethyl carbonate and sodium hydride in refluxing dioxane (Scheme 
98).
90
 Photochemically-induced cyclisation of the ester 258 to the trans-decalin ester 
256 was achieved using the procedure reported by White et al., by irradiation of the 
ester 258, in the presence of NaOMe, with a 400 W mercury lamp photochemical 
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reactor
*
 over 24 h.
91
 Typically, photochemical reactions were run on 10 g batches, 
with 4 × 10 g reactions giving around 2–3 g of ester 256. Albeit highly inefficient 
and labour intensive, this synthetic step facilitated a rapid increase in molecular 
complexity, with the formation of three required chiral centres. Moreover, β-ionone 
is inexpensive
†
 and the ester 258 could be synthesised in up to 60 g quantities in one 
day.   
Following previously reported procedures, treatment of the ester 256 with LiAlH4 
facilitated global reduction of the ester and ketone functionalities to give diol 259. 
Selective oxidation of the allylic alcohol 259 was achieved using MnO2 to give 
ketone 260. Subsequent to this, the ketone 260 was then treated with MeLi to give 
diol 261a as the major diastereomeric product, with formation of the drimane carbon 
skeleton.
92
 For all steps described henceforth, the formed diasteteromers were used 
as a mixture. Confirmation of each diastereomers stereochemistry were made during 
the characterisation of later synthesised substrates (vide infra).  
 
Scheme 98 - Synthesis of diol 261 
----------------------------- 
* Medium pressure 400 W mercury lamp, with an immersion well.  
† 100 g for £16.50 from sigmaaldrich.com  
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A key future step would involve addition of (Z)-alkene fragment 253 to aldehyde 254 
analogues, synthesised by oxidation of the primary alcohol possessed by diol 261. 
Thus, methods for the oxidation of primary alcohol 261 to the aldehyde functional 
group were probed.  
Initially Swern oxidation was attempted for the synthesis of aldehyde 262 from diol 
261. Analysis of the reaction mixture by 
1
H
 
and 
13
C NMR indicated that elimination 
of the tertiary alcohol had occurred to give dienal 263. The main new aldehyde signal 
resonated as a singlet at 10.06 ppm. It was proposed that this elimination may occur 
via alkoxysulfonium ion intermediate 264, mediating elimination of the oxygen atom 
with the neighbouring anti-conformed hydrogen atom. Alternatively, HCl generated 
by oxalyl chloride
*
 could facilitate the elimination by protonation of the tertiary 
alcohol. Nevertheless, this result was a positive indication that the tertiary alcohol 
could readily eliminate under particular conditions, as was required for a later step in 
the projected synthesis of phorone A.  
 
Scheme 99 - Degradation of diol 261 during Swern oxidation 
Undeterred by this result, it was subsequently found that utilisation of Dess-Martin 
periodinane mediated selective oxidation of the primary alcohol 261 to the aldehyde 
----------------------------- 
* DMSO was not purified before use and had undetermined H2O content.   
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262 (Scheme 100) without any problems. The reaction was buffered with sodium 
bicarbonate as it was feared the AcOH by-product of the oxidant could facilitate the 
previously encountered elimination of the tertiary alcohol.   
 
Scheme 100 - Synthesis of aldehyde 262 
Upon the synthesis of aldehyde 262 it was decided to test whether addition of the 
(Z)-iodoalkene 141, via the organolithium species generated in previous work, could 
be achieved. The (Z)-iodoalkene 141 would model the addition of the synthetically 
more challenging (Z)-haloalkene fragement 253, which would later be required.  
Treatment of (Z)-Iodoalkene 141 with n-BuLi was followed by the addition of 
aldehyde 262 (Scheme 101). After protic work-up analysis of the crude 
1
H NMR 
revealed that no resonating signal corresponding to a newly formed carbinol proton 
could be found and new aldehyde signals resonated between 9.7–10.1 ppm. The 
major new aldehyde signal resonated as a singlet, indicative of a similar elimination 
of the tertiary alcohol as was previously observed.  
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Scheme 101- Attempted addition to aldehyde 262 
To circumvent the issues involving elimination of the tertiary alcohol, it was decided 
to investigate the use of hydroxyl protecting groups.  As aldehyde 262 was also 
susceptible to degradation upon storage, it was hoped that protection of the tertiary 
alcohol would additionally prevent or slow this degradation.  
It was decided to install a TMS ether protecting group on the tertiary hydroxyl group. 
This would involve protection of both hydroxyl groups possessed by diol 261 and 
subsequent selective removal of the primary TMS ether. This selectivity was thought 
to be achievable since primary TMS ethers are vastly more labile than tertiary TMS 
ethers. Although TMS ethers are typically very labile protecting groups, it was 
proposed that their employment may be suitable in the sterically crowded 
environment provided by the trans-decaline system.  
Firstly, diol 261 was treated with TMSCl in the presence of imidazole and DMAP to 
give di-TMS ether protected substrate 266. For selective removal of the primary 
TMS ether, the substrate 266 was firstly dissolved in MeOH:petrol (9:1)
*
 and then 
oven-dried K2CO3 was added. This assisted methanolysis of the primary TMS ether 
over 4 h to give alcohol 267. The TMS protected tertiary alcohol remained intact 
using these mild conditions. The isolated primary alcohol 267 was then oxidised to 
----------------------------- 
* Petrol was required to solubilise the apolar substrate 266 in MeOH 
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aldehye 268 using pyridinium chlorochromate (PCC), buffered with NaOAc 
(Scheme 102).  
 
Scheme 102 - Synthesis of aldehyde 268  
Upon the successful synthesis of tertiary alcohol protected aldehyde 268, the addition 
of (Z)-iodoalkene 141 was again investigated. Similarly to previous examples, (Z)-
iodoalkene 141 was treated with n-BuLi at –78 °C, followed by the addition of 
aldehyde 268. After protic work-up analysis of the crude 
1
H NMR spectrum revealed 
several new aldehyde resonances between 9.5–9.8 ppm and no signal corresponding 
to a newly formed carbinol proton could be found.  
 
Scheme 103 - Attempted addition of (Z)-iodoalkene 141 to aldehyde 268 
Following these results, it was decided to investigate installation of the secondary 
alcohol possessed by phorone A. It was thought that removal of the alkene may 
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dissuade elimination and the other degradation pathways encountered thus far.  As 
was previously discussed in the retrosynthetic analysis, the alkene moiety possessed 
by the decalin system could allow installation of an epoxide which could be 
reductively ring-opened for installation of the required secondary alcohol possessed 
by phorone A. At the time it was unknown whether epoxidation would occur with 
anti- or syn-diastereofacial selectivity relative to the axial tertiary alcohol.  
To investigate this, diol 261 was treated with the alkene epoxidising agent m-CPBA. 
Gratifyingly, it was found that m-CPBA facilitated epoxidation with anti-
diastereofacial selectivity to give epoxide 270 (Scheme 104). To the author’s delight, 
the required stereochemistry of the epoxide 270 was confirmed by X-ray 
crystallographic analysis (Figure 20). The observed anti-diastereofacial selectivity 
may be due to unfavourable steric interactions between the approaching peracid and 
the two axial methyl groups of the decalin system, favouring approach from the 
opposite face. This unfavourable steric demand must outweigh the favourable effect 
of hydrogen bonding between the axial tertiary alcohol and the peracid, as is 
normally observed in cyclic allylic alcohol systems to give syn-diastereofacial 
selectivity for epoxidation.
93
  
 
 
 
Scheme 104 - Synthesis of epoxide 270; Figure 20 - ORTEP of epoxide 270 
Upon the installation of the epoxide, it was decided to investigate the addition of (Z)-
iodoalkene to an aldehyde analogue. The primary alcohol 270 was oxidised to the 
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aldehyde 271 using DMP, in a low, albeit unoptimised 23% yield. Addition of the 
(Z)-iodoalkene 141 via the organolithium species formed in situ, proved 
unsuccessful. Analysis of the 
1
H NMR spectrum after protic work-up did not reveal 
any of the desired carbinol proton signals.  Added to this, several new aldehyde 
signals resonated between 9.7–10.0 ppm.  
 
Scheme 105 - Synthesis of aldehyde 271 and attempted addition of 141 
The author was undeterred by the failure to add (Z)-iodoalkene 141 to a range of 
analogous aldehydes, and it was decided to focus towards synthesising structures 
closer resembling phorone A, in the hope that ‘natural analogues’ may demonstrate 
better stability and reactivity. To this end, it was decided to explore the ring-opening 
of epoxide 270 in order to install the desired secondary alcohol possessed by phorone 
A.  
For the reductive ring opening of epoxide 270, regioselective attack of the hydride to 
form a 1,3-diol species e.g. 273 was required (Scheme 106). Red-Al is a commonly 
utilised reagent for the highly selective synthesis of 1,3-diols by regioselective 
reductive ring-opening of 2,3-epoxy alcohols e.g. 274. The initial addition of Red-Al 
to such 2,3-epoxy alcohols results in the coordination of aluminium to the alcohol, 
releasing hydrogen gas, to give trialkoxy aluminate intermediate 275. This is 
followed by an intramolecular transfer of a hydride from aluminium, resulting in the 
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selective formation of 1,3-diols e.g. 273. Attack to form the 1,2-diol does not usually 
occur because the approach path of the hydride to form this species cannot be 
collinear to the C–O bond which must be broken. Other reducing agents, such as 
DIBAL-H, do not allow this selectivity of ring opening, and usually give large 
amounts of 1,2-diol product.  
 
Scheme 106 - 2,3-Epoxy alcohols reductive ring opening using Red-Al 
To investigate this pathway, 2,3-epoxy alcohol 270 was treated with an excess of 
Red-Al at room temp. Monitoring of the reaction by TLC analysis revealed no 
reaction had occurred over 4 h. Eventually it was found that heating the reaction to 
110 °C over 16 h allowed for regioselective ring-opening of the epoxide to give 1,3-
diol 276 (Scheme 107). The newly formed alkoxy proton resonated as a clear triplet 
of doublets in the 
1
H NMR spectrum. Comparison of the alkoxy resonance with that 
reported for phorone A revealed a very close match: for phorone A [4.3 ppm, td,  J = 
10.8, 3.1 Hz], for 276 [4.1 ppm, td,  J = 11.0, 4.0 Hz].  Further confirmation of the 
stereo- and regiochemistry was obtained by X-ray crystallographic analysis of a 
subsequently synthesised substrate (vide infra).   
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Scheme 107 - Reductive ring opening of 2,3-epoxy alcohol 270 using Red-Al 
Having triumphed in the stereo- and regioselective installation of the penultimate 
chiral centre possessed by phorone A (24), efforts were focused towards the 
oxidation of the primary alcohol 276 to an aldehyde, with which subsequent addition 
steps or protecting group strategies could be explored.  
Chemoselective oxidation of the primary alcohol to the aldehyde functionality, in the 
presence of the secondary and tertiary alcohols was required. Frequently used 
reagents for the selective oxidation of primary alcohols to aldehydes employ catalytic 
amounts of TEMPO with a co-oxidant.
94
  It was found that treatment of triol 276 
with TEMPO (0.2 eq.) and co-oxidant PhI(OAc)2  (1.1 eq.) resulted in smooth 
conversion to aldehyde 277, with no apparent oxidation of the secondary or tertiary 
alcohols (Scheme 108). Upon the isolation of large crystals of the aldehyde 277, the 
stereo- and regiochemistry of the secondary alcohol and aldehyde moieties were 
confirmed through X-ray crystallographic analysis (Figure 21). Upon storage of the 
aldehyde 277 in a fridge, no epimerisation of the aldehyde group was observed.  
            
 
 
 
Scheme 108 - Formation of aldehyde 277; Figure 21 - ORTEP image 277
*
 
----------------------------- 
* Mirror image of 277 to that depicted in Scheme 108 
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Addition of a highly basic organometallic species to the di-hydroxy group bearing 
aldehyde 277 seemed unfeasible since a large excess of the organometallic species 
would be required to generate a potentially unstable di-alkoxide species. Thus, 
protecting group strategies for the protection of the hydroxyl group(s) possessed by 
aldehyde 277 were investigated.    
It was proposed that triethylsilane (TES) protection would be most suitable for 
protection of the secondary alcohol 277. As previously discussed, this silyl group is 
commonly used for the protection of secondary alcohols due to its ‘mid-range 
susceptibility to hydrolysis’ relative to other common silyl protecting groups and can 
normally be removed with fluoride sources or other mild protocols. Aldehyde 277 
was treated with TESCl, triethylamine and DMAP (cat.). Remarkably, after 16 h the 
starting material remained unreacted. A second attempt involved treatment of 
aldehyde 277 with TESCl, imidazole and DMAP (cat.) in DMF, with heating to 60 
°C. Following the reaction by TLC analysis over 72 h again revealed only starting 
material. It was proposed that the hydroxyl groups were very poorly nucleophilic, 
perhaps due to the steric demand of the substituted decalin system.   
 
Scheme 109 - Attempted TES protection of secondary alcohol 277 
With the hypothesis that the secondary alcohol was in a very sterically crowded 
environment, it was proposed that the smaller and typically very labile TMS 
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protecting group may prove robust enough for utilisation in the projected synthetic 
steps. Surprisingly, treatment of aldehyde 277 with TMSCl, imidazole and DMAP 
(cat.) gave no reaction over 24 h.  
 
Scheme 110 - Attempted TMS protection of secondary alcohol 277 
It became evident that for protection of the alcohol(s), a stronger silylating agent (i.e. 
stronger electrophile) than silyl chlorides would be required. Indeed, treatment of 
aldehyde 277 with the potent silylating agent TMSOTf (2 eq) facilitated swift 
protection of the secondary and tertiary alcohols (Scheme 111).  
 
Scheme 111 - TMS protection of secondary and tertiary alcohols to 280 
Contemporaneously to the investigations leading to the synthesis of aldehyde 280, 
work was also focused on the synthesis of (Z)-haloalkene fragment 253. This will 
now be discussed, and work towards its addition to aldehyde 280 will be discussed in 
due course.  
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3.4  Synthesis of (Z)-Haloalkene Fragment 253  
Initial work towards the synthesis of (Z)-haloalkene fragment 253 involved the 
synthesis of phenolic acetophenone fragment 257 via some previously reported 
procedures.
95
 Firstly, commercially available 4-methyl-acetophenone was subjected 
to nitration using HNO3 and H2SO4, to give 3-nitro-4-methyl-acetophenone (281) as 
the sole product. Reduction of the nitro group to amine 282 was initially achieved via 
hydrogenation over Pd/C. Unfortunately, this convenient procedure was not scalable; 
on a scale >3 g the same conditions gave a range of unidentified products. 
Alternatively, reduction of the nitro group to aniline 282 was achieved using 
stannous chloride dihydrate in 1.2 M HCl, although frustratingly giving abundant 
amounts of insoluble and toxic tin by-products during work-up.  
With the formation of aniline 282, the synthesis of phenol 283 was achieved via a 
diazotisation step using sodium nitrite, with the in situ substitution of the diazonium 
ion by water
*
. The phenol 283 was then protected as its TBS silyl ether by treatment 
with TBSCl in the presence of imidazole, to give the novel acetophenone 284.  
 
Scheme 112 - Synthesis of acetophenone 284 
----------------------------- 
* Take care - potentially explosive diazonium salt! 
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For the synthesis of the (Z)-haloalkene fragment 253 from acetophenone 284 
utilisation of a Wittig olefination method was planned. Initial investigations using 
bromo-methyl triphenylphosphonium for the formation of (Z)-bromoalkene 285 were 
conducted (Table 6). The Wittig salt was deprotonated with NaHMDS, and then 
acetophenone 284 was added. After monitoring over 16 h, 
1
H NMR analysis after 
protic work-up revealed some trace alkene region signals, but predominantly 
unreacted starting material. Subsequently, the salt was treated with potassium t-
butoxide, which was again followed by addition of acetophenone 284. After 16 h 
analysis of the reaction mixture indicated, in similar fashion, that no/residual alkene 
formation had occurred. Also, using potassium t-butoxide and heating to 100 °C for 
16 h, 
1
H NMR spectroscopy analysis of the crude mixture gave the same result. In a 
final attempt, sodium hydride was employed as the base, and after heating at 50 °C 
for 16 h 
1
H NMR analysis of the crude mixture revealed no olefination had occured. 
It should be noted that examples for the formation of haloalkenes from acetophenone 
analogues via halogenated Wittig reagents are scarcely found in the literature. An 
alternative olefination method was sought.  
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Table 6 - Conditions for attempted Wittig olefination of acetophenone 284 
 
Conditions Yield (%) 
t-BuOK, THF, –78 °C to r.t, 16 h 0 
t-BuOK, PhMe, 100 °C, 16 h 0 
NaHMDS, THF, 16 h 0 
NaH, THF, 50 °C, 16 h 0 
Of the few known methods for such a transformation, trisubstituted bromoalkene 
formation from acetophenone has been reported by Barluenga et al.
96
 This method 
involved addition of dibromomethane deprotonated with LiNCy2 to acetophenone to 
form the tertiary alcohol 286 (Scheme 113). Subsequent to this addition, 
trimethylsilylation of 287 with HMDS was followed by treatment with n-BuLi, to 
give mono-halogenated olefins 288 in 1.0:1.1 E:Z ratio. An investigation was 
initiated into the employment of this largely unexploited olefination method for the 
synthesis of (Z)-haloalkene fragment 253.  
 
Scheme 113 - Barluenga synthesis of bromoalkenes 288a/b  
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Slightly modified conditions, reported by Ando et al., were employed towards the 
synthesis of (Z)-bromoalkene 285, using more readily available bases: lithium 
diisopropylamine (LDA) in the initial addition step and imidazole as the base during 
the trimethylsilylation step.
97
 Treatment of acetophenone 284 with dibromomethane 
which had been deprotonated by LDA facilitated smooth conversion to tertiary 
alcohol 289. Subsequently, the alcohol 289 was protected as the trimethylsilyl ether 
by treatment with TMSCl in the presence of imidazole, to give dibromo species 290 
(Scheme 114).  
Scheme 114 - Synthesis of dibromo species 290 
Finally, treatment of the dibromo species 290 with n-BuLi gave access to the novel 
(E)- and (Z)-alkenes 285a and 285b respectively (Scheme 115). The author was 
delighted that the exceptionally apolar stereoisomers were fully separable by careful 
flash column chromatography, eluted in pure n-hexane. The stereochemistry of each 
alkene isomer was determined by NOESY experiments. Irradiation of the alkenyl 
proton of the second eluting isomer revealed a 0.71% nOe enhancement at the 
neighbouring alkenyl methyl group resonance. The first eluting isomer did not reveal 
an nOe enhancement at the alkenyl methyl group resonance. The second eluting 
stereoisomer was assigned as (E)-bromo alkene 285a, and the first eluting 
stereoisomer as (Z)-bromoalkene 285b.  
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Scheme 115 - Synthesis of (Z)-alkene 285b and (E)-alkene 285a 
Analysis of the 
1
H NMR spectrum directly after protic work-up indicated a Z:E ratio 
of  1.3:1,  demonstrating that a slightly (Z)-alkene selective olefination had been 
achieved.  
With the succesful formation of novel bromoalkenes 285a/b, it was decided to probe 
methods for bromine-lithium exchange of the alkenyl bromine atom and in situ 
trapping with an electrophile. The lithiating ability of the bromoalkenes was initially 
investigated via deuteration experiments. The treatment of (E)-bromoalkene 285a 
with t-BuLi at –78 °C generated a bright-yellow solution. This was followed by the 
addition of deuterated methanol (Scheme 116). After protic work-up, analysis of the 
1
H NMR spectrum revealed remarkably clean conversion to deuterated alkene 291. 
As expected, no isomerisation of the (E)-alkene had occurred, which would 
otherwise presumably result in a mixture of isomers upon protic work-up. The 
incorporation of deuterium was further confirmed through 
13
C NMR spectroscopy 
and HRMS. Upon this result, work was focused upon trapping the analogous (Z)-
organolithium species with the previously synthesised aldehyde 280.   
 
Scheme 116 - Lithiation/deuteration of (E)-alkene 285a 
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3.5  Synthesis of Ansellane Alcohol 292 
Having demonstrated the ability to lithiate (E)-alkene 285a using t-BuLi, it was 
decided to investigate the lithiation of (Z)-bromoalkene 285b and subsequent 
nucleophilic addition to aldehyde 280. Treatment of (Z)-bromoalkene 285b with t-
BuLi mediated in situ bromine-lithium exchange, giving a bright-yellow solution, 
which was followed by the addition of aldehyde 280 (Scheme 117). Delightfully, 
analysis of the 
1
H NMR after protic work-up revealed a new carbinol proton 
resonance, suggestive of succesful addition of the organolithium species to the 
aldehyde functional group. Indeed, ansellane alcohol 292 was isolated by flash 
column chromatography. As was predicted, the TMS ether protecting groups were 
robust enough to withstand the harsh reaction conditions.  
                  
Scheme 117 - Synthesis of ansellane alcohol 292 
From analysis of the 
13
C NMR spectrum, ansellane alcohol 292 was seemingly 
isolated as a single diastereomer. The stereochemistry of the newly formed chiral 
centre was not determined since it would be destroyed in a subsequent step.  A 2D 
NOESY experiment revealed an nOe between the alkenyl proton and the alkenyl 
methyl group, confirming the expected retention of the crucial (Z)-alkene 
stereochemistry.  
This synthesis of ansellane alcohol 292 is the first reported synthesis of the ansellane 
carbon skeleton possessed by ansellones A−D (293–296), ansellone E (25), ansellone 
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F (297) and related natural product phorbadione (298) (Figure 22). The work 
presented so far has established the important stereoselective installation of the 
secondary alcohol possessed by phorones A (24) and B (242), and also ansellones B 
(294) and D (295), via a reductive epoxide ring-opening strategy. Added to these 
advancements, a strategy towards the installation of the challenging trisubstituted 
(Z)-alkene motif possessed by phorone A (24), B (242) and ansellone E (25) has been 
devised.  
                                   
Figure 22 - Ansellane skeleton possessing natural products 
Upon the satisfying construction of the entire ansellane carbon skeleton (16) and 
with the installation of all-but-one chiral centre, work was solely focused on 
achieving the first total synthesis of phorone A (24).  
The end game required oxidation of the allylic alcohol 292 to enone 299, removal of 
silyl protecting groups and treatment of the tertiary alcohol species with Lewis or 
Brønsted acid to affect the final electrophilic aromatic substitution step. It was 
anticipated that global silyl group removal and electrophilic aromatic substitution 
 121 
 
may well occur concurrently, under suitably acidic conditions, potentially making 
phorone A only two synthetic steps from reach! 
           
Scheme 118 - Anticipated steps to phorone A (24) 
3.6  End Game 
3.6.1 Attempts to oxidise ansellane alcohol 292 
Upon the first synthesis of ansellane alcohol 292, storage at room temperature over 
several days unfortunately showed total degradation to a mixture of products. One 
major constituent upon degradation was isolated by flash column chromatography 
and was revealed as ansellane diene 300 after thorough spectroscopic analysis 
(Scheme 119). The 
1
H NMR spectrum suggested the formation of a new (E)-alkene, 
with each alkenyl proton having a mutual coupling constant of 
3
JE = 15.8 Hz. The 
13
C 
NMR spectrum showed no resonance which could be attributed to the carbinol 
carbon atom, and revealed the formation of two additional alkenyl carbon atoms. The 
newly formed terminal alkenyl carbon atom resonated in a negative phase in a 
DEPT-135 experiment. Moreover, HRMS revealed the m/z ion peak expected for 
ansellane diene 300.  
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Scheme 119 - Degradation of ansellane alcohol 292 to ansellane diene 300 
Seemingly, this unforeseen transformation occurred spontaneously, although the 
author does speculate whether the degradation was as a result of potential residual 
silica gel after column chromatography
*
 or other residual reagents in the apparently 
clean storage flask. It was proposed that ansellane alcohol 292, bearing the (Z)-
alkene moiety, was under high steric demand around the newly formed alcohol. 
Thus, it was proposed that elimination of the secondary alcohol to give ansellane 
diene 300 acts to mitigate this disfavourable steric crowding in a thermodynamically 
favoured process. The formation of the further extended   bonded system possessed 
by 300 is possibly also a thermodynamically favouring factor. Nevertheless, storage 
of the ansellane alcohol 292 in a −30 °C freezer and using within several days 
prevented this set-back from occurring again.  
The labile nature of this transformation has shed some light on potential biosynthetic 
pathways of the ansellone natural products. Upon the recent reported isolation of 
ansellone F (297) in January 2015, it was remarkable to see that this natural product 
shared a similar 1,3-diene system to ansellane diene 300. The author speculates that 
ansellone F may acquire this 1,3-diene system in a similar deoxygenating elimination 
process, from proposed intermediate 301 (Scheme 120, Route 2). This elimination 
----------------------------- 
* Residual silica gel can occasionally pass through sintered disc of columns.  
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process may relieve ring strain caused by the trisubstituted (Z)-alkene motif residing 
in the 8-membered ring of the proposed intermediate 301. Alongside this, it is 
suggested that the terminal alkene possessed by ansellone B/C (294/295) is aquired 
by an alkene migration step from the same intermediate 301, perhaps to relieve the 
ring strain of the 8-membered ring (Route 1).  
Phorones A (24) and B (242) can presumably endure the ring strain caused by the 
trisubstituted (Z)-alkene motif since the strain is lower in the 7-membered ring and 
additionally isomerisation of the alkene would result in the loss of the stabilising 
conjugated         system. 
 
Scheme 120 - Proposed biosynthetic route to ansellone B/C (294/295) and F (297). 
As was mentioned, following successful formation of ansellane alcohol 292 over 17 
synthetic steps, an investigation into the oxidation of the allylic alcohol to the enone 
299 was initiated (Table 7). Initially, treatment of ansellane alcohol 292 with MnO2 
demonstrated a complete lack of reactivity. Treatment at room temperature and at 60 
°C both revealed the presence of starting material only. Remarkably, treatment of 
ansellane alcohol 292 with freshly prepared DMP also showed no apparent 
oxidation, even when a large excess of the oxidant was added. A Swern oxidation 
procedure proved to give complete degradation of the alcohol 292 to a mixture of 
degradation compounds, including ansellane alkene 300. It was proposed that this 
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elimination may occur via alkoxysulfonium ion intermediate 302, mediating 
elimination of the oxygen atom.  
 
Scheme 121 - Degradation of ansellane alcohol 292 to 300 during Swern oxidation 
Treatment with PhI(OAc)2/TEMPO over 16 h also gave no reaction, recovering 
starting material only. The final attempt of treatment with 2-iodoxybenzoic acid 
(IBX) in dimethylsulfoxide (DMSO) gave only starting material over 4 days. 
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Table 7 - Conditions for attempted oxidation of ansellane alcohol 292 
 
Conditions Conversion (%) 
MnO2, CH2Cl2, room temp, 16 h 0 
MnO2, CHCl3, 60 °C, 16 h 0 
DMP, NaHCO3, CHCl3, 16 h 0 
(COCl)2, DMSO, NEt3, CH2Cl2-78 °C degradation 
PIDA, TEMPO, CH2Cl2, 16 h 0 
IBX, DMSO, 4 days 0 
 
Frustratingly, despite being so close to phorone A, this route was abandoned at this 
point due to the astonishing inability to oxidise the allylic alcohol of 292 and the 
observed deoxygenative elimination process assisting degradation, observed using 
conventional methods for oxidation. Added to this, a lack of material at this late-
stage made oxidation method probing very challenging. An alternative pathway was 
sought, which would preferably avoid the use of such sensitive and elusive allylic 
alcohol intermediates.  
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3.6.2 Still-Gennari Olefination Approach to Phorone A 
An alternative synthetic plan to phorone A was devised. Retrosynthetic analysis of 
phorone A revealed that disconnection of the alkene could allow a Horner-
Wadsworth-Emmons strategy for installation of the alkene (Scheme 122). With the 
use of Still-Gennari phosphonate 303, a (Z)-selective olefination reaction with 
acetophenone 284 would give direct access to ansellane ketone 299. Formation of the 
desired β-ketophosphonate 303 could be achieved via the deprotonation and 
subsequent addition of commercially available bis(2,2,2-trifluoroethyl) 
methylphosphonate (304) with subsequent oxidation level alteration. 
 
 
Scheme 122 - Retrosynthetic analysis of ansellane ketone 299 
To investigate this strategy to phosphonate 303, the aldehyde 280 was added to a 
solution of phosphonate 304, which had been deprotonated using n-BuLi. After 
protic work-up, none of desired product could be identified by 
1
H NMR analysis, and 
the aldehyde starting material 280 seemed to remain unreacted.   
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Scheme 123 - Attempted phosphonate 305 formation 
With time constraints coming near the end of the PhD, efforts were not invested in 
the development of suitable reaction conditions for this strategy towards phosphonate 
303. Instead, an alternative retrosynthetic cleavage of β-ketophosphonate 303 
revealed another possible synthetic strategy (Scheme 124). Nucleophilic addition of 
ketone fragment 306, via its enolate, to halophosphonate fragment 307 could allow 
direct access to the desired phosphonate 303. The ketone 306 would be synthesised 
from aldehyde 280 using a methyl-organometallic reagent, followed by oxidation 
level correction.  
 
Scheme 124 - Alternative retrosynthetic analysis of phosphonate 303 
Firstly, treatment of aldehyde 280 with MeLi assisted conversion to alcohol 308. 
Following this, Swern oxidation provided the smooth conversion to the ketone 306.  
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Scheme 125 - Synthesis of ketone 306 
 
In order to investigate the future synthesis of Still-Gennari phosphonate fragment 
303, it was decided to initally attempt the formation of phosphonate 309 using the 
comparatively inexpensive reagent, diethyl chlorophosphate. Ketone 306 was 
enolised in situ using LDA, followed by the addition of diethyl chlorophosphate. 
Unfortunately, none of the desired product was observed by NMR analysis of the 
reaction mixture after protic work-up. In particular, the characteristic α CH2 protons 
expected around 2–3 ppm for the desired β-ketophosphonate 309 were not observed.  
 
Scheme 126 - Attempted synthesis of phosphonate 309 
Efforts towards the utilisation of a Still-Gennari phosphonate for the total synthesis 
of phorone A were unfruitful. The author believed that installation of the 
phosphonate 309 would require significant time for development and since only a 
short amount of time was available for further laboratory work, efforts were focused 
on an alternative strategy.  
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3.6.3 Cross Metathesis Strategy for Phorone A 
An alternative retrosynthetic analysis of phorone A (24) revealed that by cleavage of 
the C=C alkenyl bond possessed by ansellane ketone fragment 299, a cross 
metathesis strategy could potentially be used. A cross metathesis reaction between 
enone fragement 310 and styrenyl fragment 311 could give direct access to the 
desired enone system possessed by phorone A (24).  
 
Scheme 127 - Retrosynthesis of ansellane ketone 299 
A major concern using this planned strategy was the E:Z selectivity using 
conventional Grubbs catalysts, which normally highly favour formation of E-alkenes. 
However, it was thought that (E)- to (Z)-alkene isomerisation could be possible under 
suitable acidic conditions, which were likely to be used in the final step for 
electrophilic aromatic substitution for the formation of the phorane skeletone. Added 
to this, (Z)-alkene selective Grubbs catalysts have now been reported in the 
literature,
98
 with some being commercially available.
*
 Therefore, an investigation 
into the utility of a cross metathesis strategy towards phorone A was initiated.  
Synthesis of the ketone 310 was achieved in two steps from previously prepared 
aldehyde 280. Firstly, addition of vinyl magnesium bromide to aldehyde 280 
mediated unoptimised conversion to alcohol apparently as a single diastereomer 312, 
which was then oxidised to ketone 310 using MnO2.  
----------------------------- 
* Visit sigmaladrich.com for a selection of Grubbs catalysts 
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Scheme 128 - Synthesis of enone 310 
The synthesis of styrenyl fragment 311 was achieved via a Wittig olefination 
reaction. Treatment of acetophenone 284 with methyltriphenylphosphonium bromide 
and potassium t-butoxide facilitated smooth conversion to the novel styrene 311, in 
an unoptimised 47% yield.  
 
Scheme 129 - Synthesis of styrene 311 
Since only small quantities (<1 mg) of the enone 310 had been synthesised at the 
time, and with time set against the author towards the end the PhD, it was required to 
model the envisaged cross metathesis pathway using a more available enone 
substrate. Methyl vinyl ketone was readily available in the laboratory and a good 
model substrate enone for cross metathesis with the styrene 311.  
Using methyl vinyl ketone, firstly Grubbs 2
nd
 generation catalyst (1 mol %) was 
employed.  After 16 h and evaporation of the solvent, analysis by 
1
H NMR 
spectroscopy revealed starting materials only. Using the same catalyst at 80 °C over 
16 h also gave starting materials only. In a final attempt, Hoveyda-Grubbs catalyst (5 
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mol %) was employed at 80 °C over 16 hours. Again, analysis of the crude mixture 
by 
1
H NMR spectroscopy revealed starting materials only.  
 
Scheme 130 - Cross metathesis of styrene 311 and methyl vinyl ketone 
 
Table 8 - Conditions for attempted cross metathesis of styrene 311 and methyl vinyl 
ketone 
Catalyst Conditions Conversion (%) 
Grubbs’ 2nd gen. 0.01 eq, CH2Cl2, rt, 16 h 0 
Grubbs’ 2nd gen. 0.01 eq, PhMe, 80 °C, 16 h 0 
Hoveyda-Grubbs’ 2nd gen. 0.05 eq, PhMe, 80 °C, 16 h 0 
 
Cross metathesis of these substrates using commonly available Grubbs catalysts was 
not achieved under the conditions employed.  Due to time restrictions, efforts 
towards the development of a cross metathesis strategy for the total synthesis of 
phorone A (24) were halted at this point.    
3.7 Conclusion and Future Work 
The work presented in this chapter describes efforts towards the total synthesis of 
phorone A. An initial synthetic strategy gave access to ansellane alcohol 292, which 
is the first ever synthesis of the ansellane carbon skeleton possessed by the natural 
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products ansellones A-D (293–296), ansellone E (25), ansellone F (297) and related 
natural product phorbadione (298). 
During the initial synthetic work, a strategy was devised for the stereoselective 
installation of the secondary alcohol possessed by phorones A and B (24 and 242) 
and ansellones B and D (294 and 296), via stereoselective epoxide installation and 
reductive opening of the epoxide (Scheme 131). Added to these accomplishments, a 
strategy towards the installation of the challenging trisubstituted (Z)-alkene motif 
possessed by phorone A and B (24, 242) and ansellone E (25) has been achieved. 
The labile degradation of ansellane alcohol 292 to ansellane diene 300 and the 
astonishing inability to oxidise the secondary alcohol gives heed to avoid such 
precarious intermediates in future synthetic plans towards phorone A (24) and the 
related natural products. These synthetic accomplishments leading to ansellane 
alcohol 292 will provide invaluable guidance for future total syntheses of related 
sesterterpenoid natural products, in which there will undoubtedly be great interest.   
 
Scheme 131 - Summary of accomplishments to ansellane alcohol 292 
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Following the set-back encountered by the inability to oxidise ansellane alcohol 292 
to the desired enone functional group, alternative synthetic strategies avoiding such 
sensitive allylic alcohol moities towards phorone A (24) were investigated. An 
investigation into a Still-Genari olefination strategy firstly involved the successful 
formation of ketone 306. However, attempts at the formation of Still-Gennari 
phosphonates required for this route were unfruitful. A final strategy investigated the 
potential for using a cross metathesis route for the formation of the (Z)-alkene motif. 
Preliminary model investigations exploring the cross metathesis of styrene 311 with 
methyl vinyl ketone using some of Grubbs catalysts were discouraging with no cross 
metathesis apparent.  
Future work may involve investing further development time in exploring the Still-
Gennari and cross-metathesis propsed routes towards phorone A (24).  
A polycyclisation strategy towards phorone A (24) has been hypothesised. Treatment 
of the polyolefin 314 with a Lewis- or Brønsted acid is envisaged to result in a 
completely or partially concerted cascade reaction with electrophilic aromatic 
substitution for the formation of the phorane carbon skeleton (Scheme 132). The 
Stork-Eschenmoser hypothesis states that during polyolefin cascades a ‘trans double 
bonds lead to trans-ring junctions’ and that ‘cis-double bonds lead to cis-ring 
junctions’.99 Thus (E,E,E)-farnesal derivative 315 would give the desired trans-
decalin system 316 upon cyclisation. The synthesis of polyolefin 314 could be 
achieved via the addition of (Z)-bromoalkene 385b to farnesal derivative 315, as has 
similarly been demonstrated in this work.  
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Scheme 132 - Cascade pathway to phorone A (24), A = Lewis/Brønsted acid 
This strategy is similar to a highly enantioselective cyclisation reaction recently 
demonstrated by the group of E. J. Corey.
100
 Treatment of polyolefin 317 with the 
chiral Lewis acid catalyst, (R)-BINOL-SbCl5, resulted in a polycyclisation to give 
tetracyclic product 318 with 86% ee (Scheme 133).  
 
Scheme 133 - Corey polycyclisation to 318  
 
 
 
 
 
 
 135 
 
 
 
 
 
4.  Experimental 
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4.1 General Experimental Details 
Commercially available reagents were used as received without further purification.  
All reactions that required anhydrous conditions were conducted in flame-dried 
apparatus under an atmosphere of argon. Analytical thin-layer chromatography 
(TLC) was performed on silica gel plates (0.25 mm) precoated with a fluorescent 
indicator. Visualisation of TLC plates was performed by fluorescence quenching and 
potassium permanganate, anisaldehyde or vanillin type dips. Unless specifically 
stated flash chromatography procedures were performed using Kieselgel 60 (40–63 
µm). Basic alumina solid phases were varied in Brockmann grade by adding distilled 
H2O, shaking vigorously and leaving in sealed flask overnight: (Brockmann grade I - 
H2O added 0 wt. %, Brockmann grade II - H2O added 3 wt. %, Brockmann grade III 
- H2O added 6 wt. %, Brockmann grade IV - H2O added 10 wt. %). Petrol refers to 
the fraction of petroleum boiling from 40–60 C. Brine refers to a saturated aqueous 
solution of sodium chloride. Infrared spectra were recorded directly on a Bruker 
Tensor 37 FTIR machine fitted with a PIKE MIRacle ATR accessory as either solids 
or neat oils. Infrared spectra are reported as follows: wavelength (cm
–1
) and intensity 
of absorbance (s = strong, m = medium, w = weak, vw = very weak, br = broad). 
 1
H, 
13
C, 
31
P and 
19
F NMR spectra were typically recorded on Bruker AV400 machines at 
400, 101, 162 and 376 MHz respectively. Chemical shifts (ppm) are reported relative 
to the residual protonated solvent resonance: CDCl3 [δH 7.26, δC 77.2], C6D6 [δH 
7.16, δC 128.1], DMSO-d6 [δH 2.50, δC 39.5], acetone-d6 [δH 2.05, δC 206.3], CD4OD 
[δH 3.31, δC 49.0]. 
1
H NMR data are reported as follows: chemical shift (δ), 
integration, multiplicity (s = singlet, brs = broad singlet, d = doublet, t = triplet, q = 
quartet, qn= quintet and m = multiplet,), J coupling constant(s) (Hz), and assignment. 
1
H NMR signals were assigned using chemical shift, scalar coupling patterns, 
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standard two dimensional NMR experiments.
 13
C NMR signals were assigned using 
chemical shift, DEPT-135 experiments and standard two dimensional NMR 
experiments.  
4.2 Experimental Procedures and Compound Characterisation 
 
3-(tert-Butyldimethylsilyloxy)benzaldehyde 140 
To a stirred solution of NEt3 (1.90 mL, 13.5 mmol) and one crystal of DMAP in 
CH2Cl2 (500 mL) was added 3-Hydroxybenzaldehyde (1.10 g, 9.01 mmol) at 23 °C. 
To this was added TBSCl (2.04 g, 13.5 mmol), followed by continued stirring for 2 
h. After this time water (20 mL) was added. The aqueous layer was extracted with 
CH2Cl2 (3 × 40 mL) and the combined organic extracts were dried over MgSO4 and 
filtered. The solvent was removed in vacuo. Purification of the residue by flash 
column chromatography (SiO2, 10% Et2O in petrol) gave the title compound as 
yellow oil which slowly crystallised to orange needles on standing (2.06 g, 97%). 
Data are consistent with those previously reported in the literature.
56 
max/cm
–1
 1702s (C=O), 1583m, 1482m, 1387w, 1277s, 1144w; 
1
H NMR (400 MHz, 
CDCl3)  9.94 (1H, s, CHO), 7.45 (1H, td, J = 7.6 and 1.3 Hz, ArCH), 7.38 (1H, t, J 
= 7.6 Hz, ArCH), 7.31–7.33 (1H, m, ArCH), 7.12–7.09 (1H, m, ArCH), 0.97 (9H, s, 
SiC(CH3)3), 0.21 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3)  192.0 (CHO), 
156.4 (ArCO), 138.0 (ArCCHO), 130.1 (ArCH), 126.5 (ArCH), 123.5 (ArCH), 119.9 
(ArCH), 25.6 (SiC(CH3)3), 18.2 (SiC), –4.2 (Si(CH3)2). 
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(Z)-(tert-Butyldimethylsilyloxy)(3-(2-iodovinyl)phenoxy)) 141 
To a stirred suspension of iodomethylenetriphenylphosphorane (675 mg, 1.27 mmol) 
in THF (3 mL) was slowly added NaHMDS (0.53 mL, 2 M in THF, 1.06 mmol) at 
23 °C. The solution was stirred for 10 min before the resultant orange-red solution 
was cooled to –78 ºC, followed by addition of HMPA (1.50 mL) and then a solution 
of 3-((tert-butyldimethylsilyl)oxy)benzaldehyde 140 (250 mg, 1.06 mmol) in THF (2 
mL). After stirring at –78 ºC for 1 h, NH4Cl (sat. aq., 2 mL) was added to the 
solution and after warming to room temp, the mixture was filtered over a short pad of 
Celite

 which was then washed with n-hexane (10 mL). The solvent was removed in 
vacuo and the residue was purified by flash column chromatography (SiO2, 90% 
Et2O in n-hexane) to give the title compound as yellow oil (351 mg, 92%).  
max/cm
–1
 2927w, 2856w, 1703w, 1595w, 1575w, 1471w, 1281s, 1250s; 
1
H NMR 
(400 MHz, CDCl3)  7.06–6.99 (3H, m, 2  × ArCH, IHC=CH), 6.93 (1H, d, J = 7.7 
Hz, ArCH), 6.61 (1H, dd, J = 8.0 and 1.6 Hz, ArCH), 6.33 (1H, d, J = 8.5 Hz, 
IHC=CH), 0.79 (9H, s, SiC(CH3)3), 0.02 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, 
CDCl3)  155.6 (ArCO), 138.6 (=CH), 138.1 (Arq), 129.4 (ArCH), 122.0 (ArCH), 
120.4 (ArCH), 119.7 (ArCH), 79.2 (=CHI), 25.9 (SiC(CH3)3), 18.4 (SiC), -4.2 
(Si(CH3)3); m/z calculated for [C14H22OISi]
+
 361.0479 found [M + H]
+
 361.0478. 
 
 
 
 139 
 
 
5-(tert-Butyldimethylsilyloxy)pentan-1-ol 142
58
 
To a stirred solution of 1,5-pentanediol (25.0 mL, 239 mmol) and imidazole (4.00 g, 
58.8 mmol) in DMF (25 mL) was added a solution of TBSCl (4.00 g, 26.5 mmol) in 
CH2Cl2 (4 mL) dropwise over 1 h. The solution was then stirred for a further 2 h. 
After this time the solution was diluted with Et2O (50 mL), the separated organic 
layer was washed with water (3 × 20 mL), brine (20 mL) and dried over MgSO4. The 
solvent was removed in vacuo and the residue was purified by flash column 
chromatography (SiO2, 1% Et2O in petrol) to give the title compound as colourless 
oil (2.00 g, 35% wrt TBSCl). Data are consistent with those previously reported in 
the literature.
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max/cm
–1
 3335br (O–H), 2929w, 2857w, 1472w, 1360w, 1253w, 1096m,; 1H NMR 
(400 MHz, CDCl3)  3.59 (4H, apt t, J= 6.5 Hz, 2 × OCH2) 1.57–1.49 (4H, m, 2 × 
OCH2CH2), 1.40-1.33 (2H, m, CH2CH2CH2), 0.85 (9H, s, SiC(CH3)3), 0.00 (6H, s, 
Si(CH3)2 );
 13
C NMR (101 MHz, CDCl3)   63.0 (2 × CO), 32.5 (CH2–CH2–OH), 
26.0 (CH2–CH2–OSi), 25.6 (SiC(CH3)3), 22.0 (CH2), 18.4 (SiC), –5.3 (Si(CH3)2).   
 
5-(tert-Butyldimethylsilyloxy)pentanal 143
59
 
To a solution of oxalyl chloride (0.39 mL, 4.55 mmol) in CH2Cl2 (8 mL) cooled to –
78 ºC was added dropwise a solution of DMSO (0.65 mL, 9.15 mmol) in CH2Cl2 (3 
mL), followed by continued stirring for 20 min. Subsequently 142 (1.00 g, 4.59 
mmol) was added slowly, followed by further stirring for 20 min. After this time 
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NEt3 (3.20 mL, 23.0 mmol) was added dropwise and the solution was stirred for a 
further 15 min. After this time the reaction was then allowed to warm to room temp 
and stirring was continued for 45 min. Water (20 mL) was added and the aqueous 
layer was extracted with CH2Cl2 (3 x 10 mL). The combined organic extracts were 
washed with brine (10 mL), dried over MgSO4 and filtered. The solvent was removed 
in vacuo and the residue was purified by flash column chromatography (SiO2, 10% 
Et2O in petrol) to give the title compound as colourless oil (770 mg, 78%). Data are 
consistent with those previously reported in the literature.
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max/cm
–1
 1727s (C=O), 831m, 562m; 
1
H NMR (400 MHz, CDCl3)  9.77 (1H, t, J = 
1.7 Hz, CHO), 3.63 (2H, t, J = 6.3 Hz, H2COTBS), 2.45 (2H, td, J = 7.5 and 1.7 Hz, 
CH2CHO), 1.74–1.66 (2H, m, OHCCH2CH2), 1.59–1.51 (2H, m, CH2CH2OTBS), 
0.89 (9H, s, SiC(CH3)3), 0.05 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3)  
202.7 (CHO), 62.7 (OCH2), 43.8 (CH2), 32.3 (CH2), 26.1 (SiC(CH3)3), 18.8 (CH2), 
18.5 (SiC), –5.2 (Si(CH3)2). 
 
(Z)-7-((tert-Butyldimethylsilyl)oxy)-1-(3-((tertbutyldimethylsilyl)oxy) 
phenyl)hept-1-en-3-ol 144 
To a solution of (Z)-iodoalkene 141 (200 mg, 0.56 mmol) in THF (10 mL) cooled to 
–78 °C was added n-BuLi (0.25 mL, 2M in hexanes, 0.50 mmol) dropwise, following 
continued stirring for 30 min. After this time aldehyde 143 (134 mg, 0.62 mmol) in 
THF (2 mL) was added and the solution was stirred for a further 45 min. NH4Cl (sat. 
aq.) (2 mL) was added dropwise at –78 °C. After warming to room temp, EtOAc (10 
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mL) was added and the separated organic layer was washed with brine (20 mL), 
dried over MgSO4 and filtered. The solvent was removed in vacuo and the residue 
was purified by flash column chromatography (SiO2, 20% Et2O in petrol) to give the 
title compound as pale yellow oil (101 mg, 40%). 
 max/cm
–1
 3442br (O–H), 2920m, 2884m, 1400s, 1412m, 1319m, 1250s, 1217s, 
1099s, 1030m; 
1
H NMR (400 MHz, CDCl3)  7.19 (1H, t, J = 7.8 Hz, ArCH), 6.87 
(1H, d, J = 7.8 Hz, ArCH), 6.79–6.73 (2H, m, 2 × ArCH), 6.48 (1H, d, J = 11.6 Hz, 
Ar–HC=CH), 5.64 (dd, J = 11.6 and 2.3 Hz, Ar–HC=CH), 4.61–4.55 (1H, m, HC–
OH), 3.60 (2H, t, J = 6.4 Hz, H2C–OTBS), 1.72–1.26 (6H, m, 3 × CH2), 0.99 (9H, s, 
SiC(CH3)3) 0.89 (9H, s, SiC(CH3)3), 0.21 (6H, s, Si(CH3)2), 0.04 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3)  155.7 (ArCO), 138.2 (ArCH), 134.8 (Arq), 131.0 
(ArC=C), 129.4 (=C), 122.0 (ArCH), 120.5 (ArCH), 119.2 (ArCH), 68.0 (C–OH), 
63.2 (C–OSi), 37.5 (CH2), 32.9 (CH2), 26.1 (SiC(CH3)3), 25.8 (SiC(CH3)3), 21.9 
(CH2), 18.5 (SiC), 18.4 (SiC), –4.3 (Si(CH3)2), –5.1 (Si(CH3)2);  m/z calculated for 
[C25H46O3Si2Na]
+
 473.2878 found [M + Na]
+
 473.2874.  
 
(Z)-7-Hydroxy-1-(3-hydroxyphenyl)hept-1-en-3-one 134 
To a stirred solution of (Z)-alcohol 144  (260 mg, 0.58 mmol) in CH2Cl2 (5 mL) was 
added freshly prepared Dess–Martin periodinane60 (267 mg, 0.63 mmol) in one 
portion followed by continued stirring for 3 h. After this time, NaHCO3 (sat. aq.) (10 
mL) was added and the organic layer was separated, dried over Na2SO4 and filtered. 
Following evaporation of the solvent in vacuo, purification of the residue by flash 
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column chromatography (SiO2; 10% Et2O in petrol) gave a ketone which was used 
immediately in the next step. To a solution of the aforementioned ketone (228 mg, 
0.51 mmol) in THF (1 mL) was added TBAF (1.02 mL, 1 M in THF, 1.02 mmol). 
The resultant yellow solution was stirred at 23 ° C for 4.5 h. After this time, water (5 
mL) was added and the mixture was extracted with EtOAc (3 × 5 mL). The 
combined organic extracts were dried over Na2SO4 and filtered. The solvent was 
removed in vacuo and the residue was purified by flash column chromatography 
(SiO2, 60% Et2O in petrol) to give the title compound as light yellow oil (46 mg, 
58% for two steps). The product displayed rapid degradation and was stored in the 
dark at 4 °C.  
max/cm
–1
 3350br (O–H), 2930w, 1739s (C=O), 1610m, 1578m, 1448, 1229s, 1217s, 
1059m; 
1
H NMR (400 MHz, CDCl3) δ 7.22 (1H, appt t, J = 7.8 Hz, ArCH), 7.09 
(1H, s, ArCH), 6.94 (1H, d, J = 7.5 Hz, ArCH), 6.84 (1H, dd, J = 7.8 and 1.7 Hz, 
ArCH), 6.81 (1H, d, J = 12.8 Hz, Ar–CH=CH), 6.16 (1H, d, J = 12.8 Hz, Ar–
CH=CH), 3.55 (2H, t, J = 6.3 Hz, CH2C=O), 2.45 (2H, t, J = 7.0 Hz, CH2OH), 1.75–
1.66 (2H, m, CH2CH2C=O), 1.58–1.51 (2H, m, CH2CH2C–OH); 
 
m/z calculated for 
[C13H17O3]
+
 221.1172 found. [M + H]
+
 221.1172. 
 
 
 
4-Methoxyphenyl methyl carbonate 161
64
 
To a stirred solution of 4-hydroxyanisole (500 mg, 4.03 mmol) in pyridine (0.49 mL, 
6.08 mmol) and THF (2 mL) cooled to 0 °C was added methyl chloroformate (0.62 
mL, 8.00 mmol) dropwise very cautiously over 5 min. The solution was stirred at 0 
ºC for 1 h then allowed to reach 23 °C and stirred for a further 1 h.  After this time, 
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water (5 mL) was added and the seperated organic phase was repeatedly washed with 
copious amounts of CuSO4 (sat. aq.), brine (7 mL) and dried over MgSO4. The 
solvent was removed in vacuo to give the title compound as colourless oil (670 mg, 
quantitative yield) which was used without further purification. Data are consistent to 
those previously reported in the literature.
64 
 
max/cm
–1
 2900w, 1750s (C=O), 1230m;  
1
H NMR (400 MHz, CDCl3) δ 6.81–6.75 
(4H, m, ArCH), 3.87 (3H, s, ArCOCH3), 3.77 (3H, s, COOCH3); 
13
C NMR (101 
MHz, CDCl3) δ 157.4 (ArCO), 154.7 (C=O), 144.8 (ArCO), 121.8 (2 × ArCH), 
114.5 (2 × ArCH), 55.4 (2 × OCH3). 
 
 
5-(tert-Butyldimethylsilyloxy)-2-methoxybenzaldehyde 163
64
 
To a stirred solution of 161 (1.22 g, 7.34 mmol) in CH2Cl2 (40 mL) cooled to 0 °C 
was added TiCl4 (8.44 mL, 1 M, 8.44 mmol) was added followed by 
dichloromethoxymethane (1.58 mL, 17.30 mmol) and the solution was stirred at 23 
°C for 1 h. After this time, water (10 mL) was added and the separated aqueous layer 
was extracted with Et2O (3 × 20mL). The combined organic layers were separated, 
dried over MgSO4 and filtered. The solvent was removed in vacuo to give a crude 
brown solid. The brown solid was dissolved in THF (28 mL) and to this was added 
NaOH (29 mL, 1 M aq. sol.,). The solution was heated at 35 ºC for 24 h. After this 
time HCl (1 M) was added until pH 7 was reached. The organic layer was extracted 
with EtOAc (2 × 20 mL), dried over MgSO4 and filtered. The solvent was removed 
in vacuo to give the title compound as yellow needles (580 mg, 44% for 2 steps). 
Data are consistent with those previously reported in the literature.
64
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mp 108–110 ºC (lit 110–115 ºC)64. max/cm
–1
 3222br (O–H), 1656s (C=O), 1609w, 
1440s, 1471s, 1440s, 1306s, 1221s. 
1
H NMR (400 MHz, CDCl3) δ 10.40 (1H, s, 
CHO), 7.36 (1H, d, J = 3.2 Hz, ArCH), 7.12 (1H, dd, J = 9.0 and 3.2 Hz, ArCH), 
6.90 (1H, d, J = 9.0 Hz, ArCH), 3.88 (3H, s, OCH3); 
13
C NMR (101 MHz, CDCl3) δ 
190.3 (C=O), 156.6 (ArCO), 149.9 (ArCO), 125.0 (ArCCHO), 123.6 (ArCH), 113.7 
(ArCH), 113.4 (ArCH), 56.2 (OCH3). 
 
5-(tert-Butyldimethylsilyloxy)-2-methoxybenzaldehyde 164 
Preparation 1:  
To a stirred solution of 5-(tert-butyldimethylsilyloxy)-2-methoxybenzaldehyde 163 
(4.00 g, 26.3 mmol) in CH2Cl2 (50 mL) was added TBSCl (4.40 g, 29.2 mmol) and 
NEt3 (4.10 mL, 29.4 mmol). After continued stirring for 16 h, water (20 mL) was 
added. The organic layer was separated, dried over MgSO4 and filtered. After 
evaporation of the solvent in vacuo the crude residue was purified by flash column 
chromatography (SiO2, 20% EtOAc in petrol) to give the title compound as yellow 
oil that slowly formed yellow needles (6.93 g, quantitative yield).  
mp 30–31 °C; max/cm
–1
 2930w, 2858w, 1682s (C=O), 1491s, 1390m, 1261s, 1214s, 
1156m, 1028m;  
1
H NMR (400 MHz, CDCl3) δ 10.39 (1H, s, CHO), 7.25 (1H, d, J = 
3.1 Hz, ArCH), 7.02 (1H, dd, J = 8.9 and 3.1 Hz, ArCH), 6.84 (1H, d, J = 8.9 Hz, 
ArCH), 3.86 (3H, s, OCH3), 0.95 (9H, s, SiC(CH3)3), 0.16 (6H, s, Si(CH3)2); 
13
C 
NMR (101 MHz, CDCl3) δ 189.5 (C=O), 156.8 (ArCO), 149.4 (ArCO), 127.7 
(ArCH), 125.3 (ArCH), 118.4 (Arq), 112.9 (ArCH), 56.1 (OCH3), 25.7 (SiC(CH3)3), 
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18.1 (SiC), –4.5 (Si(CH3)2), m/z calculated for [C14H23O3Si]
+
 267.1411 found. [M + 
H]
+
 267.1115. 
Preparation 2:  
 
1-(tert-Butyldimethylsilyloxy)-4-methoxybenzene 165 
To a stirred solution of 4-methoxyphenol (4.00 g, 32.2 mmol) in CH2Cl2 (30 mL) 
was added TBSCl (5.30 g, 35.2 mmol) and imidazole (2.40 g, 35.2 mmol) at 23 °C. 
After stirring for 2 h, water (10 mL) was added and the separated organic layer was 
dried over MgSO4 and filtered. The solvent was removed in vacuo and the residue 
was purifiied by flash column chromatography (SiO2, 10% Et2O in petrol) to give the 
title compound as colourless oil (7.00 g, 92%). Data are consistent with those 
previously reported in the literature.
66 
max/cm
–1
 2951m, 2931m, 1510s, 1255m, 1235; 
1
H NMR (400 MHz, CDCl3) δ 6.76 
(4H, s, 4 × ArCH), 3.76 (3H, s, OCH3), 0.98 (9H, s, SiC(CH3)3), 0.17 (6H, s, 
Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 154.3 (ArCO), 149.5 (ArCO), 120.8 (2 × 
ArCH), 114.6 (2 × ArCH), 55.8 (OCH3), 25.9 (SiC(CH3)3), 18.3 (SiC), –4.4 
(Si(CH3)2).  
To a stirred solution of 4-(methoxyphenoxy)-tert-butyldimethylsilane 165 (2.00 g, 
8.38 mmol) and TMEDA (1.30 mL, 8.67 mmol) in anhydrous tetrahydropyran (10 
mL) was slowly added n-BuLi (6.8 mL, 2.5 M in hexanes, 17.0 mmol) dropwise at 0 
C. The solution was allowed to warm to room temp and stirring was continued for a 
further 2 h. After this time, the solution was cooled to 0 °C before DMF (1.00 mL, 
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13.0 mmol) was slowly added dropwise. The reaction was allowed to warm to room 
temp over 2 h before being cooled to 0 °C and quenched by dropwise addition of 
water (5 mL).  The reaction mixture was diluted with Et2O (20 mL) before the 
separated organic phase was washed with water (5 × 10 mL), then dried over MgSO4 
and filtered. The solvent was removed in vacuo and the residue was purified by flash 
column chromatography (SiO2, 20% EtOAc in petrol) to give the title compound as 
pale yellow oil which crystallised to pale yellow crystals upon standing (1.70 g, 
77%).  Data were in accord to the alternative preparation (page 143).  
 
Ethyl (di-p-tolylphosphono)acetate 170 
To triethyl phosphonoacetate (0.57 mL, 2.87 mmol) cooled to 0 °C was carefully 
added PCl5
*
 (1.50 g, 7.20 mmol). The mixture was then heated at 75 °C for 17 h. 
After this time, careful removal of the volatile by-products in vacuo was followed by 
dissolution of the dichlorophosphonate in PhMe (20 mL) and addition of NEt3 (0.75 
mL, 5.41 mmol) then p-cresol (454 mg, 4.20 mmol). After stirring for 17 h, water (20 
mL) was added and the separated organic layer was dried over MgSO4 and filtered. 
The solvent was removed in vacuo and the residue was purified by flash column 
chromatography to give the title compound as pale yellow oil (400 mg, 61% for 2 
steps). Data are consistent with those previously reported in the literature.
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----------------------------- 
* PCl5 is classified as fatal by inhalation!  
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1
H NMR (400 MHz, CDCl3) δ 7.11 (8H, s, 8 × ArCH), 4.23 (2H, q, J = 7.1 Hz, 
OCH2), 3.22 (2H, d, J = 21.5 Hz, CH2), 2.31 (6H, s, 2 × ArCH3), 1.28 (3H, t, J = 7.1 
Hz, CH3); 
31
P NMR (162 MHz, CDCl3) δ 12.96.  
 
 (Z)-Ethyl 3-(5-(tert-butyldimethylsilyloxy)-2-methoxyphenyl)acrylate 169  
To a stirred solution of ethyl (di-p-tolylphosphono)acetate 170 (696 mg, 2.00 mmol) 
in THF (10 mL) was added NaH (48 mg, 2.00 mmol) portionwise at –78 °C. The 
solution was allowed to warm to 0 °C with continued stirring for 30 min.  After this 
time the solution was cooled to –78 °C before the aldehyde 164 (350 mg, 1.31 mmol) 
was added portionwise. Stirring was continued at –78 °C for 2 h. The solution was 
allowed to warm to room temp before NH4Cl (sat. aq., 5 mL) was added. The 
reaction mixture was diluted with Et2O (20 mL) before the separated organic layers 
were washed with brine (10 mL), dried over MgSO4 and filtered. The solvent was 
removed in vacuo to give a residue that was determined as an 85:15 mixture of Z:E 
isomers by 
1
H NMR.  Purification by flash column chromatography (SiO2, 5% → 
10% Et2O in petrol) afforded the Z-isomer as pale yellow oil (348 mg, 80%).  
 
max/cm
–1 
2930m, 2858m, 1721s (C=O), 1628w, 1577w, 1489s, 1464m, 1424m, 
1282w, 1219s (C−O), 1163s, 1033s; 1H NMR (400 MHz, CDCl3) δ 7.08 (1H, d, J = 
12.4 Hz, CH=CHCO2), 7.04 (1H, d, J = 2.8 Hz, ArCH), 6.77 (1H, dd, J = 8.9 and 2.8 
Hz, ArCH), 6.72 (1H, d, J = 8.9 Hz, ArCH), 5.94 (1H, d, J = 12.4 Hz, CH=CHCO2), 
4.14 (2H, q, J = 7.2 Hz, OCH2), 3.78 (3H, s, OCH3), 1.21 (3H, t, J = 7.2 Hz, 
CH2CH3), 0.97 (9H, s, SiC(CH3)3), 0.17 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, 
CDCl3) δ 166.4 (C=O), 152.0 (ArCO), 148.7 (ArCO), 138.2 (CH=CHCO2), 125.0 
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(Arq), 122.0 (ArCH), 121.3 (ArCH), 120.4 (ArCH), 111.3 (CH=CHCO2), 60.2 
(OCH2), 56.1 (OCH3), 25.9 (SiC(CH3)3), 18.3 (SiC), 14.2 (CH3), –4.4 (Si(CH3)2); 
m/z calculated for [C18H29O4Si]
+
 337.1830 found [M + H]
+
 337.1834.  
 
 
 
Data for minor (E)-alkene 171: max/cm
–1
 2931m, 2858m, 1708s (C=O), 1631s, 
1575w, 1493m, 1464m, 1317m, 1278m, 1253s (C−O), 1160s, 1033s; 1H NMR (400 
MHz, CDCl3) δ 7.93 (1H, d, J = 16.1 Hz, CH=CHCO2Et), 6.98 (1H, d, J = 2.8 Hz, 
ArCH), 6.80 (1H, dd, J = 8.9 and 2.8 Hz, ArCH), 6.77 (1H, d, J = 8.9 Hz, ArCH), 
6.45 (1H, d, J = 16.1 Hz, CH=CHCO2Et), 4.26 (2H, q, J = 7.1 Hz, OCH2), 3.83 (3H, 
s, OCH3), 1.34 (3H, t, J = 7.1 Hz, CH2CH3), 0.98 (9H, s, SiC(CH3)3), 0.18 (6H, s, 
Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 167.6 (C=O), 153.3 (ArCO), 149.4 
(ArCO), 139.9 (CH=CHCO2), 124.2 (Arq), 122.8 (ArCH), 119.8 (ArCH), 119.0 
(ArCH), 112.3 (CH=CHCO2), 60.5 (OCH2), 56.1 (OCH3), 25.8 (SiC(CH3)3), 18.3 
(SiC), 14.5 (Me), –4.3 (Si(CH3)2); m/z calculated for [C18H29O4Si]
+
 337.1830 found 
[M + H]
+
 337.1834. 
 
 
(Z)-3-(5-(tert-Butyldimethylsilyloxy)-2-methoxyphenyl)prop-2-en-1-ol 172 
To a stirred solution of ester 169 (310 mg, 0.92 mmol) in PhMe (10 mL) was slowly 
added DIBAL-H (1.93 mL, 1.0 M in PhMe, 1.93 mmol) dropwise at –78 °C. After 
stirring for 2 h, MeOH (1 mL) was added slowly and the solution was allowed to 
warm to 23 C over 1 h. A saturated solution of Rochelle salt (10 mL) was added and 
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the mixture was vigorously stirred for 30 min. The separated organic phase was 
washed with water (10 mL) and brine (10 mL), dried over MgSO4 and filtered. The 
organic phase was filtered through a short plug of silica gel before being evaporated 
in vacuo to give the title compound as pale yellow oil (268 mg, 98%). 
 max/cm
–1
 3349br (OH), 2954m, 2930m, 2857m, 2897m, 1489s, 1463m, 1417m, 
1282m, 1216s (C−O), 1032m; 1H NMR (400 MHz, CDCl3) δ 6.76–6.70 (2H, m, 2 × 
ArCH), 6.65–6.58 (2H, m, ArCH and CH=CHCO), 5.90 (1H, dt, J = 11.8 and 6.6 
Hz, CH=CHCO), 4.31 (2H, dd, J = 6.6 and 5.4 Hz, OCH2), 3.78 (3H, s, OCH3), 0.98 
(9H, s, SiC(CH3)3), 0.18 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 151.7 
(ArCO), 149.0 (ArCO), 131.2 (Ar–C=C), 126.8 (Ar–C=C), 126.2 (Arq), 121.9 
(ArCH), 119.7 (ArCH), 111.6 (ArCH), 60.0 (OCH2), 56.1 (OCH3), 25.8 (SiC(CH3)3), 
18.3 (SiC), –4.3 (Si(CH3)2); m/z calculated for [C16H25O3Si]
+
 293.1567 found [M – 
2H + H]
+
 293.1572. 
 
(Z)-3-(5-(tert-Butyldimethylsilyloxy)-2-methoxyphenyl)acrylaldehyde 168 
To a stirred solution of alcohol 172 (212 mg, 0.72 mmol) in CH2Cl2 (10 mL) was 
added Dess–Martin periodinane60 (305 mg, 0.72 mmol). The solution was stirred for 
2 h after which time water (5 mL) was added.  The separated organic layer was dried 
over MgSO4 and filtered.  The solvent was removed in vacuo and the residue was 
purified by flash column chromatography (SiO2; 10% Et2O in petrol) to give the title 
compound as yellow oil (161 mg, quantitative yield). 
max/cm
–1
 2955m, 2930m, 2857m, 1674s (conjugated C=O), 1576w, 1489s, 1419m, 
1219s (C−O), 1030m; 1H NMR (400 MHz, CDCl3) δ 9.91 (1H, d, J = 8.1 Hz, CHO), 
7.70 (1H, d, J = 11.5 Hz, CH=CHCO), 6.87 (1H, dd, J = 8.8 and 2.8 Hz, ArCH), 
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6.79–6.75 (2H, m, 2 × ArCH), 6.15 (1H, dd, J = 11.5 and 8.1 Hz, CH=CHCO), 3.82 
(3H, s, OCH3), 0.98 (9H, s, SiC(CH3)3), 0.17 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, 
CDCl3) δ 192.9 (C=O), 152.2 (ArCO), 148.9 (ArCO), 144.7 (CH=CHCHO), 130.0 
(CH=CHCHO), 123.9 (Arq), 123.5 (ArCH), 122.3 (ArCH), 111.7 (ArCH), 56.0 
(OCH3), 25.7 (SiC(CH3)3), 18.2 (SiC), –4.5 (Si(CH3)2); m/z calculated for 
[C16H25O3Si]
+
 293.1567 found [M + H]
+
 293.1572. 
 
 
4-Bromo-1-butanol 174 
To stirred and refluxing THF (60 mL) was added HBr (27 mL, 48% in water, 0.24 
mol) dropwise, followed by continued reflux for 2 h. After this time the reaction was 
cooled to 0 °C and neutralised with NaHCO3 (sat. aq.) (judged as pH 7 by indicator 
paper). The organic layer was then separated and washed with water (60 mL) and 
brine (20 mL), dried over MgSO4 and filtered. The solvent was removed in vacuo to 
give the title compound as yellow oil (12.3 g, 33%) which was used without further 
purification. Data are consistent with those previously reported in the literature.
71
 
 max/cm
–1
 3338w, 2917w, 1646w, 1433w, 1049m; 
1
H NMR (400 MHz, CDCl3) δ 
3.69 (2H, t, J = 6.3 Hz, OCH2), 3.45 (2H, t, J = 6.7 Hz, BrCH2), 2.00–1.93 (2H, m, 
CH2), 1.75–1.68 (2H, m, CH2); 
13
C NMR (101 MHz, CDCl3) δ  61.7 (OCH2), 33.8 
(CH2), 31.1 (CH2), 29.3 (CH2). 
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4-Bromo-1-(tert-butyldimethylsilyloxy)butane 173 
To a solution of 4-bromo-1-butanol 174 (500 mg, 3.3 mmol) in CH2Cl2 (30 mL) was 
added imidazole (445 mg, 6.5 mmol) and TBSCl (7.39 g, 4.9 mmol) at 0 °C. After 
stirring for 2 h at 0 °C, water (20 ml) was added. The organic layer was separated, 
dried over MgSO4 and filtered. Purification of the residue by flash column 
chromatography (SiO2; 10% Et2O in petrol) gave the title compound as pale yellow 
oil (8.82 g, quantitative yield). Data are consistent with those previously reported in 
the literature.
72a 
 
max/cm
–1 
2990w, 2858w, 2361w, 1468m; 
1
H NMR (400 MHz, CDCl3) δ 3.64 (2H, t, 
J = 6.1 Hz, OCH2), 3.45 (2H, t, J = 6.8 Hz, BrCH2), 1.98–1.90 (2H, m, CH2), 1.69–
1.62 (2H, m, CH2), 0.89 (9H. s, SiC(CH3)3), 0.05 (6H, s, Si(CH3)2); 
13
C NMR (101 
MHz, CDCl3) δ 62.3 (OCH2), 34.1 (CH2), 31.4 (CH2), 29.6 (CH2), 26.1 (SiC(CH3)3), 
18.5 (SiC), –5.2 (Si(CH3)2).   
 
 
(4-((tert-Butyldimethylsilyl)oxy)butyl)magnesium bromide 175 
To a vigorously stirred suspension of magnesium turnings (0.48 g, 19.9 mmol) and a 
small pellet of I2 in THF (15 mL) was added alkyl bromide 173 (1.33 g, 4.96 mmol) 
in THF (5 mL). After warming to reflux over 1 h and then allowing to cool to 23 °C, 
a cloudly grey mixture had formed. The Grignard 175 in THF, with an undetermined 
molarity, was used immediately in the next step (page 152).
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(Z)-7-((tert-Butyldimethylsilyl)oxy)-1-(3-((tertbutyldimethylsilyl)oxy)(6-
methoxy)phenyl)hept-1-en-3-ol 176 
To a stirred solution of aldehyde 168 (670 mg, 3.00 mmol) in THF (10 mL) at –78 
°C was slowly added Grignard 175 (15 mL in THF prepared from 1.33 g of alkyl 
bromide, see page 149). The solution was stirred for 2 h, after which time NH4Cl 
(sat. aq., 2 mL) was added. The reaction was allowed to warm to room temp before 
the mixture was diluted with Et2O (20 mL).  The separated organic layer was dried 
over MgSO4 and filtered. The solvent was evaporated in vacuo before the residue 
was purified by flash column chromatography (SiO2; 30% Et2O in petrol) to give the 
title compound as pale yellow oil (484 mg, 44%).  
max/cm
–1
 3399br (O-H), 2929m, 2857m, 1490s, 1472m, 1419m, 1252s (C−O), 
1216s, 1098s, 1035m;
  1
H NMR (400 MHz, CDCl3) δ 6.76–6.66 (3H, m, 3 × ArCH), 
6.53 (1H, d, J = 11.5 Hz, HC=C), 5.68 (1H, dd, J = 11.5 and 9.4 Hz, C=CH), 4.43–
4.34 (1H, m, OCH), 3.77 (3H, s, OCH3), 3.58 (1H, t, J = 6.5 Hz, OCH2), 1.89 (1H, 
brs, OH), 1.70–1.30 (6H, m, 3 × CH2), 0.98 (9H, s, SiC(CH3)3), 0.88 (9H, s, 
SiC(CH3)3), 0.17 (6H, s, Si(CH3)2), 0.03 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, 
CDCl3) δ 151.6 (ArCO), 149.1 (ArCO), 135.1 (CH=CCO), 126.6 (Arq), 126.5 
(CH=CCO), 121.9 (ArCH), 119.6 (ArCH), 111.8 (ArCH), 68.3 (OCH), 63.3 (OCH2), 
56.2 (OCH3), 37.0 (CH2), 33.0 (CH2), 26.1 (SiC(CH3)3), 25.9 (SiC(CH3)3), 21.9 
(CH2), 18.5 (SiC), 18.3 (SiC), –4.3 (Si(CH3)2), –5.1 (Si(CH3)2); m/z calculated for 
[C26H48O4Si2Na]
+
 503.2983 found [M + Na]
+
 503.2976.  
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(Z)-7-((tert-butyldimethylsilyl)oxy)-1-(3-((tertbutyldimethylsilyl)oxy)(6-
methoxyphenyl)hept-1-en-3-one 178  
To a stirred solution of (Z)-allylic alcohol 176 (476 mg, 1.00 mmol) in CH2Cl2 (5 
mL) was added Dess–Martin periodinane (2.50 g, 5.89 mmol). Stirring was 
continued for 24 h, after which time water (2 mL) was added. The organic layer was 
separated, dried over MgSO4 and filtered. The solvent was evaporated in vacuo and 
the residue was purified by flash column chromatography (SiO2; 15% Et2O in petrol) 
to give the title compound as yellow oil (396 mg, 84%). 
max/cm
–1 
2953m, 2929m, 2886w, 2857m, 1691m (C=O), 1595w, 1576w, 1489m, 
1252m, 1218s, 1099m, 1032m; 
1
H NMR (400 MHz, CDCl3) δ 6.97 (1H, d, J = 12.7 
Hz, CH=CHCO), 6.90 (1H, d, J = 2.8 Hz, ArCH), 6.78 (1H, dd, J = 8.8 and 2.8 Hz, 
ArCH), 6.73 (1H, d, J = 8.8 Hz, ArCH), 6.14 (1H, d, J = 12.7 Hz, CH=CHCO), 3.78 
(3H, s, OCH3), 3.55 (2H, t, J = 6.4 Hz, OCH2), 2.43 (2H, t, J = 7.4 Hz, O=CCH2), 
1.64–1.54 (2H, m, CH2), 1.49–1.40 (2H, m, CH2), 0.97 (9H, s, SiC(CH3)3) 0.87 (9H, 
s, SiC(CH3)3), 0.17 (6H, s, Si(CH3)2), 0.02 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, 
CDCl3) δ 203.5 (C=O), 151.8 (ArCO), 148.9 (ArCO), 134.9 (CH=CHCO), 129.2 
(CH=CHCO), 125.4 (Arq), 122.0 (ArCH), 121.5 (ArCH), 111.5 (ArCH), 63.0 
(OCH2), 56.0 (OCH3), 42.9 (O=CCH2), 32.4 (OCH2CH2), 26.1 (SiC(CH3)3), 25.8 
(SiC(CH3)3), 20.8 (O=CCH2CH2), 18.5 (SiC), 18.3 (SiC), –4.4 (Si(CH3)2), –5.2 
(Si(CH3)2); m/z calculated for [C26H47O4Si2]
+
 479.3007 found [M + H]
+
 479.3002. 
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(Z)-7-Hydroxy-1-(3-hydroxy-6-methoxyphenyl)hept-1-en-3-one 156 
To a stirred solution of (Z)-Enone 178 (300 mg, 0.627 mmol) in THF (5 mL) was 
added a solution of TBAF (1.38 mL, 1.0 M in THF, 1.38 mmol). The solution was 
stirred at room temp for 90 min, after which time NH4Cl (sat. aq., 5 mL) was added. 
The reaction mixture was diluted with Et2O (20 mL), before the separated organic 
phase was dried over MgSO4 and filtered. The solvent was removed in vacuo before 
the residue was purified by flash column chromatography (SiO2; 100% EtOAc) to 
give the title compound as yellow oil (147 mg, 94%). 
max/cm
–1
 3361br (OH), 2939m (C–H), 1679m (C=O), 1585w, 1496s, 1463s, 
11281m, 11179m, 1222s, 1030m; 
1
H NMR (400 MHz, CDCl3) δ 7.06 (1H, d, J = 
12.7 Hz, CH=CHCO), 6.97 (1H, d, J = 3.0 Hz, ArCH), 6.84 (1H, dd, J = 8.8 and 3.0 
Hz, ArCH), 6.77 (1H, J = 8.8 Hz, ArCH), 6.17 (1H, J = 12.7 Hz, CH=CHCO), 5.80 
(brs, ArCOH), 3.80 (3H, s, OCH3), 3.61 (2H, t, J = 6.0 Hz, OCH2), 2.51 (2H, t, J = 
7.0 Hz, O=CCH2), 1.99 (1H, brs, CH2OH), 1.74–1.65 (2H, m, CH2), 1.57–1.49 (2H, 
m, CH2); 
13
C NMR (101 MHz, CDCl3) δ 204.3 (C=O), 151.6 (ArCO), 149.3 (ArCO), 
135.5 (CH=CHCO), 129.0 (CH=CHCO), 125.1 (ArCH), 123.9 (Arq), 117.7 (ArCH), 
112.1 (ArCH), 62.4 (OCH3), 56.2 (OCH2), 42.1 (O=CCH2), 31.9 (CH2), 20.0 (CH2); 
m/z calculated for [C14H19O4]
+
 251.1278 found [M + H]
+
 251.1273. 
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8a-Methoxy-3',4',5',6'-tetrahydrospiro[chromene-2,2'-pyran]-6(8aH)-one 147a 
/147b 
To a stirred solution of hydroxyphenol 156 (25 mg, 0.10 mmol) in MeCN (1 mL) 
was added PhI(OAc)2 (48 mg, 0.15 mmol). The solution was stirred for 40 min, after 
which time the solvent was evaporated in vacuo. 
1
H NMR analysis of the residue 
revealed that the spiroketal diastereomers had been produced in 1:2 ratio
*
. The 
residue was purified by flash column chromatography (SiO2; 20% EtOAc in petrol) 
to give the title compounds as yellow oils (147a = 8 mg; 147b = 6 mg; total yield 
56%). The stereochemical assignment of each diastereomer was made through 
NOESY difference experiments. 
Spiroketal 147a (8 mg): max/cm
–1
 2940m, 1667s (C=O), 1619s, 1441w, 1381w, 
1285m, 1200m, 1137s, 1090s, 1044s; 
1
H NMR (400 MHz, CDCl3) δ 6.85 (1H, d, J = 
10.2 Hz, =C2H), 6.39 (1H, d, J = 10.2 Hz, =C5H), 6.25 (1H, dd, J = 10.2 and 2.0 Hz, 
=C1H), 6.07 (1H, d, J =10.2 Hz, =C4H), 6.02 (1H, d, J = 2.0 Hz, =C3H), 4.15 (1H, 
td, J = 11.7 and 3.2 Hz, OCHa), 3.85–3.79 (1H, m, OCHb), 3.28 (3H, s, OCH3), 1.91–
1.65 (6H, m, 3 × CH2); 
13
C NMR (101 MHz, CDCl3) δ 186.0 (C=O), 146.8 (=Cq), 
----------------------------- 
* As judged by comparison of each diastereomer’s OCH3 resonance in the 
1
H NMR 
spectrum directly after the removal of solvent.  
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142.4 (=C), 137.1 (=C), 129.5 (=C), 123.3 (=C) 123.2 (=C), 95.3 (OCspiroO), 90.8 
(OCO), 62.3 (OCH2), 51.5 (OCH3), 36.4 (CH2), 24.8 (CH2), 18.3 (CH2); m/z 
calculated for [C26H17O4]
+
 249.1121 found [M + H]
+
 249.1120.  
Spiroketal 147b (6 mg): max/cm
–1
 2941m, 1662s (C=O), 1621s, 1440w, 1367w, 
1290m, 1289m, 1229m, 1200m, 1141m, 1089m, 1066m; 
1
H NMR (400 MHz, 
CDCl3) δ 6.78 (1H, d, J = 10.2 Hz, =C2H), 6.45 (1H, d, J = 10.2 Hz, =C5H), 6.29 
(1H, dd, J = 10.2 and 2.0 Hz, =C1H), 6.07 (1H, d, J = 2.0 Hz, =C3H), 6.04 (1H, d, J 
= 10.2 Hz, =C4H), 4.06 (1H, td, J = 11.7 and 3.1 Hz, OCHa), 3.77–3.71 (1H, m, 
OCHb), 3.18 (3H, s, OCH3), 2.14–1.57 (6H, m, 3 × CH2); 
13
C NMR (101 MHz, 
CDCl3) δ 185.9 (C=O), 146.2 (=Cq), 142.7 (=C), 137.2 (=C), 129.9 (=C), 124.4 (=C), 
123.5 (=C), 96.3 (OCspiroO), 92.6 (OCO), 62.4 (OCH2), 51.1 (OCH3), 35.6 (CH2), 
24.8 (CH2), 18.7 (CH2); m/z calculated for [C26H17O4]
+
 249.1121 found [M + H]
+
 
249.1121.  
6-Hydroxy-4,7-dimethyl-2H-chromen-2-one 192 
 
To a mixture of methyl hydroquininone (6.00 g, 48.3 mmol) and ethyl acetoacetate 
(3.36 mL, 25.8 mmol) was cautiously added conc. H2SO4 (20 mL). After stirring for 
16 h, the mixture was poured onto ice-cold water (500 mL) and allowed to warm to 
room temp. The precipitate was collected by vacuum filtration and rinsed with 
copious amounts of water, followed by Et2O (5 × 20 mL). The solid was then dried at 
0.1 mbar for 16 h to give the title compound as a beige amorphous solid (2.52 g, 
51%). For the purpose of melting point characterisation a small amount of 
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amorphous solid was purified by recrystallisation from EtOH to give brown needles. 
Data are consistent with those previously reported in the literature.
78 
mp 208–209 °C (lit. 207–208 °C)78; 1H NMR (400 MHz, DMSO-d6) δ 7.16 (1H, s, 
ArCH), 7.02 (1H, s, ArCH), 6.28 (1H, s, =CH), 2.35 (3H, s, CH3), 2.22 (3H, s, 
CH3);
13
C NMR (101 MHz, DMSO-d6) δ 160.2 (C=O), 152.7 (=Cq), 152.0 (ArCO), 
146.2 (ArCO), 130.3 (Arq), 117.9 (ArCH), 117.8 (Arq), 113.4 (=CH), 108.3 (ArCH), 
18.0 (CH3), 16.2 (CH3).  
 
(tert-Butyldimethylsilyloxy)-4,7-dimethyl-2H-chromen-2-one 193 
To a stirred solution of 6-hydroxy-4,7-dimethyl-2H-chromen-2-one 192 (1.00 g, 5.26 
mmol) in DMF (40 mL) was added NEt3 (0.80 mL, 5.77 mmol) and TBSCl (871 mg, 
5.77 mmol). The solution was stirred at 23 °C for 17 h, after which time water (30 
mL) was added. The separated organic layer was washed with water (4 × 20 mL), 
brine (20 mL), dried over MgSO4 and filtered. The solvent was removed in vacuo 
and the crude residue was purified by flash column chromatography (SiO2; 20% 
Et2O in petrol) to give the title compound as colourless needles (1.50 g, 94%).  
mp 92–94 °C; max/cm
–1 
2954w, 2930w, 2893w, 2858w, 1710s (C=O), 1557m, 
1501m, 1414m, 1387m, 1281m, 1234m, 1165m; 
1
H NMR (400 MHz, CDCl3) δ 7.12 
(1H, s, ArCH), 6.90 (1H, s, ArCH), 6.22 (1H, s, =CH), 2.36 (3H, s, CH3), 2.29 (3H, 
s, ArCH3), 1.04 (9H, s, SiC(CH3)3), 0.24 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, 
CDCl3) δ 161.5 (C=O), 152.0 (=Cq), 150.6 (ArCO), 148.2 (ArCO), 134.9 (Arq), 
119.0 (ArCH), 118.3 (Arq), 114.4 (=CH), 112.5 (ArCH), 25.9 (SiC(CH3)3), 18.7 
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(ArCH3), 18.4 (SiC), 17.5 (CH3), –4.1 (Si(CH3)2); m/z calculated for [C17H25O3Si]
+
 
305.1567 found [M + H]
+
 305.1567.  
 
(Z)-4-((tert-Butyldimethylsilyl)oxy)-2-(4-hydroxybut-2-en-2-yl)-5-methylphenol 
196 
To a stirred suspension of LiAlH4 (338 mg, 8.9 mmol) in THF (60 mL) was added 
BnCl (1.0 mL, 8.9 mmol) at 23 °C. After stirring for 35 min, 6-(tert-
butyldimethylsilyloxy)-4,7-dimethyl-2H-chromen-2-one 193 (1.8 g, 5.9 mmol) in 
THF (40 mL) was added dropwise via a cannula over 5 min. After 15 min the 
solution was cooled to 0 °C and cautiously quenched by dropwise addition of NH4Cl 
(sat. aq., 2 mL). After warming to room temp the mixture was filtered and the solids 
were rinsed with EtOAc (20 mL). The filtrate was washed with water (20 mL), dried 
over MgSO4 and filtered. The solvent was removed in vacuo and the crude residue 
was purified by flash column chromatography (SiO2; 25%→50% EtOAc in petrol) to 
give the title compound as pale yellow oil, which upon standing for two days formed 
pale yellow needles (1.10 g, 61%).  
mp 72–75 °C; max/cm
–1
 3287br (O–H), 2956w, 2930w, 2858w, 1659w, 1498m, 
1472m, 1255s; 
1
H NMR (400 MHz, CDCl3) δ 6.71 (1H, s, ArCH), 6.42 (1H, s, 
ArCH), 5.93–5.88 (1H, m, =CH), 5.43 (1H, s, ArCOH), 3.93 (2H, d, J = 7.3 Hz, 
OCH2), 2.15 (3H, s, ArCH3), 2.00 (3H, brs, CH3), 1.00 (9H, s, SiC(CH3)3), 0.17 (6H, 
s, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 147.6 (ArCO), 145.7 (ArCO), 137.1 
(Ar–C=), 129.6 (Arq), 127.6 (=CH), 125.0 (Arq), 118.5 (ArCH), 118.4 (ArCH), 60.5 
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(OCH2), 25.9 (SiC(CH3)3), 25.6 (CH3C=), 18.4 (SiC), 16.9 (ArCH3), –4.1 (Si(CH3)2); 
m/z calculated for [C17H28O3Si + NH4Cl]
+
 326.2146 found 326.2149. 
 
(Z)-3-(5-((tert-Butyldimethylsilyl)oxy)-2-methoxy-4-methylphenyl)but-2-enal 
197 
To a stirred solution of (Z)-allylic alcohol 196 (1.10 g, 3.57 mmol) and MeI (0.24 
mL, 3.86 mmol) in DMF (30 mL) was added Cs2CO3 (1.60 g, 4.90 mmol). Stirring 
was continued for 17 h, with subsequent addition of water (101 mL) and Et2O (100 
mL). The separated organic layer was washed with water (4 × 20 mL), brine (20 
mL), dried over MgSO4 and filtered. The solvent was removed in vacuo to give (Z)-
anisole as yellow oil which was used directly in the next step. A solution of (Z)-
anisole (610 mg, 1.9 mmol) and activated MnO2 (3.3 g, 38.0 mmol) in CH2Cl2 (20 
mL) was stirred for 1 h at 23 °C. After this time, the solid was filtered off and the 
solid was rinsed with EtOAc (2 × 10 mL). The filtrate was dried over MgSO4, and 
filtered. The solvent was removed in vacuo and purification by flash column 
chromatography (SiO2; 20% Et2O in petrol) gave the title compound as yellow oil, 
which upon standing crystallised into pale yellow plates (410 mg, 37% over 2 steps). 
 mp  40–43 °C; max/cm
–1
 2955w,  2931w, 2858w, 1677s (conjugated C=O), 1499s, 
1464m, 1399s, 1254m, 1210s;  
1
H NMR (400 MHz, CDCl3) δ 9.37 (1H, d, J = 8.2 
Hz, CHO), 6.72 (1H, s, ArCH), 6.53 (1H, s, ArCH), 6.08 (1H, dq, J = 8.2 and 1.4 
Hz, =CH), 3.76 (3H, s, OCH3), 2.23 (6H, s, 2 × CH3), 1.00 (9H, s, SiC(CH3)3), 0.18 
(6H, s, (SiCH3)2); 
13
C NMR (101 MHz, CDCl3) δ 193.8 (C=O), 160.4 (Ar–C=C), 
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150.3 (ArCO), 147.3 (ArCO), 130.5 (Arq), 129.8 (C=CH), 125.3 (Arq), 120.4 
(ArCH), 114.2 (ArCH), 56.1 (OCH3), 26.1 (=CCH3), 25.9 (SiC(CH3)3), 18.4 (SiC), 
17.3 (ArCH3), –4.1 (Si(CH3)2); m/z calculated for [C18H29O3Si]
+
 321.1880 found [M 
+ H]
+
 321.1884.  
X-Ray Crystallographic Data 197: 
These data can be obtained free of charge from The Cambridge Crystallographic 
Data Centre via www.ccdc.cam.ac.uk/data_request/cif 
CCDC 1043759 contains the supplementary crystallographic data for this compound.  
 
  
 
(E)-3,7-dimethylocta-2,6-dienal (geranial)  
Activated MnO2 (28.2 g, 0. 32 mol) was slowly added to a stirred solution of 
geraniol (5.00 g, 32.4 mmol) in CH2Cl2 (50 mL) with continued was stirring for 72 h. 
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After this time, the mixture was filtered and rinsed with CH2Cl2 (4 × 20 mL). The 
solvent was removed in vacuo to give the title compound pale yellow oil (4.20 g, 
72%) which was used without further purification. Data are consistent with those 
previously reported in the literature.
81
 
max/cm
–1
 2967w, 2916w, 2856w, 1671s (C=O), 1611m, 1441m, 1378m, 1193m, 
1120m; 
1
H NMR (400 MHz, CDCl3) δ 9.99 (1H, d, J = 8.0 Hz, CHO), 5.90–5.86 
(1H, m, =CH), 5.10–5.04 (1H, m, =CH), 2.26–2.18 (4H, m, 2 × CH2), 2.16 (3H, d, J 
= 1.7 Hz, CH3), 1.69 (3H, s, CH3), 1.61 (3H, s, CH3); 
13
C NMR (101 MHz, CDCl3) δ 
191.4 (C=O), 163.8 (=C), 133.1 (=C), 127.6 (=C), 122.7 (=C), 40.8 (CH2), 25.9 
(CH2), 25.8 (CH3), 17.9 (CH3), 17.7 (CH3). 
 
 
6,10-dimethyl-undeca-5,9-dien-1-yn-4-ol 190 
To a stirred mixture of geranial (4.20 g, 28 mmol) and zinc dust (18 g) (activated by 
washing with dilute HCl) in THF (50 mL) was added propargyl bromide (8.8 mL, 84 
mmol) at 0 °C. The solution was allowed to reach room temp and then NH4Cl (aq. 
sat., 5 mL) was added (vigorous reaction!)
*
. The mixture was vigorously stirred for 3 
h after which time more NH4Cl (sat. aq., 40 mL) was added. The mixture was filtered 
and rinsed with Et2O (50 mL). The filtrate was washed with water and the separated 
organic layer was dried over MgSO4 and filtered. The solvent was removed in vacuo 
and the residue was purified by flash column chromatography (SiO2; 5→50% Et2O 
----------------------------- 
* Reaction prone to a rapid exothermic rate increase. Use excessively large RBF to 
prevent over-spill and a blast shield.  
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in petrol) to give the title compound as pleasant smelling pale yellow oil (2.80 g, 
52%). Data are consistent with those previously reported in the literature.
81
 
1
H NMR (400 MHz, CDCl3) δ 5.27 (1H, d, J = 8.5 Hz, =CH), 5.09 (1H, t, J = 6.5 
Hz, =CH), 4.58–4.52 (1H, m, OCH), 2.43–2.40 (2H, m, CH2), 2.15–1.99 (4H, m, 2 × 
CH2), 1.83–1.80 (1H, m, C≡CH), 1.71 (3H, s, CH3), 1.68 (3H, s, CH3), 1.60 (3H, s, 
CH3); 
13
C NMR (101 MHz, CDCl3) δ 140.4 (=C), 131.9 (=C), 125.8 (=C), 123.9 
(=C), 81.0 (C≡CH), 70.5 (C≡CH), 66.9 (CO), 39.6 (CH2C≡), 27.9 (CH2), 26.5 (CH2), 
25.8 (CH3), 17.9 (CH3), 16.9 (CH3). 
 
(E)-4-(tert-Butyldimethylsilyloxy)-6,10-dimethyl-undeca-5,9-dien-1-yn-4-ol 200 
To a stirred solution of (E)-6,10-dimethyl-undeca-5,9-dien-1-yn-4-ol 190 (825 mg, 
4.26 mmol) in CH2Cl2 (30 mL) was added TBSCl (707 mg, 4.69 mmol), NEt3 (0.9 
mL, 6.49 mmol) and DMAP (1 crystal) at 23 °C. After stirring for 17 h, water (10 
mL) was added. The organic layer was separated, washed with water (10 mL), dried 
over MgSO4 and filtered. The solvent was removed in vacuo and the residue was 
purified by flash column chromatography (SiO2; 2% EtOAc in petrol ) to give the 
title compound as colourless oil (1.20 g, 92%).  
max/cm
–1
 3314w (C≡CH), 2956m, 2929m, 2856m, 2737m, 2122vw (C≡C), 1671w 
(C=C), 1471w, 1378w, 1361w, 1070s; 
1
H NMR (400 MHz, CDCl3) δ 5.18–5.14 (1H, 
m, =CH), 5.12–5.07 (1H, m, =CH), 4.53 (1H, dt, J = 8.5 and 6.4 Hz, OCH), 2.39 
(1H, ddd, J = 16.5, 6.6 and 2.6 Hz, ≡CCHa), 2.27 (1H, ddd, J = 16.5, 6.3 and 2.6 Hz, 
≡CCHb), 2.13–1.98 (4H, m, 2 × CH2), 1.92 (1H, t, J = 2.6 Hz, ≡CH), 1.67 (3H, s, 
CH3), 1.66 (3H, s, CH3), 1.60 (3H, s, CH3), 0.88 (9H, s, SiC(CH3)3), 0.06 (3H, s, 
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SiCH3), 0.04 (3H, s, SiCH3); 
13
C NMR (101 MHz, CDCl3) δ 136.5 (=C), 131.7 (=C), 
128.1 (=C), 124.2 (=C), 82.0 (C≡CH), 69.3(C≡CH), 68.6 (CO), 39.6 (CH2C≡), 28.7 
(CH2), 26.4 (CH2), 26.0 (SiC(CH3)3), 25.8 (CH3), 18.4 (SiC), 17.8 (CH3), 16.9 (CH3), 
–4.2 (Si(CH3)), –4.7 (Si(CH3)); m/z calculated for [C19H35OSi]
+ 
307.2452 found. [M 
+ H]
+
 307.2446.  
 
(2Z,9E)-8-((tert-Butyldimethylsilyl)oxy)-2-(5-((tert-butyldimethylsilyl)oxy)-2-
methoxy-4-methylphenyl)-10,14-dimethylpentadeca-2,9,13-trien-5-yn-4-ol 201 
To a stirred solution of (E)-4-(tert-butyldimethylsilyloxy)-6,10-dimethyl-undeca-5,9-
dien-1-yn-4-ol (240 mg, 0.78 mmol) and TMEDA (100 µL, 0.68 mmol) in THF (10 
mL) was added n-BuLi (2.5 M in hexanes, 0.27 mL, 0.68 mmol) at –78 °C. The 
solution was allowed to warm to 20 °C with continued stirring for 1.5 h. After this 
time the solution was cooled to –78 °C and aldehyde 197 (167 mg, 0.52 mmol) in 
THF (5 mL) was added dropwise. After 15 min the solution was allowed to warm to 
20 °C and was immediately poured onto an ice cold sol. NH4Cl (sat. aq., 10 mL). 
The separated organic layer was washed with water (10 mL), dried over NaSO4 and 
filtered. The solvent was removed in vacuo and the residue was purified by flash 
column chromatography (SiO2; 20% Et2O in petrol) to give the title compound as 
yellow oil and a undetermined mixture of diastereomers (160 mg, 49%). 
max/cm
–1
 3454br (O–H), 2955m, 2929m, 2856m, 1669m, 1573m, 1500m, 1463m, 
1399m, 1373m, 1362m, 1307m, 1253m, 1209s, 1067m; 
1
H NMR (400 MHz, CDCl3) 
δ 6.69 (1H, s, ArCH), 6.50 (1H, s, ArCH), 5.65 (1H, dq, J = 9.4 and 1.4 Hz, =CHC–
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OH), 5.13–5.06 (2H, m, 2 × =CH), 4.65–4.60 (1H, m, HOCH), 4.52–4.56 (1H, m, 
TBSO–CH), 3.73 (3H, s, OCH3), 2.45–2.37 (1H, m, ≡C–CHa), 2.30–2.23 (1H, m, 
≡C–CHb), 2.20 (3H, s, ArCH3), 2.12–1.97 (7H, m, 2 × CH2, CH3), 1.67 (3H, s, CH3), 
1.64 (3H, s, CH3), 1.59 (3H, s, CH3), 1.01 (9H, s, SiC(CH3)3), 0.869 and 0.866 (9H, 2 
× s, SiC(CH3)3), 0.19 (6H, s, Si(CH3)2), 0.052 and 0.047 (3H, 2 × s, Si(CH3)2), 0.029 
and 0.026 (3H, 2 × s, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 150.3, 147.7, 137.2, 
136.3, 131.8, 131.7, 128.9, 128.4, 127.5, 124.3, 120.1, 114.8, 83.3, 83.2, 81.5, 81.4, 
69.02, 69.00, 60.8, 56.6, 39.8, 39.8, 29.3, 26.5, 26.1, 26.1, 26.0, 25.0, 18.5, 18.0, 
17.3, 17.02, 17.0, –3.9, –4.0, –4.1, –4.1, –4.5*; m/z calculated for [C37H62O4Si2 + 
NH4]
+ 
644.4525 found 644.4513.  
 
(2Z,5Z,9E)-8-((tert-Butyldimethylsilyl)oxy)-2-(5-((tert-butyldimethylsilyl)oxy)-2-
methoxy-4-methylphenyl)-10,14-dimethylpentadeca-2,5,9,13-tetraen-4-ol 202 
A solution of (Z)-propargyl alcohol 201 (160 mg, 0.26 mmol), Lindlar catalyst (60 
mg) and quinoline (6 µL) in EtOAc (9 mL) was vigorously stirred under 1 atm of 
hydrogen at 23 °C. After 23 h additional Lindlar catalyst (150 mg) was added over 8 
h with continued stirring.  After this time the solution was filtered and rinsed with 
EtOAc (10 mL). The solvent was removed in vacuo and the residue was purified by 
flash column chromatography (SiO2; 10% Et2O in petrol) to give the title compound 
as pale yellow oil and an undetermined mixture of diastereomers (126 mg, 78%).  
----------------------------- 
*
 Due to a mixture of two diastereomers the 
13
C NMR spectrum could not be 
assigned.  
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max/cm
–1
 3459br (O–H), 2855w, 2929w, 2857w, 1500m, 1464m, 1398m, 1253m, 
1208s, 1058m 1012m; 
1
H NMR (400 MHz, CDCl3) δ 6.68 (1H, s, ArCH), 6.54–6.50 
(1H, m, ArCH), 5.61–5.51 (2H, m, ArC=CH, HOC–CH=CH), 5.48–5.37 (1H, m, 
HOC–CH=CH), 5.09–5.02 (2H, m, 2 × =CH), 4.70–4.61 (1H, m, HO–CH), 4.30–
4.21 (1H, m, TBSO–CH), 3.73 (3H, s, OCH3), 2.36 (s, OH),  2.20 (3H, s, CH3), 
2.13–1.84 (9H, m, 3 × CH2, CH3), 1.66 (3H, s, CH3), 1.59 (3H, s, CH3), 1.51 (3H, m, 
CH3), 1.01 (9H, s, SiC(CH3)3), 0.83 (9H, s, SiC(CH3)3), 0.18 (6H, m, Si(CH3)), –0.03 
(3H, 2 × s, Si(CH3)2), –0.04 (3H, 2 × s, Si(CH3)); 
13
C NMR (101 MHz, CDCl3) δ 
150.1, 150.1, 147.6, 147.6, 134.8, 134.8, 133.5, 133.1, 131.6, 129.8, 129.0, 128.9, 
128.4, 128.3, 128.3, 128.2, 127.9, 124.2, 119.9, 119.8, 114.4, 69.7, 69.5, 66.4, 65.8, 
56.3, 39.6, 39.6, 36.8, 36.7, 26.4, 26.4, 26.0, 26.0, 25.9, 25.8, 18.3, 17.8, 17.1, 16.5, –
4.0, –4.1, –4.2, –4.3, –4.6, –4.7; m/z calculated for [C37H64O4Si2]
+
 628.4338 found 
[C37H64O4Si2]
+
 628.4341  
 
(2Z,5Z,9E)-8-((tert-butyldimethylsilyl)oxy)-2-(5-((tert-butyldimethylsilyl)oxy)-2-
methoxy-4-methylphenyl)-10,14-dimethylpentadeca-2,5,9,13-tetraen-4-one 203 
To a stirred solution of (Z),(Z)-dienol 202 (84 mg, 0.13 mmol) in CHCl3 (1 mL) was 
added activated MnO2 (464 mg, 5.2 mmol) at 23 °C. After 25 h, the mixture was 
filtered over a 3 cm plug of silica and washed with Et2O (10 mL). The solvent was 
removed in vacuo to give the title compound as yellow oil (56 mg, 69%).  
max/cm
–1
 2956m, 2929m, 2857m, 1652m (C=O), 1609m (C=O), 1501m, 1464m, 
1400m, 1374m, 1254m, 1211s, 1064m, 1021w, 1005m, 1064m, 1021m; 
1
H NMR 
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(400 MHz, CDCl3) δ 6.66 (1H, s, ArCH), 6.43 (1H, s, ArCH), 6.15 (1H, s, Ar–
C=CH), 5.91–5.81 (2H, m,O=C–CH=CH, O=C–CH=CH), 5.12–5.03 (2H, m, 2 × 
=CH), 4.38 (1H, dt, J = 8.4, 6.5 Hz, OCH), 3.72 (3H, s, OCH3),  2.67–2.62 (2H, m, 
TBSO–C–CH2), 2.20 (3H, s, CH3), 2.11 (3H, s, CH3), 2.09–2.02 (2H, m, CH2), 1.97–
1.93 (2H, m, CH2), 1.65 (3H, s, CH3), 1.59–1.55 (6H, m, 2 × CH3), 0.99 (9H, s, 
SiC(CH3)3), 0.84 (9H, s, SiC(CH3)3), 0.13 (6H, s, Si(CH3)2), –0.01 (3H, s, Si(CH3)), 
–0.02 (3H, s, Si(CH3)); 
13
C NMR (101 MHz, CDCl3) δ 192.7 (C=O), 149.9 (=Cq), 
148.7 (ArCO), 147.4 (ArCO), 143.5 (=CH), 135.1 (Arq), 131.6 (Arq), 130.4 (=CH), 
129.5 (=Cq), 129.0 (=CH), 128.0 (=CH), 128.0 (=Cq), 124.3 (=CH), 119.5 (ArCH), 
114.1 (ArCH), 69.5 (OCH), 56.0 (OCH3), 39.6 (CH2), 38.6 (CH2), 26.4 (CH3), 26.2 
(CH2), 26.0 (CH3), 25.9 (SiC(CH3)3), 25.8 (SiC(CH3)3), 18.33 (SiC), 18.29 (SiC), 
17.8 (CH3), 17.3 (CH3), 16.6 (CH3), –4.10 (Si(CH3)), –4.13 (Si(CH3)), –4.7 
(Si(CH3)2).  
 
(E)-4-(Triethylsilyloxy)-6,10-dimethyl-undeca-5,9-dien-1-yn-4-ol 206 
To a stirred solution of 6,10-dimethyl-undeca-5,9-dien-1-yn-4-ol (2.5 g, 13 mmol) in 
CH2Cl2 (20 mL) was added TESCl (2.3 mL, 14 mmol) and imidazole (2.1 g, 30 
mmol). The solution was stirred for 17 h, after which time water (20 mL) was added. 
The organic layer was separated and washed with NH4Cl (sat. aq., 10 mL), water (30 
mL), dried over MgSO4 and filtered. The solvent was removed in vacuo to give a 
crude residue that was filtered over 3 cm plug of silica to give the title compound as 
colourless oil (3.99 g, quantitative yield).   
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max/cm
–1
 3314w (H−C≡C), 2955m, 2935m, 2913m, 2876m, 2122w (C≡C), 1671w, 
1513m, 1378m, 1238m, 1070s, 1005s; 
1
H NMR (400 MHz, CDCl3) δ 5.21–5.16 (1H, 
m =CH), 5.12–5.07 (1H, m, =CH), 4.53 (1H, dt, J = 8.7 and 6.4 Hz, OCH), 2.41 (1H, 
ddd, J = 16.5, 6.2, 2.7 Hz, CHa), 2.29 (1H, ddd, J = 16.5, 6.7 and 2.7 Hz, CHb ), 
2.14–1.98 (4H, m, 2 × CH2), 1.92 (1H, apparent t, J = 2.7 Hz, C≡CH), 1.68–1.66 
(6H, m, 2 × CH3), 1.61 (3H, s, CH3), 0.95 (9H, s, J = 7.8 Hz, Si(CH3)3), 0.59 (6H, q, 
J = 7.8 Hz, Si(CH2)3); 
13
C NMR (101 MHz, CDCl3) δ 136.7 (=C), 131.7 (=C), 127.8 
(=C), 124.2 (=C), 81.7 (HC≡), 69.5 (≡C), 68.2 (OC), 39.7 (CH2), 28.8 (CH2), 26.4 
(CH2), 25.8 (CH3), 17.8 (CH3), 17.0 (CH3), 6.9 (Si(CH2)3(CH3)3), –5.0 
(Si(CH2)3(CH3)3); m/z calculated for [C19H34OSi + NH4]
+
 324.2717 found  [M + 
NH4]
+
 324.2717.  
 
(2Z,9E)-8-((Triethylsilyl)oxy)-2-(5-((tert-butyldimethylsilyl)oxy)-2-methoxy-4-
methylphenyl)-10,14-dimethylpentadeca-2,9,13-trien-5-yn-4-ol 207 
To a stirred solution of alkyne 206 (2.08 g, 6.78 mmol) in THF (20 mL) was added 
n-BuLi (2.3 mL, 2.5 M in hexanes, 5.75 mmol) at –78 °C. After stirring for 30 min, 
the solution was warmed to –45 °C with continued stirring for 30 min. After this time 
the solution was cooled to –78 °C followed by the slow addition of aldehyde 197 
(1.67 g, 5.45 mmol) in THF (5 mL). After stirring for 10 min the solution was 
allowed to warm to 0 °C and was then quenched with NH4Cl (sat. aq.). The organic 
layer was diluted with Et2O (50 mL) and washed with water (50 mL), dried over 
MgSO4 and filtered. The solvent was removed in vacuo to give a crude residue which 
 168 
 
was purified by flash column chromatography (SiO2; 10% Et2O in petrol) to give the 
title compound as pale yellow oil and an unidentified mixture of diastereomers (3.13 
g, 94%). 
 max/cm
–1
 3343br (O–H), 2954m, 2930m, 2877m, 2858m, 1750w, 1667w, 1500m, 
1463m, 1399m, 1209s, 1058m, 1013m;  
1
H NMR (400 MHz, CDCl3) δ 6.69 (1H, s, 
ArCH), 6.50 (1H, s, ArCH), 5.65 (1H, d, J = 9.3 Hz, ArC=CH), 5.16–5.07 (2H, m, 2 
× =CH), 4.62 (1H, m, HOCH), 4.49 (1H, dt, J = 8.6 and 6.7 Hz, TESOCH), 3.73 
(3H, s, OCH3), 2.47–2.40 (1H, m, ≡CCHa), 2.33–2.26 (1H, m, ≡CCHb), 2.20 (3H, s, 
CH3), 2.10–1.96 (7H, m, 2 × CH2, CH3), 1.68–1.65 (6H, m, 2 × CH3), 1.60 (3H, s, 
CH3), 1.00 (9H, s, SiC(CH3)3), 0.94 (9H, t, J = 7.9 Hz, Si(CH2CH3)3), 0.57 (6H, q, J 
= 7.9 Hz, Si(CH2CH3)3), 0.19 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 
150.1, 147.6, 137.1, 136.5, 131.7, 128.7, 128.2, 128.0, 127.3, 124.2, 119.9, 119.9, 
114.6, 82.9, 81.4, 81.3, 68.5, 60.7, 56.5, 39.7, 39.7, 29.2, 26.4, 26.4, 25.9, 25.8, 24.9, 
18.4, 17.8, 17.2, 16.9, 16.9, 6.9, 5.0, –4.1, –4.1; m/z calculated for [C37H64O4Si2]
+
 
628.4338 found [M]
+
 628.4328. 
 
 
 
(2Z,5Z,9E)-2-(5-((tert-Butyldimethylsilyl)oxy)-2-methoxy-4-methylphenyl)-
10,14-dimethyl-8-((triethylsilyl)oxy)pentadeca-2,5,9,13-tetraen-4-ol 208 
A solution of (Z)-propargyl alcohol 207 (3.13 g, 4.99 mmol), Lindlar catalyst (945 
mg) and quinoline (0.30 mL) in EtOAc (15 mL) was stirred under 1 atm of hydrogen. 
After 72 h, the mixture was filtered and the solids were rinsed with EtOAc (4 × 10 
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mL). The solvent was removed in vacuo and puification of the residue by flash 
column chromatography (SiO2; 10% Et2O in petrol) gave the title compounds as pale 
yellow oil and an unidentified mixture of diastereomers (2.80 g, 89%).  
max/cm
–1
 3444br (O–H), 2954m, 2930m, 2877m, 2858m, 1500m, 1463m, 1398m, 
1398m, 1254m, 1208s, 1058m, 1011s; 
1
H NMR (400 MHz, CDCl3) δ 6.68 (1H, s, 
ArCH), 6.56–6.50 (1H, m, ArCH), 5.64–5.56 (2H, m, 2 × =CH), 5.48–5.38 (1H, m, 
=CH), 5.11–5.05 (2H, m, 2 × =CH), 4.70–4.61 (1H, m, OCH), 4.33–4.22 (1H, m, 
OCH), 3.72 (3H, s, OCH3), 2.20 (3H, s, CH3), 2.08–1.92 (9H, m, 3 × CH2, CH3), 
1.67 (3H, s, CH3), 1.59 (3H, s, CH3), 1.55–1.53 (3H, m, CH3), 1.01 (9H, s, 
SiC(CH3)3), 0.89 (9H, t, J = 7.9 Hz, Si(CH2CH3)3), 0.51 (6H, q, J = 7.9 Hz, 
Si(CH2CH3)3), 0.18 (6H, m, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 150.2, 150.2, 
147.6, 147.5, 135.1, 135.0, 134.0, 133.7, 131.6, 131.6, 129.8, 129.8, 128.8, 128.6, 
128.4, 128.3, 128.2, 127.6, 124.2, 124.2, 119.9, 119.8, 114.4, 69.2, 69.0, 66.2, 65.5, 
56.3, 39.6, 39.6, 36.9, 36.6, 26.4, 26.4, 25.9, 25.8, 25.8, 25.3, 25.2, 18.3, 17.8, 17.1, 
16.6, 16.6, 6.9, 6.9, 4.9, 4.9, –4.0, –4.1, –4.1; m/z calculated [C37H62O4Si2] 626.4181 
found [M]
+
 626.4186.  
 
(2Z,5Z,9E)-2-(5-((tert-Butyldimethylsilyl)oxy)-2-methoxy-4-methylphenyl)-
10,14-dimethyl-8-((triethylsilyl)oxy)pentadeca-2,5,9,13-tetraen-4-one 209 
To a stirred solution of (Z),(Z)-dienol 208 (1.30 g, 2.07 mmol) in CH2Cl2 (10 mL) 
was added activated MnO2 (1.8 g, 20.7 mmol) at room temp. Upon stirring for 48 h 
the flask was equipped with a reflux condenser and the reaction was warmed to 40 
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°C with the further addition of MnO2 (2.3 g). After stirring for 17 h, the mixture was 
filtered under vacuum and the solid was rinsed with EtOAc (4 × 25 mL). The bright-
yellow filtrate was dried over MgSO4, filtered and the solvent was removed in vacuo. 
Purification of the residue by flash column chromatography (SiO2; 10% Et2O in 
petrol) gave the title compound as yellow oil (1.0 g, 77%). The compound was stored 
under argon in the dark at –80 °C.  
 max/cm
–1
 2955m, 2931m, 2877m, 2858m, 1651m (C=O), 1609m (C=O),  1500m, 
1463m, 1399m, 1374m, 1255m, 1210s, 1062m, 1210m; 
1
H NMR (400 MHz, CDCl3) 
δ 6.66 (1H, s, ArCH), 6.43 (1H, m, ArCH), 6.15 (1H, q, J = 1.4 Hz, Ar–C=CH), 
5.91–5.80 (2H, m, 2 × =CH), 5.12 (1H, dq, J = 8.6 and 1.3 Hz, =CH), 5.09–5.04 
(1H, m, =CH), 4.39 (1H, dt, J = 7.8 and 6.8 Hz, OCH), 3.72 (3H, s, OCH3), 2.72–
2.58 (2H, m, CH2), 2.20 (3H, s, CH3), 2.12 (3H, s, CH3), 2.08–2.02 (2H, m, CH2), 
1.98–1.92 (2H, m, CH2), 1.65 (3H, s, CH3), 1.58 (6H, s, 2 × CH3), 0.99 (9H, s, 
SiC(CH3)3), 0.90 (9H, t, J = 7.9 Hz, Si(CH2CH3)3), 0.53 (6H, q, J = 7.9 Hz, 
Si(CH2CH3)3), 0.13 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 192.7 (C=O), 
149.9 (ArC=Cq), 148.7 (ArCO), 147.4 (ArCO), 143.3 (=CH), 135.3 (Arq), 131.6 
(Arq), 130.4 (=CH), 129.4 (=Cq), 128.9 (=CH), 128.1 (=Cq), 128.0 (=CH), 124.3 
(=CH), 119.5 (ArCH), 114.1 (ArCH), 69.1 (OCH), 56.0 (OCH3), 39.7 (CH2), 38.6 
(CH2), 26.4 (CH2), 26.2 (CH3), 25.9 (SiC(CH3)3), 25.8 (CH3), 18.3 (SiC), 17.8 (CH3), 
17.3 (CH3), 16.7 (CH3), 7.0 (Si(CH2CH3)3), 5.1 (Si(CH2CH3)3), –4.1 (Si(CH3)2); m/z 
calculated for [C25H62O4Si2] 626.4181 found [M]
+
 626.4174.  
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(2Z,5Z,9E)-8-Hydroxy-2-(5-hydroxy-2-methoxy-4-methylphenyl)-10,14-
dimethylpentadeca-2,5,9,13-tetraen-4-one  205 
To a stirred solution of (Z),(Z)-dienone 209 (1.00 g, 1.59 mmol) in THF (15 mL) was  
slowly added TBAF (1.60 mL, 1M in THF, 1.60 mmol) over 2 min at 0 °C. 
Subsequently, the solution was allowed to warm to 23 °C and after stirring for a 
further 15 min, the solution was poured onto CH2Cl2 (20 mL) and NH4Cl (sat. aq., 10 
mL) with vigorous stirring. The organic layer was separated, washed with brine (20 
mL) and dried over MgSO4. The solvent was removed in vacuo and the residue was 
purified by flash column chromatography (SiO2; 20% Et2O in petrol) to give the title 
compound as thick orange oil (620 mg, 97%). The compound was left under high 
vacuum (ca. 0.1 mmHg) overnight under darkness and then stored under argon in a –
80 °C freezer.  
max/cm
–1
 3306br (O–H), 2965w, 2916w, 2855w, 1641m (conjugated C=O), 1621m 
(conjugated C=O), 1505m, 1454m, 1408s, 1202s, 1057m, 1016m, 1002m; 
1
H NMR 
(400 MHz, CDCl3) δ 6.66 (1H, s, ArCH), 6.47 (1H, s, ArCH), 6.16 (1H, s, Ar–
C=CH), 5.92–5.78 (3H, m, O=C–CH=CH, O=C–CH=CH, ArCOH), 5.21 (1H, d, J = 
8.3 Hz, HOCC=CH), 5.09–5.03 (1H, m, CH2C=CH), 4.49–4.42 (1H, m, HOCH), 
3.74 (3H, s, OCH3), 2.95 (OH), 2.80–2.71 (1H, m, HOC–CHa), 2.55–2.47 (1H, m, 
HOC–CHb), 2.25 (3H, s, CH3), 2.18 (3H, s, CH3), 2.10–1.95 (4H, m, 2 × CH2), 1.66 
(3H, s, CH3), 1.65 (3H, s, CH3), 1.59 (3H, s, CH3); 
13
C NMR (101 MHz, CDCl3) δ 
194.1 (C=O), 151.7 (=C–Me ), 149.5 (ArCO), 147.8 (ArCO), 141.0 (=CH), 138.6 
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(Arq), 131.9 (Arq), 130.9 (=CH), 130.0 (=CH), 127.4 (=Cq), 127.2 (=CH), 125.8 
(=Cq), 124.1 (=CH), 117.4 (ArCH), 114.2 (ArCH), 68.7 (OCH), 56.2 (OCH3), 39.6 
(CH2) , 37.5 (CH2), 26.5 (CH2), 25.9 (CH3), 25.8 (CH3), 17.8 (CH3), 16.7 (CH3), 16.4 
(CH3) ppm; m/z calculated for [C25H32O4]
+
 397.2379 found [M – H]+ 397.2376. 
 
 
 
 
1-(tert-Butyldimethylsilyloxy)-4-fluorobenzene 220 
To a stirred solution of 4-fluorophenol (4.21 g, 37.6 mmol) in CH2Cl2 (20 mL) was 
added imidazole (5.40 g, 79.3 mmol) and then TBSCl (6.20 g, 41.1 mmol). The 
solution was stirred for 16 h and then NH4Cl (aq. sat.) (10 mL) was added with 
vigorous stirring. The organic layer was separated, dried over MgSO4 and filtered. 
The solvent was removed in vacuo to give pale yellow oil (7.97 g, 93%). The title 
compound was used without further purification. Data are consistent with those 
previously reported in the literature.
84
 
1
H NMR (400 MHz, CDCl3) δ 6.94–6.88 (2H, m, 2 × ArCH), 6.80–6.74 (2H, m, 2 × 
ArCH), 0.99 (9H, s, (SiC(CH3)3)), 0.18 (6H, s, (Si(CH3)2); 
13
C NMR (101 MHz, 
CDCl3) δ 157.7 (d, J = 238.6 Hz, ArF), 156.6 (ArCO), 151.8 (d, J = 2.2 Hz, 2 × 
ArCH), 121.0 (d, J = 8.1 Hz, 2 × ArCH), 25.8 (SiC(CH3)3), 18.3 (SiC), –4.4 
(Si(CH2)2); m/z calculated for [C12H19FOSi + NH4Cl]
+
 186.0925 found [M + 
NH4Cl]
+
 186.0922.  
 
 173 
 
 
5-(tert-Butyldimethylsilyloxy)-2-fluoro-benzaldehyde 221 
A attired solution of 1-(tert-butyldimethylsilyloxy)-4-fluorobenzene 220 (3.96 g, 
17.5 mmol) and TMEDA (2.9 mL, 19.5 mmol) in THF (50 mL) was cooled to –78 
°C and then n-BuLi (9.4 mL, 23.5 mmol) was added slowly.  Upon stirring for 1 h 
DMF (2.2 mL, 28.8 mmol) was added, followed with continued stirring for 30 min. 
After this time the solution was allowed to warm to 23 °C and NH4Cl (aq. sat., 10 
mL) was added. The reaction was diluted with Et2O (30 mL) and water (30 mL) was 
added. The separated organic phase was dried over MgSO4 and filtered. The solvent 
was removed in vacuo to give a residue which was purified by flash column 
chromatography (SiO2; petrol → 5% Et2O in petrol) to give the title compound as 
slightly pale yellow oil (2.06 g, 45%). Data are consistent with those previously 
reported in the literature.
84
 
1
H NMR (400 MHz, CDCl3) δ 10.30 (1H, s, CHO), 7.27–7.25 (1H, m, ArCH), 7.06–
7.03 (2H, m, 2 × ArCH), 0.98 (9H, s, SiC(CH3)3), 0.20 (6H, s, Si(CH3)2); 
13
C NMR 
(101 MHz, CDCl3) δ 187.1 (d, J = 6.6 Hz, CHO), 157.4 (d, J = 252.4 Hz, ArF), 
152.3 (d, J = 2.5 Hz, ArCO), 128.2 (d, J = 8.6 Hz, ArCH), 124.7 (d, J = 9.5 Hz, Ar) 
118.1 (d, J = 2.1 Hz, ArCH), 117.4 (d, J = 22.1 Hz, ArCH)   25.7 (SiC(CH3)3), 18.3 
(SiC), –4.4 (Si(CH3)2); 
19
F NMR (376 MHz, CDCl3) δ –131.81 to –131.86 (m, ArF).  
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(Z)-Ethyl 3-(5-((tert-butyldimethylsilyl)oxy)-2-fluorophenyl)acrylate 223 
To a stirred solution of ethyl (diphenylphosphono)acetate
69
 (1.45 g, 4.37 mmol) in 
THF (50 mL) was added NaH (60% in mineral oil) (119 mg, 4.95 mmol) in three 
portions at 0 °C. After 20 min the solution was cooled to –78 °C and aldehyde 221 
(740 mg, 2.91 mmol) in THF (10 mL) was added slowly (along the side of the RBF 
wall). Stirring was continued at –78 °C for 2 h before the solution was allowed to 
warm to 20 C over 15 min followed with the addition of NH4Cl (sat. aq.) (5 mL). 
The reaction mixture was diluted with Et2O (50 mL) before the organic layer was 
washed with water (50 mL), dried over MgSO4 and filtered. The solvent was 
removed in vacuo to give a residue that contained a 9:19 mixture of E:Z isomers as 
judged by 
1
H NMR spectroscopy via integration of alkenyl-proton signals. The 
isomers were separated by flash column chromatography (SiO2; 2% Et2O → 10% 
Et2O in petrol) to give the (Z)-isomer title compound as pale yellow oil (550 mg, 
55%).   
1
H NMR (400 MHz, CDCl3) δ 7.07 (1H, dd, J = 3.0 and 3.2 Hz, ArCH), 6.93 (1H, d, 
J = 12.5 Hz, ArCH=C), 6.88 (1H, d, J = 9.1 Hz, ArCH), 6.75 (1H, ddd, J = 9.1, 4.1 
and 3.2 Hz, ArCH), 6.04 (1H, d, J = 12.5 Hz, ArCH=CH), 4.16 (2H, q, J = 7.1 Hz, 
CH2), 1.23 (3H, t, J = 7.1 Hz, CH3), 0.98 (9H, s, SiC(CH3)3), 0.19 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δC 165.9 (C=O), 155.2 (d, J = 243.7 Hz, ArF), 151.1 
(d, J = 2.57, ArCO), 134.9 (d, J = 3.36 Hz, ArCH), 123.7 (d, J = 14.8 Hz,  Arq), 
122.5 (d, J<1 Hz, =CH), 121.8 (d, J = 8.2 Hz, ArCH), 121.5 (d, J = 2.7 Hz, ArCH), 
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115.7 (d, J = 23.7 Hz, =CH), 60.5 (OCH2), 25.8, 18.3, 14.2 (CH3), –4.5; m/z 
calculated [C17H26O3SiF]
+
 325.1630 found [M + H]
+
 325.1632.  
 
  
(Z)-4-Fluoro-3-(3-hydroxyprop-1-en-1-yl)phenol 217 
To a stirred solution of (Z)-ester 223 (550 mg, 1.7 mmol) in PhMe (10 mL) was 
added DIBAL-H (3.6 mL, 3.6 mmol) at –78 °C. After stirring for 2 h, the solution 
was allowed to warm to 20 C and NH4Cl (5 mL) then a saturated solution of 
Rochelle salt (10 mL) was added and the mixture was vigorously stirred for 30 min. 
The separated organic phase was diluted with Et2O (10 mL), washed with water (10 
mL), dried over MgSO4 and filtered. The organic phase was filtered through a 1 inch 
plug of Celite
® 
before the solvent was evaporated in vacuo to give the alcohol 
colourless oil (410 mg, 89%) which was used directly. To a stirred solution of (Z)-
allylic alcohol (220 mg, 0.78 mmol) in THF (5 mL) was added TBAF (0.86 mL, 0.86 
mmol) at 0 °C. The solution was allowed to warm to 20 °C and after 1 h, was poured 
onto CH2Cl2 (10 mL) and ice cold NH4Cl (10 mL, sat. aq.) with vigorous stirring. 
The organic layer was separated, dried over MgSO4 and filtered. The solvent was 
removed in vacuo to give a residue which was purified by flash column 
chromatography (SiO2; 100% petrol then 100% EtOAc) to give the title compound as 
thick orange oil (71 mg, 55%). 
max/cm
–1
 3284br (O–H), 3021m, 2930m, 1588m, 1492s, 1454s, 1292m, 119s, 
1014m; 
1
H NMR (400 MHz, acetone-d6 ) δH 6.97–6.91 (1H, m, ArCH), 6.77–6.72 
(2H, m, 2 × ArCH), 6.46–6.42 (1H, m, ArCH=C), 5.95 (1H, dt, J = 11.8 and 6.3 Hz, 
ArCH=CH), 4.29 (2H, dd, J = 6.3 and 1.3 Hz, CH2), 3.98 (1H, brs, CH2OH), 3.07 
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(1H, brs, PhOH); 
13
C NMR (101 MHz, Acetone-d6) δ 154.7 (ArF, d, J = 237.0 Hz), 
154.0 (ArCO, d, J = 2.2 Hz), 135.8 (s, =CH), 125.6 (d, J = 16.1 Hz, Arq), 122.4 (d, J 
= 3.7 Hz, =CH), 117.4 (d, J = 3.2 Hz, ArCH), 116.4 (d, J = 24.1 Hz, ArCH), 116.2 
(d, J = 8.1 Hz, ArCH), 59.7 (s, OCH2); m/z calculated for [C9H9FO2 + NH4]
+
 found 
186.0925 [M + NH4]
+
 186.0922.  
 
 
(E)-Ethyl-3-(5(tert-butyldimethylsilyl)oxy)-2-methoxyphenyl)acrylate 233 
To a stirred solution of triethyl phosphonoacetate (700 mg, 2.6 mmol) in PhMe (10 
mL) was added NaH (127 mg, 5.3 mmol) portionwise over 2 min. After 30 min 
aldehyde 164 (700 mg, 5.3 mmol) in PhMe (5 mL) was added. After stirring for 1 h, 
the reaction was quenched by the addition of NH4Cl (sat. aq., 5 mL). The seperated 
organic phase was washed with water (20 mL), separated, dried over MgSO4 and 
filtered. The residue was purified by flash column chromatography (SiO2; 20% Et2O 
in petrol) to give the title compound as pale yellow oil (770 mg, 88%). Data were in 
accord with those obtained via Ando-olefination method (page 145).  
 
Ethyl 3-(5-((tert-butyldimethylsilyl)oxy)-2-methoxyphenyl)propanoate 234 
A solution of (E)-ester 233 (770 mg, 2.3 mmol) and 10% Pd/C (100 mg) in EtOH (10 
mL) was vigorously stirred under 1 atm of hydrogen for 4 h. After this time the 
solution was diluted with EtOAc (30 mL) and filtered. The solvent was removed in 
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vacuo and the residue was purified by flash column chromatography (SiO2; 20% 
Et2O in petrol) to give the title compound as pale yellow oil (670 mg, 86%).  
max/cm
–1
 2955w, 2930w, 2858w, 1735m (C=O), 1497s, 1444m, 1221s (C−O), 
1180m, 1036s; 
1
H NMR (400 MHz, CDCl3) δ 6.68 (1H, d, J = 8.6 Hz, ArCH), 6.66–
6.62 (2H, m, 2 × ArCH), 4.12 (2H, q, J = 7.1 Hz, CH2), 3.76 (3H, s, ArCOCH3), 2.88 
(2H, t, J = 8.1 Hz, CH2), 2.57 (2H, t, J = 8.1 Hz, CH2), 1.24 (3H, t, J = 7.1 Hz, CH3), 
0.97 (9H, s, SiC(CH3)3), 0.16 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 
173.4 (C=O), 152.2 (ArCO), 149.1 (ArCO), 129.9 (Arq), 121.9 (ArCH), 118.0 
(ArCH), 111.1 (ArCH), 60.4 (CH2), 55.7 (OCH3), 34.4 (CH2), 26.1 (CH2), 25.8 
(SiC(CH3)3), 18.3 (SiC), 14.4 (CH3), –4.4 (Si(CH3)2); m/z calculated for 
[C18H31O4Si]
+
 339.1986 found [M + H]
+
 339.1989. 
 
3-(5-((tert-Butyldimethylsilyl)oxy)-2-methoxyphenyl)propanal 232 
To a stirred solution of ester 234 (5.46 g, 16 mmol) in PhMe (150 mL) cooled to –78 
°C was very slowly added DIBAL-H (17.7 mL, 1 M in PhMe, 17.7 mmol) over 15 
min. After continued stirring for 1 h, MeOH (5 mL), HCl (1 M, 5 mL) and Rochelle 
salt (sat. aq., 5 mL) were slowly added sequentially to the reaction. After allowing 
the solution to warm to 23 °C, the organic phase was washed with water (30 mL), 
separated, dried over MgSO4 and filtered. The solvent was removed in vacuo and 
purification of the residue by flash column chromatography (SiO2; 20% Et2O in 
petrol) gave the title compound as pale yellow oil (3.60 g, 65%). 
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 max/cm
–1
 2954m, 2930m, 2899m, 2857m, 2834m, 1830m (C=O), 1496s, 1285m, 
1253m, 1219s, 1181m, 1035m; 
1
H NMR (400 MHz, CDCl3) δ 9.79 (1H, t, J = 1.7 
Hz, CHO), 6.70–6.63 (3H, m, 3 × ArCH), 3.76 (3H, s, OCH3), 2.88 (2H, t, J = 7.5 
Hz, CH2), 2.69 (2H, td, J = 7.5 and 1.7 Hz, CH2), 0.97 (9H, s, SiC(CH3)3), 0.16 (6H, 
s, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 202.4 (C=O), 152.0 (ArCO), 149.2 
(ArCO), 129.6 (Arq), 121.9 (ArCH), 118.2 (ArCH), 111.1 (ArCH), 55.7 (OCH3), 
44.0 (CH2), 25.8 (SiC(CH3)3), 23.6 (CH2), 18.3 (SiC), –4.4 (Si(CH3)2); m/z calculated 
for [C16H27O3Si]
+ 
295.1724 found [M + H]
+
 295.1728.  
 
1-(tert-Butyldimethylsiloxy)-3-propyne 238 
To a stirred solution of propargyl alcohol (6.00 g, 0.107 mol) in CH2Cl2 (70 mL) was 
added imidazole (15.3 g, 0.225 mol) and TBSCl (17.8 g, 0.118 mol) at 20 °C.  After 
stirring for 2 h, water (10 mL) was added. The separated organic layer was washed 
with water (50 mL), dried over MgSO4 and filtered. The solvent was removed in 
vacuo and purification of the residue by flash column chromatography (SiO2; 5% 
Et2O in petrol) gave the title compound as yellow liquid (12.7 g, 70%). Data are 
consistent with those previously reported in the literature.
87
 
max/cm
–1
 3313m (HC≡C), 2956m, 2930m, 2899m, 2858m, 2121w (C≡C), 1499m, 
1427m, 1254m, 1091s, 1004m.  
1
H NMR (400 MHz, CDCl3) δ 4.32–4.31 (2H, brs, 
OCH2), 2.39–2.37 (1H, brs, C≡CH), 0.91 (9H, s, SiC(CH3)3), 0.13 (6H, s, Si(CH3)2). 
13
C NMR (101 MHz, CDCl3) δ 82.6 (C≡C), 73.0 (C≡C), 51.7 (CH2), 25.9 (SiC), 18.4 
(SiC(CH3)3), –5.1 (Si(CH3)2).  
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6-((tert-Butyldimethylsilyl)oxy)-1-(5-((tert-butyldimethylsilyl)oxy)-2-
methoxyphenyl)hexan-3-ol 240 
To a stirred solution of  1-(tert-butyldimethylsiloxy)-3-propyne (2.30 g, 13.5 mmol) 
in THF (50 mL) was added n-BuLi (4.1 mL, 2.5 M, 10.3 mmol) at –40 °C. After 
stirring for 40 min aldehyde 232 (2.00 g, 6.79 mmol) in THF (20 mL) was added. 
After continued stirring for 50 min at –40 °C, the reaction was quenched by the 
addition of NH4Cl (sat. aq., 5 mL) and then allowed to warm to 20 °C. The separated 
organic phase was dried over MgSO4 and filtered. After removal of the solvents in 
vacuo the residue was Purified by flash column chromatography (SiO2; 5% Et2O in 
petrol to 50% Et2O in petrol) gave propargylic alcohol 236 as pale yellow oil (2.9 g, 
92%). A solution of propargylic alcohol 236 (450 mg, 0.97 mmol) and 10% Pd/C (45 
mg) in MeCN (2 mL) was vigorously stirred under 1 atm of hydrogen. After stirring 
for 19 h the hydrogen balloon was removed and MgSO4 (approx. 500 mg) was added 
to the mixture which was then filtered and rinsed with Et2O. The solvent was 
removed in vacuo to give the title compound as colourless oil (413 mg, 91%) which 
was used without further purification.  
max/cm
–1
 3422br (O–H), 2953m, 2929m, 2897m, 2858m, 1496s, 1471m, 1464m, 
1283m, 1253m, 1220m, 1096m, 1038m, 981m. 
1
H NMR (400 MHz, CDCl3) δ 6.70–
6.61 (3H, m, 3 × ArH), 3.78 (3H, s, OCH3), 3.64 (2H, t, J = 5.8 Hz, OCH2), 3.57–
3.51 (1H, m, OCH), 2.78 (1H, OH), 2.74–2.61 (2H, m, CH2), 1.81–1.43 (6H, m, 3 × 
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CH2),  0.97 (9H, s, SiC(CH3)3)), 0.89 (9H, s, SiC(CH3)3), 0.16 (6H, s, Si(CH3)2), 0.05 
(6H, s, Si(CH3)2). 
13
C NMR (101 MHz, CDCl3) δ 152.1 (ArO), 149.4 (ArO), 131.7 
(Ar), 122.0 (ArH), 117.6 (ArH), 111.3 (ArH), 63.7 (OCH2), 56.1 (OCH3), 38.0 
(CH2), 34.4 (CH2), 29.4 (CH2), 26.3 (CH2), 26.1 (SiC(CH3)3), 25.9 (SiC(CH3)3), 18.5 
(SiC), 18.3 (SiC), –4.3 (Si(CH3)2), –5.2 (Si(CH3)2); m/z calculated for [C25H49O4Si2]
+
 
469.3164 found [M + H]
+
 469.3159. 
 
 
 
 
6-((tert-Butyldimethylsilyl)oxy)-1-(5-((tert-butyldimethylsilyl)oxy)-2-
methoxyphenyl)hexan-3-one 241 
Oxalyl chloride (0.61 mL, 7.11 mmol) was slowly added to a solution of DMSO 
(1.01 mL, 1.42 mmol) in CH2Cl2 (30 mL) at –78 °C. After stirring for 10 min, 
alcohol 240 (1.10 g, 2.35 mmol) in CH2Cl2 (10 mL) was added. After continued 
stirring for 1 h, NEt3 (3.20 mL, 23.1 mmol) was added and then the reaction was 
allowed to warm to 23 °C over 90 min. After this time water (5 mL) was added and 
the separated organic phase was washed with water (20 mL). The separated organic 
layer was dried over MgSO4 and filtered to give a residue which was purified by 
flash column chromatography (SiO2; petrol → 50% Et2O in petrol) to give the title 
compound as yellow oil (860 mg, 89%).   
max/cm
–1
 2954m, 2929m, 2896m, 2857m, 1715m (C=O), 1497s, 1464m, 1442m, 
1284m, 1220s, 1095s, 1037m. 
1
H NMR (400 MHz, CDCl3) δ 6.69–6.61 (3H, m, 3 × 
ArH), 3.76 (3H, s, OCH3), 3.60 (2H, t, J = 6.1 Hz, OCH2), 2.81 (2H, t, J = 7.3 Hz, 
O=C–CH2), 2.67 (2H, t, J = 7.2 Hz, O=C–CH2), 2.47 (2H, t, J = 7.3 Hz, CH2), 1.81–
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174 (2H, m, CH2), 0.97 (9H, s, SiC(CH3)3), 0.88 (9H, s, SiC(CH3)3), 0.16 (6H, s, 
Si(CH3)2), 0.03 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δC210.6 (C=O), 
152.2 (ArO), 149.2 (ArO), 130.5 (Ar), 121.9 (ArH), 117.9 (ArH), 111.2 (ArH), 62.4 
(OCH2), 55.8 (OCH3), 43.0 (CH2), 39.3 (CH2), 27.0 (CH2), 26.1 (SiC(CH3)3), 25.9 
(SiC(CH3)3), 25.2 (CH2), 18.5 (SiC), 18.3 (SiC), –4.3 (Si(CH3)2), –5.2 (Si(CH3)2); 
m/z calculated for [C25H47O4Si2]
+
 467.3007 found [M + H]
+
 467.2998.  
 
 
 
6-Hydroxy-1-(5-hydroxy-2-methoxyphenyl)hexan-3-one 226 
To a solution of ketone 241 (860 mg, 1.84 mmol) in THF (50 mL) was added TBAF 
(3.86 mL, 1.0 M in THF, 3.86 mmol). After stirring for 2.5 h, the solution was 
poured into a beaker of NH4Cl (aq. sat.) and CH2Cl2. After stirring for 5 min the 
organic layer was separated, dried over MgSO4 and filtered. The solvent was 
removed in vacuo to give a crude residue which was purified by flash column 
chromatography (SiO2; petrol → 100% EtOAc) to give the title compound as pale 
yellow oil (240 mg, 55%). 
 max/cm
–1
 3355 (O–H), 2936w, 2834w, 1701m (C=O), 1596w, 1500s, 1461m, 
1436s, 1285m, 1217s, 1030s. 
1
H NMR (400 MHz, CDCl3) δ 6.70–6.61 (3H, m 3 × 
ArH), 6.18 (s, PhOH), 3.75 (3H, s, OCH3), 3.61 (2H, t, J = 6.1 Hz, OCH2), 2.82 (2H, 
t,  J = 6.3 Hz, Ar–CH2), 2.70 (2H, t, J = 7.2 Hz, CH2), 2.52 (2H, t, J = 6.8 Hz, 
ArCH2), 1.81 (2H, apparent qn, J = 6.4 Hz, CH2). 
13
C NMR (101 MHz, CDCl3) δ 
212.4 (C=O), 151.5 (ArO), 149.8 (ArO), 130.4 (Ar), 117.4 (Ar), 113.6 (Ar), 111.8 
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(Ar), 62.4 (OCH3), 56.0 (OCH2), 42.7 (CH2), 40.0 (CH2), 26.4 (CH2), 25.2 (CH2); 
m/z calculated for [C13H18O4 + Na]
+
 261.1097 found [M + Na]
+
 261.1099. 
 
 
1-(tert-Butyldimethylsilyloxy)-3-butyne 235 
To a solution of 3-butyn-1-ol (1.12 g, 16.0 mmol) in CH2Cl2 (30 mL) was added 
TBSCl (2.71 g, 18.0 mmol) and imidazole (2.29 g, 33.6 mmol). After stirring for 16 
h, water (10 mL) was added. The separated organic layer was dried over MgSO4 and 
filtered. Purification of the residue by flash column chromatography (SiO2; 5% Et2O 
in petrol) gave the title compound as a colourless liquid.  Data are in agreement with 
those previously reported in the literature.
86 
 
max/cm
–1
 3315w (HC≡C), 2955w 2930w, 2885w, 2858w, 2124w (C≡C), 1472w, 
1464w, 1387w, 1362w, 1254m, 1103s. 
1
H NMR (400 MHz, CDCl3) δ 3.74 (2H, t, J 
= 7.2 Hz, OCH2), 2.40 (2H, dt, J = 7.2 and 2.7 Hz, CH2), 1.95 (1H, t, J = 2.7 Hz, 
≡H), 0.90 (9H, s, SiC(CH3)3), 0.07 (6H, s, Si(CH3)2). 
13
C NMR (101 MHz, CDCl3) 
δC 81.7 (C≡C), 69.4 (C≡C), 61.9 (OCH2), 26.0 (SiC(CH3)2), 23.0 (CH2), 18.5 (SiC), 
–5.2 (SiC(CH3)2).  
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7-((tert-Butyldimethylsilyl)oxy)-1-(5-((tert-butyldimethylsilyl)oxy)-2-
methoxyphenyl)hept-4-yn-3-ol 236 
To a stirred solution of alkyne 235 (1.45 g, 7.30 mmol) in THF (20 mL) was added 
n-BuLi (2.2 mL, 2.5 M in hexanes, 5.50 mmol) at –40 °C. After stirring for 1 h 
aldehyde 232 (1.08 g, 3.66 mmol) in THF (5 mL) was added. Upon continued 
stirring for 10 min the solution was warmed to 0 °C and after 5 min the reaction was 
quenched with the addition of NH4Cl (sat. aq) (5 mL). The organic layer was washed 
with NH4Cl (sat. aq, 5 mL), water, then dried over MgSO4 and filtered. The solvent 
was removed in vacuo and purification by flash column chromatography (SiO2; 5% 
Et2O in petrol to Et2O) gave the title compound as colourless oil (1.75 g, 99%).  
max/cm
–1
 3426br (O–H), 2954w, 2929w, 2857w, 2857w, 1496m, 1419w, 1283w, 
1253s, 1104m. 
1
H NMR (400 MHz, CDCl3) δ 6.69 (1H, d, J = 8.5 Hz, ArCH), 6.66–
6.61 (2H, m, 2 × ArCH), 4.32–4.26 (1H, m, HO–CH), 3.77 (3H, s, OCH3), 3.71 (2H, 
t, J = 7.3 Hz, OCH2), 2.79–2.63 (2H, m, Ar–CH2), 2.43 (2H, td, J = 7.2 and 2.0 Hz, 
≡CCH2), 2.08 (1H, m, OH), 2.02–1.85 (2H, m, CHCH2), 0.97 (9H, s, SiC(CH3)3), 
0.89 (9H, s, SiC(CH3)3), 0.16 (6H, s, Si(CH3)2), 0.07 (6H, s, Si(CH3)2); 
13
C NMR 
(101 MHz, CDCl3) δ  152.1 (ArCO), 149.3 (ArCO), 130.7 (Arq), 122.1 (ArCH), 
117.9 (ArCH), 111.3 (ArCH), 82.40 (C≡C) , 82.39 (C≡C), 62.1 (OCH2, OCH3), 56.0 
(OCH), 38.3 (CH2), 26.1 (CH2), 26.0 (SiC(CH3)3) , 25.9 (SiC(CH3)3), 23.3 (CH2), 
18.5 (SiC), 18.3 (SiC), –4.3 (SiC(CH3)2), –5.1 (SiC(CH3)2); m/z calculated 
[C26H46O4Si2 + NH4] 496.3273 found [M + NH4] 496.3277. 
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7-((tert-Butyldimethylsilyl)oxy)-1-(5-((tert-butyldimethylsilyl)oxy)-2-
methoxyphenyl)heptan-3-ol 237 
A solution of alcohol 236 (1.61 g, 3.44 mmol) and 5% Pd/C (319 mg) in MeCN (7 
mL) was vigorously stirred under 1 atm of hydrogen.  After stirring for 20 h, the 
hydrogen balloon was removed and MgSO4 (approx. 500 mg) was added to the 
mixture which was then filtered and rinsed with Et2O (30 mL). The solvent was then 
removed in vacuo to give the title compound as colourless oil (1.61 g, quantitative 
yield), which was used without further purification.  
max/cm
–1
 3435br (O–H), 2952w, 2929w, 2857w, 1496m, 1389m, 1284m, 1219s, 
1098m, 1038m, 1005m. 
1
H NMR (400 MHz, CDCl3) δ 6.70 (1H, d, J = 8.4 Hz, 
ArCH), 6.65–6.61 (2H, m, 2 × ArCH), 3.78 (3H, s, OCH3), 3.60 (2H, t, J = 6.4 Hz, 
OCH2), 3.53–3.46 (1H, m, OCH), 2.83–2.59 (2H, m, ArCH2), 2.09 (1H, d, J = 4.3 
Hz, OH), 1.73–1.63 (2H, m, CH2), 1.53–1.31 (6H, m, 3 × CH2), 0.97 (9H, s, 
SiC(CH3)2), 0.89 (9H, s, SiC(CH3)2), 0.16 (Si(CH3)2), 0.04 (Si(CH3)2); 
13
C NMR 
(101 MHz, CDCl3) δ 152.1 (ArCO), 149.5 (ArCO), 131.5 (Arq), 122.0 (ArCH), 117.7 
(ArCH), 111.4 (ArCH), 70.8 (OCH), 63.4 (OCH2), 56.1 (OCH3), 38.1 (CH2), 37.2 
(CH2), 33.0 (CH2), 26.14 (SiC(CH3)3), 26.1 (CH2), 25.9 (SiC(CH3)3), 22.2 (CH2), 
18.5 (SiC), 18.3 (SiC), –4.3 (SiC(CH3)2), –5.1 (SiC(CH3)2). m/z calculated 
[C26H51O4Si2]
+
 483.3320 found [M + H]
+
 483.3324.  
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7-((tert-Butyldimethylsilyl)oxy)-1-(5-((tert-butyldimethylsilyl)oxy)-2-
methoxyphenyl)heptan-3-one 238 
Oxalyl chloride (0.86 mL, 10.0 mmol) was slowly added to a stirred solution of 
DMSO (1.40 mL, 0.020 mol) in CH2Cl2 (30 mL) at –78 °C. After stirring for 10 min 
alcohol 237 (1.60 g, 3.31 mmol) in CH2Cl2 (20 mL) was added. After continued 
stirring for 1 h, NEt3 (4.6 mL, 0.03 mol) was added and then the cooling bath was 
removed with continued stirring at room temp for 1 h. After this time NH4Cl (aq. 
sat., 5 mL) was added and the mixture was transferred to a separating funnel. The 
separated organic layer was dried over MgSO4 and filtered to give a crude residue 
which was purified by flash column chromatography (SiO2; 10% Et2O in petrol) to 
give the title compound as yellow oil (1.40 g, 88%).  
 max/cm
–1
 2953w, 2929w, 2895w, 2857w, 1715m (C=O), 1497m, 1284m, 1221s, 
1098m. 
1
H NMR (400 MHz, CDCl3) δ 6.68 (1H, d, J = 9.5 Hz, ArCH), 6.64–6.61 
(2H, m, 2 × ArCH), 3.76 (3H, s, OCH3), 3.60 (2H, t, J = 6.3 Hz, OCH2), 2.81 (2H, t, 
J = 7.7 Hz, ArCH2), 2.65 (2H, t, J = 7.7 Hz, O=CCH2), 2.41 (2H, t, J = 7.4 Hz, 
O=CCH2), 1.66–1.58 (2H, m, CH2), 1.53–1.46 (2H, m, CH2), 0.97 (SiC(CH3)2), 
0.89(SiC(CH3)2), 0.16 (Si(CH3)2), 0.04 (Si(CH3)2). 
13
C NMR (101 MHz, CDCl3) δ 
210.7 (C=O), 152.2 (ArCO), 149.2 (ArCO), 130.5 (Arq), 121.9 (ArCH), 117.9 
(ArCH), 111.2 (ArCH), 63.0 (OCH2), 55.8 (OCH3), 42.9 (CH2), 42.7 (CH2), 32.5 
(CH2), 26.1(SiC(CH3)3), 25.9 (SiC(CH3)3), 25.2 (CH2), 20.5 (CH2), 18.5 (SiC), 18.3 
(SiC), –4.3 (Si(CH3)2), –5.2 (Si(CH3)2). m/z calculated [C26H49O4Si2]
+
 481.3164 
found [M + H]
+
 481.3166.  
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7-Hydroxy-1-(5-hydroxy-2-methoxyphenyl)heptan-3-one 227 
To a solution of ketone 238 (1.41 g, 2.93 mmol) in THF (30 mL) was added TBAF 
(6.10 mL, 1M in THF, 6.10 mmol). After stirring for 2.5 h NH4Cl (aq. sat., 5 mL) 
was added. Subsequently Et2O (30 mL) was added and the separated organic layer 
was washed with NH4Cl (aq. sat., 20 mL). The separated organic layer was dried 
over MgSO4 and filtered. The solvent was removed in vacuo to give a residue which 
was purified by flash column chromatography (SiO2; 10% EtOAc in petrol → 
EtOAc) to give the title compound as pale yellow thick oil (550 mg, 75%).  
max/cm
–1
 3350br (O–H), 2942w, 2834w, 1699m (C=O), 1569w, 1500s, 1458m, 
1438m, 1407w, 1365w, 1285s, 1031s.  
1
H NMR (400 MHz, CDCl3) δ 6.68–6.61 (3H, 
m, 3 × ArCH), 3.72 (3H, s, OCH3), 3.57 (3H, s, OCH2), 3.06 (1H, s, ArCOH), 2.79 
(2H, t, J = 7.3 Hz, CH2), 2.66 (2H, t, J = 7.3 Hz, CH2), 2.38 (2H, t, J = 7.0 Hz, 
OCH2), 1.64–1.55 (2H, m, CH2), 1.52–1.45 (2H, m, CH2). 
13
C NMR (101 MHz, 
CDCl3) δ 212.5 (C=O), 151.3 (ArCO), 149.90 (ArCO), 130.29 (Arq), 117.39 (ArCH), 
113.5 (ArCH), 111.8 (ArCH), 62.2 (OCH3), 56.0 (OCH2), 42.5 (ArCH2 and 
O=CCH2) 31.9 (O=CCH2), 25.1 (CH2), 19.8 (CH2). m/z calculated for [C14H20O4 + 
NH4]
+
 270.1700 found [M + NH4]
+
 270.1700.  
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Methyl-5-(2′,6′,6′-trimethylcyclohex-1′-enyl)-3-keto-4-pentenoate 258 
Dimethyl carbonate (42.0 g, 0.43 mol) was added to a strongly stirred suspension of 
NaH (60% in mineral oil) (18.5 g, 0.46 mol) in dioxane (130 mL) at 23 °C. After 
heating to reflux, β-ionone (22.0 g, 0.11 mol) in dioxane (30 mL) was added over 4 h 
(using a syringe pump)
*
, following continued heating for 1.5 h. After this time the 
reaction was cooled to 0 °C, and neutralised by cautious addition of 4 M HCl (until 
pH 7 as judged by indicator paper) and then Et2O (200 mL) was added. The organic 
layer was repeatedly washed with water, then brine (100 mL), separated, dried over 
MgSO4 and filtered. The solvents were removed in vacuo to give the title compound 
as orange oil (23 g, 79%). Data are consistent with those previously reported in the 
literature.
90 
1
H NMR indicates equilibration of enol:ketone 3:7 with the alkenyl proton resonating 
at 4.97 ppm. 
max/cm
–1
 2931w, 2866w, 1743m (C=O), 1715m (C=O), 1655m (C=O), 1590m, 
1445w, 1398w, 1362w, 1236s, 1153s, 1020m. Characterisation for ketone in 
mixture:
 1
H NMR (400 MHz, CDCl3) 7.36 (1H, d, J = 16.0 Hz, =CH), 6.19 (1H, d, J 
=16.0 Hz, =CH), 3.73 (3H, s, CH3), 3.62 (2H, s, CH2), 2.09–2.01 (2H, m, CH2), 1.76 
(3H, s, CH3), 1.64–1.43 (4H, m, 2 × CH2),  1.06 (6H, s, 2 × CH3); m/z calculated for 
[C15H23O3]
+
 251.1642 found [M + H]
+
 251.1638.  
----------------------------- 
* Slow addition is crucial for succesful reaction.  
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Methyl 5,5,8a-trimethyl-2-oxo-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-
carboxylate 256 
A solution of sodium methoxide (freshly prepared from 1.83 g sodium sticks and 
anhydrous MeOH) in anhydrous MeOH (50 mL), was added to a solution of ester 
258 (13.0 g, 52.9 mmol) in anhydrous MeOH (100 mL). The solution was irradiated 
in an immersion well photochemical reactor using a high pressure 400 W Hg lamp 
under a stream of nitrogen with strong stirring for 20 h.
*
 After this time NH4Cl (aq. 
sat., 100 mL) was added. The solution was diluted with Et2O (200 mL), washed with 
NH4Cl (aq. sat., 20 mL), separated, dried over MgSO4 and filtered. After removal of 
the solvents in vacuo, purification of the residue by flash column chromatography 
(SiO2; 10% Et2O → 50% Et2O in petrol) gave the title compound as pale yellow 
needles (1.90 g, 15%). Data are consistent with those previously reported in the 
literature.
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mp 111–115 °C (lit91 111–113 °C); 1H NMR (400 MHz, CDCl3) δ 6.99 (1H, dd, J = 
10.3 and 2.1 Hz, OC–CH=CH), 6.14 (1H, dd, J = 10.3 and 3.3 Hz, OC–CH=CH), 
3.73 (3H, s, OCH3), 3.26 (1H, s, MeO2CCH), 2.19 (1H, apparent t, J = 2.7 Hz, 
CH=CH–CH), 1.57–1.09 (6H, m, 3 × CH2), 1.06 (3H, s, CH3), 0.89 (3H, s, CH3), 
0.80 (3H, s, CH3); 
13
C NMR (101 MHz, CDCl3) δ 194.2 (O=C), 169.2 (O=C), 150.5 
(=C), 130.2 (=C), 69.4 (HC–C=O), 56.3 (CH), 51.7 (OCH3), 43.7 (Cq), 41.1 (CH2), 
37.9 (CH2), 32.9 (Cq), 32.7 (CH3), 22.6 (CH3), 18.3 (CH2), 14.0 (CH3). 
----------------------------- 
*
 Fire risk - always use a water flow cut-off switch!  
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1-(Hydroxymethyl)-5,5,8a-trimethyl-4a,5,6,7,8,8a-hexahydronaphthalen-2(1H)-
one 260 
To a stirred solution of ester 256 (1.70 g, 6.79 mmol) in Et2O (50 mL) was added 
LiAlH4 (520 mg, 13.7 mmol) at 0 °C. After 2 h at 0 °C NH4Cl (sat. aq., 10 mL) was 
added cautiously to the resultant green-solution with vigorous stirring. The separated 
organic layer was washed with water (30 mL), brine (30 mL), dried over MgSO4 and 
filtered under vacuum. The solid was washed with Et2O (5 × 20 mL). The filtrate was 
reduced in vacuo to give the title compound as orange needles which were used 
directly. To a stirred solution of the diol 259 (1.25 g, 5.57 mmol) in CH2Cl2 (20 mL) 
was added MnO2 (5.80 g, 66.7 mmol), with continued stirred for 24 h or until 
completion by TLC. After this time the mixture was filtered under vaccum and 
rinsed repeatedly with EtOAc. The filtrate was then dried over MgSO4, filtered and 
the solvent was removed in vacuo to give the title compound as orange waxy oil (870 
mg, 67% for two steps) which was used without further purification. Data are 
consistent with those previously reported in the literature.
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max/cm
–1
 3440br (O–H), 2926m, 2869m, 1662s (C=O), 1460w, 1385w, 1385m, 
1367m, 1204m, 1033s; 
1
H NMR (400 MHz, CDCl3) δ 7.00 (1H, dd, J = 10.2 and 2.1 
Hz, =CH), 6.07 (1H, dd, J =10.2 and 3.3 Hz, =CH), 3.92 (1H, dd, J = 11.1 and 8.7 
Hz, OCHa), 3.67 (1H, m, OCHb), 3.25 (1H, s, OH), 2.30 (1H, dd, J = 8.7 and 3.2 Hz, 
HOCH2CH), 2.23 (1H, appt t, J = 2.7 Hz, CH=CHCH), 1.73–1.04 (6H, m, 3 × CH2), 
1.02 (3H, s, CH3), 0.91 (3H, s, CH3), 0.87 (3H, s, CH3); 
13
C NMR (101 MHz, 
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CDCl3) δ 204.0 (C=O), 151.5 (=C), 130.0 (=C), 64.0 (HCC=O), 58.6 (OCH2), 56.3 
(HCC=), 43.2 (Cq), 40.9 (CH2), 37.6 (CH2), 32.8 (Cq), 32.7 (CH3), 22.5 (CH3), 18.4 
(CH2), 14.9 (CH3); m/z calculated for [C14H23O2]
+
 223.1693 found [M + H]
+
 
223.1692.  
 
1-(Hydroxymethyl)-2,5,5,8a-tetramethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-
2-ol 261 
To a stirred solution of ketone 260 (2.05 g, 9.22 mmol) in Et2O (20 mL) was added 
MeLi (29.0 mL, 1.6 M, 46.4 mmol) at –78 °C. After stirring for 6 h at –78 °C the 
reaction was allowed to warm to 23 °C and upon immediate cooling to –78 °C 
NH4Cl (sat. aq.) (10 mL) was added. After allowing warming to 23 °C the separated 
organic layer was washed with water (50 mL), dried over MgSO4 and filtered. The 
solvent was removed in vacuo to give an orange residue which was purified by flash 
column chromatography (SiO2; 20% → 50% EtOAc in petrol) to give the title 
compound as a cream coloured solid (663 mg, 31%) and identified as a ≈15:1 
mixture of diastereomers. Data were consistent with those previously reported in the 
literature.
92
 
m.p. 120–122 °C; max/cm
–1
 3350br (O–H), 2924s, 2869s, 1453m, 1383m, 1384s, 
1131s, 1080s, 1035s; NMR assignments for major diastereomer: 
1
H NMR (400 
MHz, CDCl3) δ 5.73 (1H, dd, J = 10.1, 2.1 Hz, =CH), 5.64 (1H, dd, J = 10.1 and 3.0 
Hz, =CH), 4.05 (2H, d, J = 4.4 Hz, OCH2), 2.51 (1H, brs, OH), 1.91–1.82 (1H, m, 
CHa), 1.71–1.63 (1H, m, CHb), 1.59 (1H, apparent t, J = 2.4 Hz, CH=CHCH), 1.54–
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1.41 (2H, m, CH2), 1.37 (3H, s, OCCH3),  1.29 (1H, t, J = 4.4 Hz, OCH2CH), 1.19–
1.15 (2H, m, CH2), 1.08 (3H, s, CH3), 0.91 (3H, s, CH3), 0.88 (3H, s, CH3); 
13
C 
NMR (101 MHz, CDCl3) δ 134.5 (=C), 128.0 (=C), 72.1 (OCq), 60.3 (OCH2), 58.6 
(OCH2CH), 54.8 (=CCH), 41.2 (CH2), 37.6 (CH2), 36.8 (Cq), 32.9 (CH3), 32.8 
(Me2Cq), 30.8 (CH3), 22.0 (CH3), 18.4 (CH2), 15.8 (CH3); m/z calculated [C15H26O2 –
H2O + NH4] 238.2165 found [M –H2O + NH4] 238.2163.  
 
2-Hydroxy-2,5,5,8a-tetramethyl-1,2,4a,5,6,7,8,8a octahydronaphthalene-1-
carbaldehyde 262 
To a solution of alcohol 261 (80 mg, 0.34 mmol) in CHCl3 (0.5 mL) was added 
NaHCO3 (80 mg, 0.95 mmol) and Dess-Martin periodinane
60
 (258 mg, 0.61 mmol). 
After stirring for 10 min, water (0.5 mL) and CHCl3 (3 mL) were added. The organic 
layer was separated, dried over MgSO4 and filtered. The title compound was purified 
by flash column chromatography (SiO2; 20% EtOAc in petrol) to give the title 
compound as pale yellow oil (23 mg, 65%). The compound showed degradation and 
was used immediately. 
1
H NMR (400 MHz, CDCl3) δ 10.02 (1H, d, J = 3.1 Hz, CHO), 5.76 (1H, dd, J = 
10.2 and 1.6 Hz, C=CH-Cq), 5.65 (1H, dd, J = 10.2 and 3.0 Hz, HC=C-Cq), 2.42 
(1H, s, OH), 2.06 (1H, d, J = 3.1 Hz, CHOCH), 1.77–1.67 (2H, m, CH2), 1.64 (1H, 
m, C=CCH), 1.54–1.46 (2H, m, CH2), 1.32 (3H, s, CH3), 1.27 (3H, s, CH3), 1.25–
1.16 (2H, m, CH2), 0.94 (3H, s, CH3), 0.90 (3H, s, CH3); 
13
C NMR (101 MHz, 
CDCl3) δ 207.3 (CHO), 133.8 (C=CCq), 127.7 (=CCq), 70.5 (OCq), 68.8 (CHO–CH), 
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54.10 (=CCH), 41.2 (CH2), 37.7 (CH2), 37.2 (Cq), 32.9 (Cq(Me)2), 32.7 (CH3), 30.7 
(CH3), 21.9 (CH3), 18.1 (CH2), 16.5 (CH3).
*
 
 
2,5,5,8a-Tetramethyl-2-((trimethylsilyl)oxy)-1,2,4a,5,6,7,8,8a 
octahydronaphthalen-1-yl)methanol 267 
To a solution of diol 261 (320 mg, 1.34 mmol) in CH2Cl2 (5 mL) was added 
imidazole (1.37 g, 20.1 mmol), TMSCl (1.7 mL, 13.4 mmol) and DMAP (16 mg, 
0.13 mmol). After stirring for 24 h, water (2 mL) was added. The seperated organic 
layer was washed with water (2 mL), dried over MgSO4 and filtered.  The solvent 
was removed in vacuo, and then trimethylsilanol was removed by azeotroping with 
PhMe (20 mL) to give di-TMS substrate 266 as yellow oil which was used directly 
in. A stirred solution of di-TMS substrate 266 (410 mg, 1.07 mmol) was dissolved in 
anhydrous MeOH/petrol (15:1) (16 mL) and cooled to –15 °C. Upon cooling, oven 
dried K2CO3 (86 mg, 0.54 mmol) was added in one portion.  The solution was 
warmed to –10 °C over 4 h, after which time the solution was diluted with Et2O (20 
mL) and then water (20 mL) was added. The separated organic layer was dried over 
MgSO4 and filtered. The solvent was removed in vacuo to give a crude residue which 
was purified by flash column chromatography (SiO2; 10% EtOAc in petrol) to give 
the title compound as white crystals (180 mg, 54% for 2 steps). 
m.p 80–82 °C; max/cm
–1
 3333br (O–H), 3023w, 2951w, 2846w, 2810w, 1460w, 
1438w, 1384w, 1369w, 1214s, 1144s, 1088s, 1057s, 1027s, 1000s; 
1
H NMR (400 
MHz, CDCl3) δ 5.75–5.69 (2H,  m,  2 × =CH), 4.05 (1H, apparent dt, J = 12.1 and 
----------------------------- 
* Due to seeming instability of analogous substrates m/z was not analysed.  
 193 
 
3.5 Hz, OCHa1), 3.97 (1H, ddd, J = 12.1, 8.2 and 4.1 Hz, OCHb1), 2.83 (1H, dd, J = 
8.2 and 3.6 Hz, OH), 1.89–1.84 (1H, m, CHa2), 1.74–1.64 (1H, m, CHb2),  1.52 (1H, 
apparent brs, =CCH), 1.51–1.41 (2H, m, CH2), 1.39 (3H, s, CH3), 1.08–1.04 (6H, m, 
CH2, HO–CCH, CH3), 0.90 (3H, s, CH3), 0.89 (3H, s, CH3), 0.15 (9H, s, Si(CH3)3);  
13
C NMR (101 MHz, CDCl3) δ 134.1 (=C), 127.7 (=C), 75.7 (OCq), 60.6 (OCH2), 
59.6 (OCCH), 55.2 (=CCH), 41.3 (CH2), 37.7 (CH2), 36.9 (Cq), 33.1 (CH3), 32.8 
(Cq), 31.3 (CH3), 22.2 (CH3), 18.4 (CH2), 15.9 (CH3), 2.7 (2 × Si(CH3)3); m/z the 
expected ions were not observed.  
 
2,5,5,8a-Tetramethyl-2-((trimethylsilyl)oxy)-1,2,4a,5,6,7,8,8a 
octahydronaphthalene-1-carbaldehyde 268 
To a stirred mixture of alcohol 267 (135 mg, 0.43 mmol), NaOAc (53 mg, 0.65 
mmol) and 4 Å molecular sieves (approx. 100 mg) in CH2Cl2 (6 mL) was added PCC 
(157 mg, 0.65 mmol) at 0 °C. After warming to 23 °C over 1 h, the mixture was 
diluted with EtOAc (10 mL) and filtered over a 1 inch pad of silica gel. After 
washing the organic solution with water, the organic solvent was removed in vacuo 
to give the title compound as yellow oil (57 mg, 43%). The compound showed 
degradation and was used immediately.  
max/cm
–1
 2950m, 2924m, 2871m, 2844m, 1710s (C=O), 1421m, 1391m; 
1
H NMR 
(400 MHz, CDCl3) δ 9.88 (1H, d, J = 4.6 Hz, CHO), 5.72 (2H, s, 2 × =CH), 1.73–
1.41 (6H, m, CH2, 4 × CH), 1.32 (3H, s, CH3), 1.31 (3H, s, CH3), 1.27–0.98 (2H, m, 
2 × CH), 0.91 (6H, s, 2 × CH3), 0.11 (9H, s, Si(CH3)3); 
13
C NMR (101 MHz, CDCl3) 
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δC 207.9 (CHO), 134.0 (=C), 127.1 (=C), 73.6 (OCq), 69.7 (OHCC), 54.0 (=CCH), 
41.2 (CH2), 37.7 (CH2), 36.2 (Cq), 32.7 (CH3), 30.8 (CH3), 22.0 (CH3), 18.0 (CH2), 
16.5 (Cq), 16.0 (CH3), 2.5 (Si(CH3)3).  
 
3-(Hydroxymethyl)-2,3a,7,7-tetramethyldecahydronaphtho[1,2-b]oxiren-2-ol 
270 
To a stirred solution of diol 261 (775 mg, 3.3 mmol) in CH2Cl2 (5 mL) was added m-
CPBA (1.12 g, 6.5 mmol) with continued for 25 h. After this time the reaction 
mixture was vigorously washed with 1 M aq. sol. NaHCO3 (2 × 5 mL). The 
separated organic layer was dried over MgSO4, filtered and the solvent was removed 
in vacuo. Purification of the crude residue by flash column chromatography (SiO2; 
50% EtOAc in petrol) gave the title compound as pale yellow crystals (475 mg, 
58%).  
mp 66–75 °C; max/cm
–1 
3363br (OH), 2951m, 2925m, 2870m, 1706w, 1458m, 
1392m, 1369m, 1262m, 1128m, 1070m, 1025m,;  
1
H-NMR (400 MHz, CDCl3) δ 
4.08 (1H, dd, J = 12.0 and 3.5 Hz, HOCHa), 4.03 (1H, dd, J = 12.0 and 3.6 Hz, 
HOCHb), 3.15 (1H, dd, J = 3.9 and 2.7 Hz, CHCOCH), 2.98 (1H, d, J = 3.9 Hz, 
OCHCq), 2.96 (1H, s, OH), 2.36 (1H, s, OH), 1.76–1.63 (2H, m, CH2), 1.54–1.46 
(5H, m, CH2, CH3), 1.22 (3H, s, CH3) 1.18–0.98 (8H, m, CH2, 2 × CH3), 0.95 (1H, d, 
J = 3.9 Hz, OCHCH), 0.88 (1H, t, J = 3.5 Hz, H2CCH); 
13
C NMR (101 MHz, 
CDCl3) δC 72.8 (OCq), 60.3 (OCH2), 59.6 (OepoxideC), 56.3 (OepoxideC), 55.0 
(CH), 54.8 (CH), 41.5 (CH2), 37.21 (Cq), 37.18 (CH2), 33.2 (Cq), 32.8 (CH3), 27.7 
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(CH3), 22.5 (CH3), 18.4 (CH2), 18.2 (CH3); m/z calculated for [C15H27O3 + NH4]
+
 
272.2220 found [M + NH4]
+
 272.2216. 
X-Ray Crystallographic Data 270: 
These data can be obtained free of charge from The Cambridge Crystallographic 
Data Centre via www.ccdc.cam.ac.uk/data_request/cif 
CCDC 1043793 contains the supplementary crystallographic data for this compound. 
 
 
2-Hydroxy-2,3a,7,7 tetramethyldecahydronaphtho[1,2-b]oxirene-3-
carbaldehyde 271 
To a stirred solution of epoxide 270 (52 mg, 0.20 mmol) in CHCl3 (1 mL) was added 
Dess-Martin periodinane
60
 (190 mg, 0.45 mmol). After stirring for 24 h, 1 M (sat. 
aq.) NaHCO3 (0.1 mL) was added, and the diluted organic layer (CHCl3, 6 mL) was 
further washed with 1 M (sat. aq.) NaHCO3 (2 mL). The separated organic layer was 
dried over MgSO4 and filtered. The solvent was removed in vacuo and purification 
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of the residue by flash column chromatography (SiO2; 30% EtOAc in petrol) gave 
the title compound as colourless oil (15 mg, 23%).   
max/cm
–1
 3466br (O–H), 2952m, 2926m, 2870m, 2848m, 1709s (C=O), 1459m, 
1391m, 1371m, 1204m, 1026m;  
1
H NMR (400 MHz, CDCl3) δ 9.96 (1H, d, J = 2.6 
Hz, CHO), 3.37 (1H, s, OH), 3.14 (1H, dd, J = 3.9 and 2.4 Hz, CHCOCH), 2.99 (1H, 
d, J = 3.9 Hz, OCHCq), 1.98 (1H, d, J = 2.6 Hz, HCCHO), 1.76–1.48 (4H, m, CH2, 
CHa1, CHa2), 1.39 (3H, s, CH3), 1.33–1.21 (5H, m, CHb1,CHb2, CH3), 1.18 (1H, d, J = 
2.4 Hz, OCHCH), 1.08 (3H, s, CH3), 1.03 (3H, s, CH3);  
13
C NMR (101 MHz, 
CDCl3) δ 208.1 (C=O), 70.6 (OCq), 65.4 (CHOCH), 59.0 (OCH), 55.7 (OCH–CH), 
54.1 (OCH), 41.3 (CH2), 38.7 (Cq), 37.3 (CH2), 33.2 (Cq), 32.6 (CH3), 27.9 (CH3), 
22.2 (CH3), 18.3 (CH3), 18.0 (CH2). m/z calculated for [C15H25O3]
+ 
253.1798 found 
[M + H]
+
 253.1798.  
 
4-(Hydroxymethyl)-3,4a,8,8-tetramethyldecahydronaphthalene-1,3-diol 276 
To a stirred solution of epoxide 270 (475 mg, 1.87 mmol) in PhMe (10 mL) was 
added Red-Al (2.0 mL, 65 wt% in PhMe, 5.6 mmol) at 23 °C. After 10 min the 
evolution of hydrogen had subsided and the solution was heated to reflux with 
continued stirring for 24 h. After this time NH4Cl (aq. sat., 2 mL) was added and the 
mixture was filtered through a 1 inch pad of MgSO4. The solvent was removed in 
vacuo to give a crude solid which was purified by flash column chromatography 
(SiO2; 50% in petrol → EtOAc) to give the title compound as pale yellow needles 
(475 mg, 99%).  
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mp 190–192 °C; max/cm
–1
 3300br (O–H), 3004w, 2959m, 2926m, 2891m, 2872m, 
2842m, 1461m, 1373s, 1190m, 1118m, 1047s; 
1
H NMR (400 MHz, CD3OD) δ 4.12 
(1H, td, J = 11.0 and 4.0 Hz, OCH), 4.00 (1H, dd, J = 11.8 and 2.6 Hz, OCHa1), 3.90 
(1H, dd, J = 11.8 and 3.4 Hz, OCHb1), 2.04 (1H, dd, J = 13.2 and 4.1 Hz, 
OCqCHa2), 1.93–1.87 (1H, m, CHa3), 1.75–1.65 (1H, m, CHa4), 1.58 (1H, dd, J = 
13.2 and 11.2 Hz, OCqCHb2), 1.50-1.38 (2H, m, CHb4, CHa5), 1.36 (3H, s, CH3), 
1.31-1.23 (1H, m, CHb5), 1.21 (3H, s, CH3), 1.19 (3H, s, CH3), 1.11 (3H, s, CH3), 
1.06–0.99 (2H, m, CHb3, HOCCH); 
13
C NMR (101 MHz, CD3OD) δ 75.2 (OCq), 
68.3 (OCH), 61.7 (OCCH), 60.4 (OCH2), 59.9 (CH2), 53.5 (CH2), 45.1 (CH2), 41.3 
(CH2), 41.0 (CH), 37.5 (CH3), 34.7 (CH3), 31.4 (CH3), 22.8 (CH3), 19.3 (CH2), 18.1 
(CH3); m/z calculated for [C15H26O2 + NH4 – H2O]
+
 256.2271 found [M + NH4 – 
H2O]
+
 256.2265 
 
2,4-Dihydroxy-2,5,5,8a-tetramethyldecahydronaphthalene-1-carbaldehyde 277 
To a stirred mixture of triol 276 (475 mg, 1.85 mmol) in CH2Cl2 (5 mL) was added 
TEMPO (58 mg, 0.37 mmol) and PhI(OAc)2 (715 mg, 2.2 mmol). After stirring for 5 
h, the solution had become clear and NaHCO3 (sat. aq., 1 mL) was added. The 
separated organic layer was then dried over MgSO4 and filtered. The solvent was 
removed in vacuo to give a crude solid which was purified by flash column 
chromatography (SiO2; 30% EtOAc in petrol) to give the title compound as 
colourless crystals (339 mg, 72%).   
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mp 144–147 °C;  max/cm
–1
 3390br (O–H), 2969w, 2923w, 2906w, 2874w, 2846w, 
1698s (C=O), 1459m, 1291m, 1175m, 1040s;  
1
H NMR (400 MHz, CDCl3) δH 10.04 
(1H, d, J = 2.6 Hz, CHO), 4.20 (1H, td, J = 10.8 and 4.1 Hz, OCH), 3.06 (1H, s, 
OH), 2.18 (1H, d, J = 2.6 Hz, CHOCH), 2.09–2.03 (1H, m, CHa1), 1.70–1.56 (2H, m, 
CHa2, CHa3), 1.47–1.22 (8H, m, CHb3, CHb2, CHb1, CH2, CH3), 1.26 (3H, m, CH3), 
1.20 (3H, s, CH3), 1.18 (3H, s, CH3), 1.08−1.04 (4H, s, CH3, CH);  
13
C NMR (101 
MHz, CDCl3) δ 209.5 (C=O), 72.7 (OCq), 68.6 (O=CCH), 67.6 (HCO), 60.1 (CH), 
52.3 (CH2), 43.5 (CH2), 41.8 (Cq), 40.9 (CH2), 37.1 (CH3), 33.9 (Cq), 31.2 (CH3), 
22.3 (CH3), 18.2 (CH3), 18.00 (CH2); m/z calculated [C15H24O3]
+
 253.1798 found [M 
– H]+ 253.1796.  
X-Ray Crystallographic Data 277: 
These data can be obtained free of charge from The Cambridge Crystallographic 
Data Centre via www.ccdc.cam.ac.uk/data_request/cif 
CCDC 1043794 contains the supplementary crystallographic data for this compound.  
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2,5,5,8a-Tetramethyl-2,4-bis((trimethylsilyl)oxy)decahydronaphthalene-1-
carbaldehyde 280 
To a stirred solution of aldehyde 277 (18 mg, 0.071 mmol) in CH2Cl2 (1 mL) cooled 
to –15 °C was added NEt3 (200 µL, 1.4 mmol) and TMSOTf (≈30 µL, 0.17 mmol). 
After stirring for 30 min 1M NaHCO3 (sat. aq., 5 mL) was added. After allowing to 
warm to 23 °C the organic layer was separated, dried over MgSO4 and filtered. The 
solvent was removed in vacuo to give a crude residue which was purified by flash 
column chromatography (SiO2; 5% Et2O in petrol) to give the title compound as a 
pale yellow waxy oil (26 mg, 93%). 
 max/cm
–1
 2954m, 2928m, 2848m, 1715m (C=O), 1288s, 1105s, 1047m; 
1
H NMR 
(400 MHz, CDCl3) δ 9.87 (1H, d, J = 5.3 Hz, CHO), 4.32 (1H, td, J = 10.5 and 4.0 
Hz, TMSOCH), 2.08 (1H, dd, J = 13.6 and 4.0 Hz, CqCHa1), 1.60–1.43 (3H, m, 
CHOCH, CHa2, CqCHb1 ), 1.40–1.31 (6H, m, CHb2, CHa3, CHa4, CH3), 1.23–1.01 
(11H, 3 × CH3, CHb4, CHb3), 0.93 (1H, d, J = 10.5 Hz, CH), 0.18 (9H, s, Si(CH3)3), 
0.16 (9H, s, Si(CH3)3); 
13
C NMR (101 MHz, CDCl3) δ 209.1 (C=O), 75.8 (OCq), 
70.6 (CHOCH), 68.7 (TMSOCH), 60.0 (CH), 53.2 (CH2), 44.1 (CH2), 41.3 (CH2), 
39.6 (Cq), 36.9 (CH3), 33.6 (Cq), 30.6 (CH3), 22.6 (CH3), 18.1 (CH3), 17.9 (CH2), 2.6 
(Si(CH3)3), 1.2 (Si(CH3)3); m/z calculated [C21H40O3Si2]
+
 397.2589 found [M – H]+ 
397.2584.  
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3-Nitro-4-methylacetophenone 281 
4-Methylacetophenone (10.0 g, 0.075 mol) was slowly added over 30 min to a 
stirring mixture of conc. HNO3 (31 mL) and conc. H2SO4 (40 mL) cooled to 0 °C, 
maintaining the internal reaction temp below 10 °C. After continued stirring for 10 
min, the solution was poured onto crushed ice and allowed to warm to 20 °C. The 
precipitate was collected by filtration and washed with copious amounts of water and 
then n-hexane (300 mL). The solid was collected and dried under high vacuum to 
give the title compound as a light yellow amorphous solid (8.1 g, 60 %) which was 
used without further purification. Data are consistent with those previously reported 
in the literature.
95
 
mp 60–62 °C (lit95 60–61 °C); 1H NMR (400 MHz, CDCl3) δ 8.50 (1H, s, ArCH), 
8.07 (1H, d, J = 8.0 Hz, ArCH), 7.46 (1H, d, J = 8.0 Hz, ArCH), 2.65 (3H, s, CH3), 
2.64 (3H, s, CH3); 
13
C NMR (101 MHz, CDCl3) δ 196.0 (C=O), 149.4 (ArCH), 138.8 
(ArCH), 136.1 (ArCH), 133.5 (Arq), 132.1 (Arq), 124.7 (Arq), 26.7 (CH3), 20.7 
(CH3). 
 
 
3-Amino-4-methylacetophenone 282 
Preparation 1: To a stirring solution of 3-nitro-4-methylacetophenone (3.1 g, 17 
mmol) in MeOH (60 mL) was added 5% Pd/C (500 mg) followed by vigorous 
stirring under 1 atm of hydrogen. After 1.5 h the mixture was filtered under vaccum. 
The filtrate was collected and the solvent was removed in vacuo to give the title 
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compound as cream-coloured crystals (2.40 g, 94%) which were used without further 
purification. Data are consistent with those previously reported in the literature.
 95 
mp  78–79 °C (lit95 80–81 °C); 1H NMR (400 MHz, CDCl3) δ 7.28 (1H, d, J = 1.7 
Hz, ArCH), 7.26 (ArCH), 7.10 (1H, d, J = 7.5 Hz, ArCH), 3.75 (2H, s, NH2), 2.53 
(3H, s, CH3), 2.20 (3H, s, CH3); 
13
C NMR (101 MHz, CDCl3) δ 198.3 (C=O), 145.0 
(NCq), 136.4 (OCCq), 130.5 (ArCH), 128.1 (MeCq), 119.1 (ArCH), 114.0 (ArCH), 
26.6 (CH3) , 17.6 (ArCH3).   
Preparation 2 (for ˃3 g): To a stirred suspension of 3-nitro-4-methylacetophenone 
(14.0 g, 78 mmol) in 1.2 M HCl (100 mL) was added SnCl2·2H2O (53 g, 0.23 mol). 
The suspension was heated to 70 °C with continued stirring for 1 h. After cooling to 
0 °C NaHCO3 (sat. aq.) was added until neutralisation (judged as pH 7 by indicator 
paper). The tin by-products were removed by vacuum filtration and then rinsed with 
EtOAc (50 mL) to give a biphasic filtrate. The separated organic layer was dried over 
MgSO4 and filtered. The solvent was removed in vacuo to give the title compound as 
orange crystals (7.2 g, 62%) which were used without further purification. Data are 
consistent those previously reported in the literature.
95
 Data were in accord to those 
reported for preparation 1.  
 
3-Hydroxy-4-methylacetophenone 283 
To a stirred suspension of aniline 282 (15.8 g, 0.11 mol) in ice-cold water (200 mL) 
was slowly added conc. H2SO4 (54 mL). After 30 min the resultant clear solution 
was cooled to 0 °C. To the cooled solution was added NaNO2 (9.0 g, 0.13 mol) in 
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water (30 mL).
*
 After stirring for 10 min the solution was heated to reflux and 
stirring was continued for 5 h. After this time, the mixture was poured onto ice-cold 
water (50 mL) which was then allowed to warm to 23 °C over 17 h. After this time, 
the precipitate was filtered under vacuum. Dissolution of the collected solid in 
EtOAc (40 mL) was followed by washing with water (50 mL), NaHCO3 (sat. aq., 20 
mL), brine (20 mL), drying over MgSO4 and filtering. The solvent was removed in 
vacuo to give the title compound as light brown crystals (16.3 g, 99%). The data are 
consistent with those previously reported in the literature.
95
 
m.p 108–109 °C (lit95 110–111 °C); 1H NMR (400 MHz, CDCl3) δ 7.48 (1H, d, J = 
1.6 Hz, ArCH), 7.45 (1H, dd, J = 7.7 and 1.6 Hz, ArCH),  7.20 (1H, d, J = 7.7 Hz, 
ArCH), 5.61 (1H, s, OH), 2.57 (3H, s, CH3), 2.32 (3H, s, CH3); 
13
C NMR (101 MHz, 
CDCl3) δ 198.4 (C=O), 154.4 (Arq), 136.6 (Arq), 131.2 (ArCH), 130.8 (Arq), 121.5 
(ArCH), 114.1 (ArCH), 26.7 (CH3), 16.25 (CH3). 
 
 
3-(tert-Butyldimethylsiloxy)-4-methylacetophenone 284 
To a stirred solution of 3-hydroxy-4-methylacetophenone 283 (16.3 g, 0.11 mol) in 
CH2Cl2 (100 mL) was added imidazole (22.2 g, 0.33 mol) and TBSCl (24 g, 0.16 
mol). After stirring for 16 h, water (100 mL) was added. The separated organic layer 
was washed with NH4Cl (sat. aq., 100 mL), water (5 × 300 mL), dried over MgSO4 
and filtered. The solvent was removed in vacuo to give the title compound as brown 
oil (18.3 g, 63%), which was used without further purification.  
----------------------------- 
*
 Use a blast shield - potentially explosive diazonium salt! 
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max/cm
–1
 2956w, 2930w, 2858w, 1684s (C=O), 1602w, 1573w, 1500m, 1410m, 
1356s, 1224s, 1193m, 1136w, 1068w; 
1
H NMR (400 MHz, CDCl3) δ 7.45 (1H, dd, J 
= 7.8 and 1.6 Hz, ArCH), 7.36 (1H, d, J = 1.6 Hz, ArCH), 7.20 (1H, d, J = 7.8 Hz, 
ArCH), 2.55 (3H, s, CH3), 2.26 (3H, s, CH3), 1.03 (9H, s, SiC(CH3)3), 0.25 (6H, s, 
Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 197.7 (C=O), 154.3 (Arq), 136.5 (Arq), 
135.4 (Arq), 131.0 (ArCH), 121.7 (ArCH), 117.7 (ArCH), 26.7 (CH3), 25.9 
(SiC(CH3)3), 18.4 (SiC), 17.3 (CH3), –4.06 (Si(CH3)2): m/z calculated for 
[C15H25O2Si]
+
 265.1618 found [M + H]
+
 265.1620.  
 
tert-Butyl(5-(1,1-dibromo-2-((trimethylsilyl)oxy)propan-2-yl)-2-
methylphenoxy)dimethylsilane 290 
A solution of acetophenone 284 (1.0 g, 3.8 mmol) and dibromomethane (1.4 g, 7.9 
mmol) in THF (10 mL) was transferred via cannula into an RBF containing a THF 
(10 mL) solution of freshly prepared lithium diisopropylamide (7.6 mmol) at –78 °C. 
After being stirred for 4 h at the same temperature, NH4Cl aq. (2 mL) and Et2O (20 
mL) were added. The separated organic layer was dried over MgSO4, filtered and the 
solvent was removed in vacuo. Volatiles were removed under high vacuum over 17 
h. The crude residue (1.3 g) was dissolved in CH2Cl2 (20 mL) and imidazole (1.0 g, 
14.9 mmol) and TMSCl (1.5 mL, 11.9 mmol) were added. After stirring for 4 h, 
water (10 mL) was added. The separated organic layer was dried over MgSO4 and 
filtered. The solvent was removed in vacuo to give a crude residue which was 
purified by flash column chromatography (SiO2; petrol → 10% Et2O in petrol) to 
give the title compound as brown thick oil (1.3 g, 66% for two steps)   
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max/cm
–1
 2956w, 2930w, 2897w, 2858w, 1609w, 1576w, 1502m, 1463m, 1251m, 
1184m, 1065m;  
1
H NMR (400 MHz, CDCl3) δ 7.08 (1H, d, J = 8.22 Hz, ArCH), 
6.93–6.90 (2H, m, 2 × ArCH), 5.65 (1H, s, Br2CH), 2.20 (3H, s, CH3), 1.90 (3H, s, 
CH3), 1.03 (9H, s, SiC(CH3)3), 0.23 (3H, s, SiC(CH3)2), 0.22 (3H, s, SiC(CH3)2), 
0.10 (9H, s, Si(CH3)3); 
13
C NMR (101 MHz, CDCl3) δ 153.6 (ArCO), 141.8 (Arq), 
130.5 (ArCH), 128.9 (Arq), 119.24 (ArCH), 117.42 (ArCH), 79.4 (CBr2), 58.6 (C–
OTMS), 26.0 (SiC(CH3)3), 23.7 (CH3), 18.4 (SiC), 16.7 (CH3), 2.2 (Si(CH3)3), –3.89 
(Si(CH3)2), –3.96 (Si(CH3)2); m/z the expected ions could not be observed.  
 
3-(tert-Butyldimethylsiloxy)-4-methylbromostyrene 
To a solution of dibromo 290 (1.3 g, 2.5 mmol) in THF (10 mL) was added n-BuLi 
(1.1 mL, 2.8 mmol) at –78 °C. After stirring for 1 h the reaction was quenched with 
the addition of NH4Cl (sat. aq., 1 mL) followed with the addition of Et2O (15 mL) 
and warming to room temp. The organic layer was separated, dried over MgSO4 and 
filtered. The solvent was removed in vacuo to give a crude mixture of E/Z alkenes 
determined by 
1
H NMR as 1.0:1.3 ratio respectively. The isomers were separated by 
flash column chromatography (SiO2; n-hexane) to give (Z)-alkene 285b (140 mg, 
16%) and (E)-alkene 285a (100 mg, 12%) both as colourless oil. The geometry of 
each alkene was determined by NOESY experiments.  
 
 
(Z)-Alkene 285b: max/cm
–1
 2955w, 2929w, 2858w, 1607w, 1566m, 1500m, 1250s, 
1130m; 
1
H NMR (400 MHz, CDCl3) δ 7.15 (1H, d, J = 7.7 Hz, ArCH), 6.84 (1H, dd, 
J = 7.7 and 1.7 Hz, ArCH), 6.82 (1H, d, J = 1.7 Hz, ArCH), 6.19 (1H, q, J = 1.5 Hz, 
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=CH), 2.24 (3H, s, ArCH3), 2.11 (3H, d, J = 1.5 Hz, CH3), 1.05 (9H ,s, SiC(CH3)3), 
0.27 (6H, s, Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 153.6 (ArCO), 141.3 (=Cq), 
138.7 (Arq), 130.8 (ArCH), 128.6 (Arq), 120.2 (ArCH), 118.2 (ArCH), 101.1 (CBr), 
25.9 (SiC(CH3)3), 25.15 (CH3), 18.4 (SiC), 16.9 (CH3), –4.0 (Si(CH3)2); m/z 
calculated for [C16H26BrSi]
+
 341.0931 found [M + H]
+
 341.0933.  
 
 
 (E)-Alkene 285a: max/cm
–1
 2956w, 2930w, 2887w, 2858w, 1608w, 1562w, 1510w, 
1499w, 1402m, 1252s, 1180w, 1134w, 1001m; 
1
H NMR (400 MHz, CDCl3) δ 7.09 
(1H, d, J = 7.8 Hz, ArCH), 6.85 (1H, dd, J = 7.8 and 1.7 Hz, ArCH), 6.75 (1H, d, J 
= 1.7 Hz, ArCH), 6.40 (1H, q, J = 1.2 Hz, CH), 2.21 (3H, s, ArCH3), 2.20 (3H, d, J 
= 1.2 Hz, CH3), 1.04 (9H, s, SiC(CH3)3), 0.24 (6H, s, Si(CH3)2); 
13
C NMR (101 
MHz, CDCl3) δ 154.0 (ArCO), 141.4 (=Cq), 139.7 (Arq), 131.1 (ArCH), 128.9 (Arq), 
118.8 (ArCH), 116.4 (ArCH), 104.7 (CBr), 25.9 (SiC(CH3)3), 19.8 (CH3), 18.4 (SiC), 
16.7 (CH3), –4.0 (Si(CH3)2); m/z calculated for [C16H26BrSi]
+
 341.0931 found [M + 
H]
+
 341.0929.  
 
Deuterated-alkene 291 
To a stirred solution of (E)-alkene 285a (145 mg, 0.43 mmol) in THF (2 mL) at –78 
°C was added t-BuLi (0.53 mL, 0.84 mmol) dropwise over 2 min. The resultant 
bright-yellow solution was stirred for a further 30 min and then a newly opened 
ampoule of CD3OD (1 mL) was added, immeadiately followed by NH4Cl (1 mL, sat. 
 206 
 
aq.). The solution was allowed to warm to 23 °C and then diluted with Et2O (5 mL). 
The organic layer was separated, dried over MgSO4 and filtered. The solvent was 
then removed in vacuo to give the title compound as pale yellow oil.  
1
H NMR (400 MHz, CDCl3) δ 7.10 (1H, d, J = 7.8 Hz, ArCH), 7.00 (1H, dd, J = 7.8 
and 1.8 Hz, ArCH), 6.91 (1H, d, J = 1.8 Hz, ArCH), 5.30 (1H, s, CH), 2.22 (3H, s, 
ArCH3), 2.13 (3H, d, J = 0.66 Hz, CH3), 1.05 (9H, s, SiC(CH3)3), 0.25 (6H, s, 
Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 153.8 (ArCO), 143.1 (=Cq), 140.1 (Arq), 
130.7 (ArCH), 128.3 (Arq), 118.4 (ArCH), 116.0 (ArCH), 111.3 (t,  J = 24 Hz, 
=CD), 26.0 (SiC(CH3)3), 21.9 (CH3), 18.4 (SiC), 16.7 (CH3), –4.0 (Si(CH3)2); m/z 
calculated for [C16H26DOSi]
+
 264.1888 found [M + H]
+
 264.1892. 
 
(Z)-3-(3-((tert-Butyldimethylsilyl)oxy)-4-methylphenyl)-1-((2,5,5,8a-tetramethyl-
2,4-bis((trimethylsilyl)oxy)decahydronaphthalen-1-yl)but-2-en-1-ol 292 
To a stirred solution of (Z)-bromoalkene 285b (174 mg, 0.51 mmol) in THF (1 mL) 
at –78 °C was added t-BuLi (0.6 mL, 1.0 mmol) dropwise over 2 min. After stirring 
for 25 min a solution of aldehyde 280 (68 mg, 0.17 mmol) in THF (1 mL) was added 
dropwise to the bright-yellow solution. After continued stirring for 30 min the 
solution had become near-colourless and the reaction was quenched by the addition 
of NH4Cl (sat. aq., 0.1 mL), and the mixture was diluted with Et2O (5 mL). After 
warming to 23 °C the separated organic layer was dried over MgSO4 and filtered. 
The solvent was removed in vacuo to give a crude residue which was purified by 
flash column chromatography (SiO2; petrol → 5% Et2O in petrol) to give the title 
compound as pale yellow oil (60 mg, 53%).  
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max/cm
–1
 3518br (O–H), 2955m, 2929m, 2859m, 1503m, 1201s, 1081s; 1H NMR 
(400 MHz, CDCl3) δ 7.06 (1H, d, J = 7.6 Hz, ArCH), 6.66 (1H, dd, J = 7.6 and 1.3 
Hz, ArCH), 6.57 (1H, d, J = 1.3 Hz, ArCH), 5.88 (1H, d, J = 8.3 Hz, =CH), 4.89–
4.85 (1H, m, OHCH), 4.09 (1H, dt, J = 9.5 and 4.4 Hz, TMSOCH), 2.62 (1H, s, 
OH), 2.17 (3H, s, ArCH3), 2.01 (1H, dd, J = 14.0 and 4.4 Hz, CHa1), 1.97 (3H, s, 
=CCH3), 1.89–1.83 (1H, m, CHa2), 1.55–1.26 (6H, m, CH2, CH3, CHa3), 1.22–1.06 
(2H, m, CHb3, CHb2), 1.03 (3H, s, CH3), 1.02 (9H, s, SiC(CH3)3)), 0.99–0.95 (4H, m, 
CH3, HOCCH), 0.92 (1H, d, J = 9.5 Hz, TMSOCCH), 0.89 (3H, s, CH3), 0.22 (3H, s, 
Si(CH3)), 0.20 (3H, s, Si(CH3)), 0.130 (9H, s, Si(CH3)3), 0.126 (9H, s, Si(CH3)3); 
13
C 
NMR (101 MHz, CDCl3) δ 154.0 (ArCO), 140.9 (=Cq), 136.1 (Arq), 131.7 (=CH), 
130.9 (ArCH), 127.3 (Arq), 120.6 (ArCH), 117.9 (ArCH), 79.7 (OCq), 70.7 (HOCH), 
68.8 (TMSOCH), 62.3 (HOCCH), 61.3 (TMSOCCH), 52.6 (CH2), 43.8 (CH2), 42.9 
(CH2), 41.3 (Cq), 36.7 (CH3), 33.6 (Cq), 32.0 (CH3), 26.3 (CH3), 26.0 (SiC(CH3)3), 
22.9 (CH3), 18.9 (SiC), 18.4 (CH2), 16.7 (CH3), 2.8 (Si(CH3)3), 1.28 (Si(CH3)3), –
3.85 (Si(CH3)), –3.94 (Si(CH3)); m/z calculated for [C37H68O4Si3]
+
 660.4365 found 
[M]
+
 660.4420. 
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(E)-Ansellane diene 300 
Ansellane alcohol 292 (approximately 60 mg) was left standing for several days in a 
fumehood at 23 °C, to give a mixture of degradation products. Purification of the 
mixture by flash column chromatography (SiO2; petrol) gave the title compound as 
pale yellow oil (approximately 10 mg).   
max/cm
–1 
2931m, 1860m, 1885m, 1836m, 1774m, 1411m, 1250m; 
1
H NMR (400 
MHz, CDCl3) δ 7.07 (1H, d, J = 7.7 Hz, ArCH), 6.83 (1H, dd, J = 7.7 and 1.6 Hz, 
ArCH), 6.73 (1H, d, J = 1.6 Hz, ArCH), 6.14 (1H, d, J = 15.8 Hz, HC=CHCq), 5.76 
(1H, dd, J = 15.8 and 10.0 Hz, HC=CHCq), 5.14 (1H, d, J = 1.9 Hz, Cq=CH), 5.04 
(1H, d, J = 1.9 Hz, Cq=CH), 4.21 (1H, td, J = 10.6 and 4.0 Hz, TMSOCH), 2.20 (3H, 
s, ArCH3),  2.07–2.01 (1H, m, CHa1), 1.56–1.16 (7H, m, 2 × CH2, CHb1, CHa2, 
CqCH), 1.13 (3H, s, CH3), 1.11 (3H, s, CH3), 1.01 (10H, brs, SiC(CH3)3, CqCH), 0.99 
(6H, brs, 2 × CH3), 0.20 (6H, s, Si(CH3)2), 0.16 (9H, s, Si(CH3)3), 0.00 (9H, s, 
Si(CH3)3); 
13
C NMR (101 MHz, CDCl3) δ 153.7 (ArCO), 148.2 (Arq), 139.6 (=Cq), 
134.9 (C=CHCq), 132.8 (HC=CHCq), 130.5 (ArCH), 128.1 (Arq), 120.9 (ArCH), 
118.4 (ArCH), 113.4 (=CH2), 76.4 (OCq), 69.0 (TMSOC), 64.5 (CH), 60.7 (CH), 
53.8 (CH2), 44.6 (CH2), 41.9 (CH2), 40.0 (Cq), 36.9 (CH3), 33.8 (Cq), 30.9 (CH3), 
25.9 (Si(CH3)3), 22.5 (CH3), 18.4 (SiC), 18.3 (CH2), 17.2 (CH3), 16.8 (CH3), 2.6 
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(Si(CH3)3), 1.2 (Si(CH3)3), –3.99 (Si(CH3)), –4.01 (Si(CH3)); m/z calculated for 
[C37H66O3Si3]
+
 642.4320 found [M]
+
 642.4316. 
 
 
1-2,5,5,8a-Tetramethyl-2,4-bis((trimethylsilyl)oxy)decahydronaphthalen-1-
yl)ethanone 306 
To a stirred solution on aldehyde 280 (102 mg, 0.26 mmol) in THF (3 mL) was 
added MeLi (0.3 mL, 0.51 mmol) at –78 °C. After continued stirring for 1.5 h NH4Cl 
(sat. aq., 0.2 mL) was added. Upon warming to 23 °C the mixture was diluted with 
Et2O (5 mL) and the organic layer was separated, dried over MgSO4 and filtered. The 
solvent was removed in vacuo to give alcohol 308 as pale yellow oil and a mixture 
two diastereomers (99 mg, 58%) which was used without further purification. To a 
stirred solution of DMSO (0.03 mL, 0.42 mmol) in CH2Cl2 (2 mL) was added 
(COCl)2 (0.019 mL, 0.23 mmol). After stirring for 15 min a solution of alcohol 308 
(50 mg, 0.076 mmol) in CH2Cl2 (1 mL) was added slowly. After a further 15 min 
NEt3 (0.13 mL, 0.91 mmol) was added and the solution was allowed to warm to 
room temp over 1 h. After this time water (2 mL) was added and the organic layer 
was separated, dried over MgSO4 and filtered. The solvent was removed in vacuo to 
give crude residue which was purified by flash column chromatography (SiO2; petrol 
→ Et2O) to give the title compound as pale yellow oil (18 mg, 58%).  
1
H NMR (400 MHz, CDCl3) δ 4.24 (1H, dt, J= 10.6 and 4.1 Hz, TMSOCH), 2.19 
(3H, s, O=CCH3), 2.14 (1H, s, O=CCH), 2.00 (1H, dd, J = 13.2 and 4.0 Hz, CHa1), 
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1.63–0.97 (20H, m, CHb1, 4 × CH3, 3 × CH2, CqCH), 0.17 (9H, s, Si(CH3)3), 0.15 
(9H, s, Si(CH3)3); 
13
C NMR (101 MHz, CDCl3) δC 211.0 (C=O), 74.9 (OCq), 72.9 
(O=CCH), 69.0 (TMSOCH), 61.0 (CqCH), 53.9 (CH2), 44.2 (CH2), 41.3 (CH2), 39.9 
(Cq), 37.0 (O=C–CH3), 33.6 (Cq), 30.4 (CH3), 22.3 (CH), 18.0 (CH2), 16.8 (CH3), 
14.2 (CH3), 2.7 ((Si(CH3)3), 1.2 ((Si(CH3)3); m/z calculated for [C22H45O3Si2]
+
 
413.2902 found [M + H]
+
 413.2894. 
 
1,2,5,5,8a-Tetramethyl-2,4-bis((trimethylsilyl)oxy)decahydronaphthalen-1-
yl)prop-2-en-1-ol 312 
To a stirred solution of aldehyde 280 (11 mg, 0.04 mmol) in DME (1 mL) was added 
vinyl magnesium bromide (1M, 0.09 mL, 0.09 mmol) at –40 °C. After continued 
stirring for 1 h, the reaction was quenched with NH4Cl (sat. aq., 0.2 mL) and, after 
warming to room temp, was diluted with Et2O (4 mL). The organic layer was 
separated and dried over MgSO4 and filtered. The solvent was removed in vacuo to 
give a crude oil. Analysis of the crude oil by 
1
H NMR indicated an 8:2 mixture of 
diastereomer products from which only the major diastereomer (5 mg, 44%) was 
isolated by flash column chromatography (SiO2; 5% Et2O in petrol). The 
stereochemistry of the newly formed carbinol chiral centre was not determined.  
max/cm
–1
 3518br (O–H), 2954m, 2926m, 2871m, 1721w, 1250s, 1082s, 1030m; 1H 
NMR (400 MHz, CDCl3) δ 6.10 (1H, ddd, J = 17.3, 10.7 and 4.2 Hz, HOCCH=C), 
5.19 (1H, apt dt, J = 17.3 and 2.0 Hz, C=CHtrans ), 4.99 (1H, apt dt, J = 10.7, 2.0 Hz, 
=CHcis), 4.90–4.87 (1H, m, HCOH), 4.15 (1H, td, J =  9.5 and 4.4 Hz, TMSOCH), 
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3.02 (1H, s, OH), 2.18 (1H, dd, J = 14.1 and 4.4 Hz, CHa1), 2.03-1.98 (1H, m, CHa2), 
1.63 (1H, dd, J= 14.1 and 9.4 Hz, CHb1), 1.54-1.42 (4H, m, CH3, CHa3), 1.37-1.25 
(6H, m, CHb3, CH3, CHa4), 1.18-0.93 (10H, m, CHb2, CHb4, 2 × CH, 2 × CH3), 0.21 
(9H, s, Si(CH3)3), 0.17 (9H, s, Si(CH3)3);  
13
C NMR (101 MHz, CDCl3) δ 143.7 
(=CH), 111.0 (=CH2), 79.6 (OCq), 73.1 (HOCH), 68.7 (TMSOCH), 62.9 (CH), 61.5 
(CH), 52.3 (CH2), 43.7 (CH2), 42.9 (CH2), 41.7 (Cq), 36.7 (CH3), 33.6 (CH3), 32.7 
(CH3), 22.9 (Cq), 18.9 (CH3), 18.3 (CH2), 2.9 (Si(CH3)3), 1.3 (Si(CH3)3); m/z the 
expected ions were not observed. 
 
1-2,5,5,8a-Tetramethyl-2,4-bis((trimethylsilyl)oxy)decahydronaphthalen-1-
yl)prop-2-en-1-one 310 
To a stirred solution of alcohol 312 (5 mg, 0.018 mmol) in CH2Cl2 (1 mL) was added 
MnO2 (31 mg, 0.35 mmol). After stirring for 48 h, the mixture was diluted with Et2O 
(6 mL) and filtered through a plug of SiO2. The solvent was removed in vacuo to 
give a crude residue which was purified by flash column chromatography (SiO2; 5% 
Et2O in petrol) to give the title compound as colourless oil (<1 mg).
*
  
1
H NMR (600 MHz, cryoprobe, CDCl3) δ 6.63 (1H, dd, J = 17.2 and 10.7 Hz, =CH), 
6.12 (1H, dd, J = 17.2 and 1.4 Hz, =CH), 5.57 (1H,  dd, J = 10.7 and 1.4 Hz, =CH), 
4.26 (1H, td, J = 10.6 and 4.0 Hz, OCH), 2.02 (1H, dd, J = 13.2 and 4.1 Hz, CHa1), 
1.55 (CHa2), 1.48 (1H, dd, J = 13.2 and 10.7 Hz, CHb1), 1.33–1.17 (11H, m, 2 × CH3, 
CqCH, CHb2, CH2, CHa3), 1.09 (3H, s, CH3), 1.08–1.01 (2H, m, CHb3, O=CCH), 1.00 
----------------------------- 
* Full characterisation was not attempted due to small quantity obtained.  
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(3H, s, CH3), 0.17 (9H, s, Si(CH3)3), 0.15 (9H, s, Si(CH3)3); 
13
C NMR (101 MHz, 
cryoprobe, CDCl3) δ 202.3 (C=O), 126.1 (2 × =C)
*
, 75.2 (OCq), 69.0 (OCH), 61.0 
(O=CCH), 54.0 (CH2), 44.2 (CH2), 41.3 (CH2), 40.3 (Cq), 37.0 (CH3), 33.6 (Cq), 30.4 
(CH3), 29.9 (CH), 22.4 (CH3), 18.0 (CH2), 17.1 (CH3), 2.7 (Si(CH3)3), 1.2 
(Si(CH3)3).   
 
 
 
3-(tert-Butyldimethylsiloxy)-4-methylmethystyrene 311 
To a stirred solution of methyltriphenylphosphonium bromide (1.35 g, 3.78 mmol) in 
PhMe (10 mL) was added KO
t
Bu (318 mg, 2.84 mmol). After 30 min acetophenone 
284 (500 mg, 1.89 mmol) in PhMe (5 mL) was added to the resultantly yellow 
solution. After a further 30 min NH4Cl (sat. aq., 2 mL) was added. The crude mixture 
was directly placed onto a column (SiO2; petrol) to give the title compound as pale 
yellow oil (231 mg, 47%).  
max/cm
–1
 2957w, 2931w, 2859w, 1508w, 1253m; 
1
H NMR (400 MHz, CDCl3) δ 
7.00 (1H, d, J = 7.8 Hz, ArCH), 6.91 (1H, dd, J = 7.8 and 1.8 Hz, ArCH), 6.83 (1H, 
d, J = 1.8 Hz, ArCH), 5.23 (1H, m , =CH), 4.96–4.94 (1H, m, =CH), 2.14 (3H, s, 
ArCH3), 2.05 (3H, dd, J = 1.4, 0.8 Hz, CH3), 0.97 (9H, s, SiC(CH3)3), 0.17 (6H, s, 
Si(CH3)2); 
13
C NMR (101 MHz, CDCl3) δ 153.8 (ArCO), 143.2 (Arq), 140.2 (=Cq), 
130.8 (ArCH), 128.3 (Arq), 118.4 (ArCH), 116.0 (ArCH), 111.6 (=CH2), 26.0 
((SiC(CH3)2),), 22.0 (CH3), 18.4 (SiC), 16.7 (CH3), −4.0 (Si(CH3)2); m/z calculated 
for [C16H27O1Si]
+
 263.1826 found [M + H]
+
 263.1827. 
----------------------------- 
† Co-resonant carbon signals confirmed by HSQC analysis.  
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